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In the peripheral nervous system (PNS), Schwann cells ensheathe and myelinate 
axons to promote saltatory conduction of nerve impulses. Close interactions between 
Schwann cells and axons, and Schwann cells and the basal lamina are essential for 
the regulation of Schwann cell development and function. Myelinating Schwann 
cells are highly polarized radially and longitudinally for specifying distinct domains 
in the axon, which is required for fast action potential propagation. In addition, the 
Schwann cell cytoplasm is organized into discrete compartments, called Cajal bands, 
which contain different dystrophin-glycoprotein complexes that are believed to 
segregate the Schwann cell plasma membrane into appositions between the outer 
surface of the myelin sheath and the cytoplasmic face of the Schwann cell plasma 
membrane.  
Periaxin is expressed in myelinating Schwann cells, and homodimerizes at its 
PDZ domain to form a transmembrane complex with dystrophin-related protein 2 
(DRP2) and dystroglycan. This PDG complex is concentrated at the appositions, and 
is essential for myelin sheath maintenance and stability in the mature PNS. In mice 
lacking Periaxin, an intact myelin sheath is formed but subsequently becomes 
unstable. Periaxin-null Schwann cells are also shorter, which has been proposed to 
result in a reduction in nerve conduction velocity. 
This thesis is a study of how Periaxin PDZ domain dimerization contributes 
to the regulation of PDG complex stability, apposition maintenance, Schwann cell 
internodal distance and myelin stability. I have studied the function of Periaxin by 
generating a conditional mutant mouse that lacks the PDZ domain, which is 
predicted to abrogate dimerization. In these mutants, DRP2 is severely depleted and 
appositions containing DRP2 fail to form. Mutant Schwann cells also have disrupted 
Cajal bands and shorter internodal lengths. In the mature peripheral nerves, mutant 
mice display a peripheral neuropathy characterized by hypermyelination with focally 
folded
 
myelin. Nerve conduction velocity, motor coordination and sensory function 
were also studied in these mutant mice. Taken together, these data suggest that 
dimerization of the Periaxin PDZ domain is required for the stabilization of the PDG 
and appositions, and regulation of Schwann cell elongation and myelin maintenance.  
 xiii 
By analyzing a tamoxifen-inducible conditional mouse lacking Periaxin’s 
PDZ domain in mature myelinating Schwann cells, this work also shows that 
Periaxin dimerization is essential for maintaining Schwann cell 
compartmentalization and myelin stability in adult nerves.  
Finally, studies of single amino acid mutations of the Periaxin PDZ reveal 
that subtle changes in the structure of the PDZ domain can abrogate dimerization, 





A fundamentally important step in the evolution of the vertebrate nervous system 
was the acquisition of the myelin sheath, which has allowed the development of a 
complex system for rapid impulse propagation resulting in, among other things, more 
rapid and sustained responses in a predator-and-prey environment (Hartline and 
Colman, 2007; Nave, 2010). Myelin-forming glial cells ensheathe and form a 
multilamellar structure with a high lipid-to-protein ratio (70-80% lipids and 20-30% 
proteins) around axons in order to facilitate rapid saltatory conduction of action 
potentials (Garbay et al., 2000). Myelination involves close interactions between the 
neuron and the myelin-forming glia (Sherman and Brophy, 2005). In the vertebrate 
peripheral nervous system (PNS), Schwann cells, named after the German 
physiologist Theodor Schwann, are the major glial cells that are responsible for 
forming and maintaining the myelin sheath around axons (Schwann, 1839). Their 
counterparts in the central nervous system (CNS) are oligodendrocytes, first 
described as mesoglia by William Ford Robertson (Robertson, 1899). Though they 
perform a similar function in the nervous system, the origins of these two 
myelinating cell types differ. Schwann cells are generated from the neural crest 
(Jessen and Mirsky, 2005), and most oligodendrocytes are derived in the 
subventricular germinal zone in the forebrain, and in the ventral ventricular zone in 
the spinal cord in the CNS (Richardson et al., 2006).   
The close association between neurons and glia has offered mutual benefits 
for both cell types. In the PNS, Schwann cells depend on axonal signals such as 
Neuregulin-1 (NRG1) throughout development for survival, migration, proliferation, 
differentiation and myelination (Jessen and Mirsky, 2005). Neurons benefit from 
myelination of their axons by glia for fast propagation of action potentials. The non-
conductive lipid-rich myelin sheath coats and thus provides insulation for the most 
part of the axonal surface, increasing electrical resistance and decreasing capacitance 
between the inside and outside of a nerve fiber. This prevents internodal current 
leakage and restricts ion currents to gaps not covered by myelin that occupies less 
than 0.5% of the axonal surface, namely the nodes of Ranvier (Hartline and Colman, 
2007). This arrangement allows action potential regeneration exclusively at the 
nodes followed by rapid electrotonic conduction along the internode. Consequently, 
 3 
energy consumption from restoring the ion gradients between the interior and 
exterior surfaces of the nerve fiber is highly reduced (Nave, 2010). The speed of 
action potential conduction, therefore, is increased up to 100-fold. Moreover, 
myelinating glia continue to support axons by ensuring the long-term integrity and 
survival of axons throughout life, although the mechanisms underlying this trophic 
support are still not clear (Nave, 2010). 
 In addition to the close communication with axons, all Schwann cells in the 
endoneurium are surrounded by a basal lamina, which is composed of extracellular 
matrix molecules that regulate crucial aspects of Schwann cell development 
including proliferation, formation and function of myelin, and formation of Remak 
bundles (Feltri and Wrabetz, 2005; Yu et al., 2009b). In the following three main 
parts, I will review the development of a myelinating Schwann cell, how its 
interactions with the axon and the basal lamina impact its function, with special 




1.1 SCHWANN CELL LINEAGE DEVELOPMENT 
During vertebrate development, the neural crest comprises a population of cells 
originating from the dorsal-most surface of the neural tube. Following neurulation, 
the crest cells segregate from the dorsal regions of the neural folds, extensively 
migrate within the developing embryo and differentiate into diverse cell types, 
including neurons and glia of the sensory, autonomic and enteric nervous systems, 
smooth muscle cells, melanocytes in the skin, and cells of the cranio-facial skeleton 
(Le Douarin and Dupin, 2003). In the PNS, generation of myelinating and non-
myelinating Schwann cells from migrating neural crest cells involves three main 
transitional stages. First, neural crest cells are specified to form Schwann cell 
precursors (SCPs), which are present at around embryonic day (E) 14-15 in rat 
nerves (E12-13 in mouse). They give rise to immature Schwann cells, which occupy 
nerves from E17-18 in the rat (E15-16 in mouse). At birth, immature Schwann cells 
transform into either myelinating or non-myelinating Schwann cells, depending on 
the axons they randomly associate with (Fig. 1) (Jessen and Mirsky, 2005). Schwann 
cells in the dorsal and ventral spinal roots are believed to be derived from a distinct 
population of neural crest derivatives, namely the boundary cap cells that are in small 





Figure 1. The Schwann cell lineage. 
A. The successive stages in the relationship between Schwann cells and axons 
during development. (i-ii) Schwann cells extend cytoplasmic processes into 
the nerves dividing axons into bundles. (iii) Schwann cells segregate large 
diameter axons (Z), (v) form a 1:1 relationship with the axon, and (vii) later 
myelinate it. (iv) Schwann cells that ensheathe small diameter axons progress 
to become mature non-myelinating Schwann cells, (vi) forming Remak 
bundles. This is the first demonstration of radial axonal sorting and two 
mature Schwann cell populations in the rat (Peters and Muir, 1959). 
B. The diagram depicts the development of mature Schwann cells from neural 
crest cells. Lineage progression of Schwann cells involves two intermediate 
stages, Schwann cell precursors and immature Schwann cells. Dashed arrows 
represent the reversibility of the final, mainly postnatal transition that 
generates mature myelinating and non-myelinating Schwann cells (Jessen and 
Mirsky, 2005). 
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1.1.1 THE MOLECULAR PROFILE OF THE SCHWANN CELL LINEAGE 
IN DEVELOPMENT  
Each transitional stage of the Schwann cell lineage is characterized by a distinct set 
of molecular markers. A number of molecules including the NRG1 receptor 
ErbB2/3, the transcription factor Sox10, p75 neurotrophin receptor (p75
NTR
) and L1 
cell adhesion molecule, are universally expressed at all developmental stages of the 
Schwann cell. Transition from neural crest cells to SCPs can be identified by the 
appearance of stage specific markers such as brain fatty acid-binding protein 
(BFABP), desert hedgehog (DHH), growth-associated protein-43 (GAP43), myelin 
protein zero (P0), cadherin19 and connexin 29 (Mirsky et al., 2008). With the 
exception of cadherin19, which is specific to SCPs (Takahashi and Osumi, 2005), 
these markers also persist in the progeny of SCPs, i.e. immature Schwann cells. In 
addition, the transcription factor AP2 and N-cadherin are strongly downregulated in 
the transition to immature Schwann cells. Immature Schwann cells display some of 
the same molecular markers as SCPs, and can be distinguished from SCPs by the 
expression of glial fibrillary acidic protein (GFAP), S100, the transcription factor 
Oct-6 and lipid antigen O4 (Mirsky et al., 2008). 
During myelination at birth, maturation of immature Schwann cells into 
myelinating Schwann cells is accompanied by an upregulation of myelin-associated 
markers including Krox-20, P0, myelin basic protein (MBP), Periaxin and myelin-
associated glycoprotein (MAG), peripheral myelin protein 22 (PMP22), connexin32 
and galactocerebroside (GalC). Expression of immature Schwann cell molecules, 
which still persist in mature non-myelin forming Schwann cells, such as NCAM, L1, 
GAP-43 and p75
NTR
, are downregulated in myelinating Schwann cells. Non-
myelinating Schwann cells are distinct from immature Schwann cells in that they 




Figure 2. The phenotypic profile of each of the developmental stages of the 
Schwann cell lineage. 
The boxes above the lineage drawing during embryonic development (from neural 
crest cells to immature Schwann cells), and those on the right of the drawing of the 
mature phenotypes show the molecular profile of each step. Yellow boxes show 
molecules expressed by all three embryonic cell types, while the other boxes show 
stage-restricted markers. Mature myelinating Schwann cells express myelin-specific 
proteins. AP2α, activator protein 2α; BFABP, brain fatty acid–binding protein; DHH, 
desert hedgehog; ErbB3, neuregulin receptor; GAP43, growth-associated protein 43; 
L1, L1 cell adhesion molecule; Ncad, N-cadherin; Oct6, octamer-binding 
transcription factor 6; O4, lipid antigen; PLP, proteolipid protein; PMP22, peripheral 
myelin protein 22 kDa; P0, protein zero; p75
NTR
, p75 neurotrophin receptor; Sox10, 
SRY (sex-determining region Y) box 10. Figure adapted and modified from (Jessen 
and Mirsky, 2005; Mirsky et al., 2008). 
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1.1.2 ORIGIN OF SCHWANN CELLS: NEURAL CREST CELLS 
The extracellular signals that instruct neural crest cells to adopt a glial cell fate are 
currently not well defined. The commitment of neural crest cells to the Schwann cell 
lineage has been proposed to be enabled by a default pathway when neurogenesis or 
other cell fates are suppressed (Jessen and Mirsky, 2005). A key transcription factor 
Sox10 that regulates glial cell differentiation is expressed in all developmental stages 
of Schwann cells, including neural crest cells (Kuhlbrodt et al., 1998). Initial 
generation of neurons in dorsal root ganglia in mice mutant for Sox10 is normal, but 
SCPs and satellite cells are not present (Britsch et al., 2001). Later in development, 
the absence of SCPs leads to severe death of sensory and motor neurons. However, 
the observation that Sox10 is not confined to the glial lineage but is expressed by all 
neural crest cells and other lineages such as melanocytes renders it unlikely that 
Sox10 alone is sufficient to activate glial cell acquisition (Britsch et al., 2001). 
Sox10 may function through maintaining the ability of neural crest cells to 
respond to the axonal signal NRG1, which is required for different stages of 
Schwann cell development, since expression of the NRG1 receptor ErbB3 in neural 
crest cells is downregulated when Sox10 is inactivated (Britsch et al., 2001). In 
neural crest cell cultures, NRG1 promotes the glial cell fate by inhibition of 
neurogenesis (Shah et al., 1994). However, mice deficient for NRG1 or NRG1 
receptors, ErbB2 or ErbB3, show a dramatic loss of SCPs along peripheral nerves, 
but satellite glia form normally in the DRGs (Garratt et al., 2000a; Riethmacher et 
al., 1997), suggesting that NRG1 is not essential for determination of glial 
differentiation from neural crest cells.  
Similar to NRG1 activity, Notch promotes glial specification of neural crest 
cells (Kubu et al., 2002; Morrison et al., 2000). Constitutive activation of the Notch 
pathway in chick embryos has been demonstrated to suppress neuronal 
differentiation and enhance gliogenesis by neural crest cells. In the same study, 
addition of the Notch ligand Delta to neural crest cell cultures, irreversibly inhibited 
neurogenesis, and instructed and accelerated glial differentiation (Morrison et al., 
2000). Interestingly, conditional deletion of RBPJ, an effector of the canonical Notch 
signaling from neural crest cells suppresses gliogenesis in the peripheral ganglia of 
the developing PNS, but glial differentiation in the peripheral nerve remains normal 
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(Taylor et al., 2007). This suggests that Notch may be required for gliogenesis in the 
ganglia by neural crest cells, but perhaps not for glial fate acquisition in general in 
the PNS. 
1.1.3 SCHWANN CELL PRECURSORS 
1.1.3.1 Survival of Schwann cell precursors 
Around E12-13 in mouse, Schwann cell precursors (SCPs) are in close contact with 
axons. Unlike neural crest cells, which need to maintain contact with the 
extracellular matrix for NRG1-dependent survival, survival of SCPs is ECM-
independent (Woodhoo et al., 2004), but relies on axonal-derived signals. Transition 
from neural crest cells also increases the responsiveness of SCPs to survival factors, 
such as fibroblast growth factor (FGF2) and insulin-like growth factor (IGF1) 
(Jessen and Mirsky, 2005).  
SCPs are the intermediates in the generation of Schwann cells from neural 
crest cells, thus constituting the source of Schwann cells in peripheral nerves (Jessen 
and Mirsky, 2005). They provide essential trophic support for survival of sensory 
and motor neurons in developing nerves and are important for nerve fasciculation 
(Morris et al., 1999; Woldeyesus et al., 1999). Inactivation of ErbB2 in mice, with a 
genetic rescue of cardiac development, results in the absence of SCPs in peripheral 
nerves due to their dependence on NRG1 for survival. Sensory and motor neurons 
are initially generated. However, loss of SCPs leads to defects in fasciculation of 
nerves and aberrant axonal projections to final target tissues, and eventually to 
neuronal cell death by E18 (Morris et al., 1999; Woldeyesus et al., 1999). Similarly, 
initial formation of sensory and motor neurons in the DRG is normal in mice mutant 
for ErbB3 or Sox10. However, the absence of SCPs and Schwann cells leads to 
neuronal degeneration at later stages (Britsch et al., 2001; Riethmacher et al., 1997).  
Selective ablation of membrane-bound NRG1 type III isoform, the major 
NRG1 in sensory and motor neurons, in mice results in a depletion of SCPs that 
populate spinal nerves by E14 (Wolpowitz et al., 2000). Isoform specific Nrg1 
mutations in mice show that the presence of Type III isoform is sufficient to drive 
early development of Schwann cells (Meyer et al., 1997). Recently, it has been 
shown that stage-dependent release of soluble Type I/II isoforms mediated by 
BDNF/TrkB signaling plays a critical role in SCP differentiation and survival in 
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chick (Ma et al., 2011), although mice lacking Type I and II isoforms display normal 
peripheral glia development (Meyer et al., 1997; Wolpowitz et al., 2000). 
1.3.1.2 Transition of SCPs to Schwann cells 
Differentiation of SCPs into immature Schwann cells is also dependent upon close 
axo-glial relationships. Several axonal signals and growth factors have been shown 
to promote the conversion of SCPs into Schwann cells. In culture, FGF-2 supports 
the generation of Schwann cells from SCPs (Jessen et al., 1994), and accelerates the 
Schwann cell maturation mediated by NRG1 (Dong et al., 1999).  
NRG1 signaling is important for the transition of SCPs into Schwann cells. 
Isolated E14 SCPs from rat, when cultured in the presence of NRG1 for 2-4 days 
show characteristics of Schwann cells removed from nerves at the equivalent ages in 
vivo, i.e. E16-18, including the development of autocrine survival mechanisms, S100 
expression and mitogenic response to FGF-2. The phenotypic change in vivo can be 
reproduced on schedule in a NRG1-mediated manner in vitro (Dong et al., 1995; 
Dong et al., 1999).  
Recently, Notch signaling has also been demonstrated to drive the 
differentiation of SCPs to Schwann cells. SCPs express Notch receptors on their cell 
surface. Inactivation of Notch signaling in SCPs results in a delay in the generation 
of immature Schwann cells. On the contrary, constitutive overexpression of the 
active Notch intracellular domain (NICD) accelerates the transition of SCPs to 
Schwann cells (Woodhoo et al., 2009).  
Negative regulation of SCP differentiation involves endothelin signaling. In 
vitro, endothelin promotes the survival of SCPs but retards their progression into 
Schwann cells. Endothelin also opposes the effects of NRG1 on SCP maturation 
(Brennan et al., 2000). Transcription factor AP2 expressed in SCPs also negatively 
regulates their transition to Schwann cells. In vitro, the rate of SCP-Schwann cell 
transition is slowed down by enforced expression of AP2 in SCPs (Stewart et al., 
2001). In summary, SCP progression is controlled by positive and negative 
regulators that direct the timing of Schwann cell generation. 
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1.1.4 IMMATURE SCHWANN CELLS 
By E17-18 in rat nerves (E15-16 in mouse), immature Schwann cells ensheathe 
groups of axons in clusters forming irregular Schwann cell-axon bundles. These 
Schwann cell-axon units, alongside blood vessels, endoneurial fibroblasts and 
extracellular matrix are enclosed by the developing perineurium. Apart from the 
distinct molecular profile, immature Schwann cells differ from SCPs in that they 
have a basal lamina and develop autocrine survival mechanisms, which are absent in 
SCPs. When removed from axonal contacts, unlike SCPs, immature Schwann cells 
do not undergo cell death, but are able to survive by secreting a combination of 
survival growth factors, such as FGF plus IGF, and neurotrophin 3 (NT3) (Woodhoo 
and Sommer, 2008). The autocrine survival circuits ensure axon-independent 
survival of Schwann cells, which may provide trophic support for axons in injured 
postnatal nerves (Jessen and Mirsky, 2005).  
1.1.4.1 Radial axonal sorting 
Immature Schwann cells continuously associate with axons in peripheral nerves 
during embryonic stages. The postnatal fate of immature Schwann cells depends on 
the axons they associate with, and may become either myelinating or non-
myelinating Schwann cells. Schwann cells associating with larger caliber axons 
(Nave and Salzer, 2006), typically with a diameter of at least 1 µm, will segregate 
them to the periphery of an axon bundle and then into a 1:1 relationship, and 
subsequently myelinate them. Non-myelinating Schwann cells remain associated 
with multiple small diameter axons that are unmyelinated in Remak bundles (Jessen 
and Mirsky, 2005). The establishment of the characteristic 1:1 ratio between 
myelinating Schwann cells and large diameter axons is referred to as radial sorting, 
which involves several distinct but concerted steps: Schwann cell proliferation, 
bipolar shape formation and process extension (Martin and Webster, 1973). 
Extensive Schwann cell proliferation ensures a precise match of Schwann cell 
number with axon number for individual axon ensheathment by the end of radial 
sorting. The change to spindle-shaped morphology of Schwann cells followed by 
process extension is necessary for interdigitation and ensheathment of axons. The 
process of radial axonal sorting involves the following steps (Berti et al., 2011):  
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(1) Schwann cell families are formed and surrounded by a common basal lamina,  
(2) Schwann cells extend and insert processes within axons,  
(3) Schwann cells recognize and segregate large axons at the periphery,  
(4) Schwann cells extensively proliferate to match axons and SC number,  
(5) Axons are defasciculated with formation of an independent basal lamina. 
 
A growing spectrum of signals that regulate radial sorting, and more 
specifically proliferation and/or process extension associated with sorting has been 
identified. These include focal adhesion kinase (FAK), laminins (laminin-2, laminin-
8 and laminin-1), laminin receptors, β1-integrin and dystroglycan, the Rho GTPases 
Rac1 and cdc42 and leucine-rich, glioma-inactivated 4 (LGI4). (Benninger et al., 
2007; Bermingham et al., 2006; Berti et al., 2011; Grove et al., 2007; Nodari et al., 
2007; Yang et al., 2005; Yu et al., 2005; Yu et al., 2009b). Schwann cell-specific 
deletion of these molecules in mouse mutants profoundly impairs radial axonal 
sorting, which will be discussed in detail in the following subsections. 
1.1.4.1a- Process extension and stabilization in radial sorting 
Prior to myelination at birth, immature Schwann cells insert cytoplasmic processes 
into axon bundles, progressively defasciculating them into smaller bundles, and 
establish a 1:1 relationship with single large caliber axons (Jessen and Mirsky, 2005). 
The deposition of basal lamina, or at least the major basal lamina component 
laminin, is required for axonal sorting by Schwann cells (Bunge et al., 1986; Podratz 
et al., 2001). Schwann cells lacking laminin-1 lose all laminin expression and 
display severe sorting defects. The impairment of radial sorting in laminin-1 
mutants is contributed by a dramatic decrease in proliferation, increased postnatal 
apoptosis, and reduced ErbB2 phosphorylation (Yu et al., 2005), as well as defective 
process extension (Yu et al., 2009b). It is widely accepted that laminin signals 
through 61 integrin on Schwann cells for proper radial sorting of axons (Bradley 
and Jenkison, 1973; Chen and Strickland, 2003; Feltri et al., 2002; Previtali et al., 
2003b; Yang et al., 2005; Yu et al., 2005). Genetic deletion of 1-integrin in 
Schwann cells impairs process extension in the interdigitation and sorting of axons 
(Feltri et al., 2002) (see section 1.2).  
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Laminin signaling, originating from the basal lamina on the outside of the 
Schwann cell surface, controls axon sorting that dynamically rearranges the inner 
Schwann cell membrane through the activation of the Rho family GTPase Rac1 in 
Schwann cells. This has been demonstrated by the inactivation of the downstream 
effector of 1-integrin, Rho GTPase Rac1 in Schwann cells, which impairs extension 
of radial lamellae of cytoplasm without affecting proliferation during radial sorting 
(Benninger et al., 2007; Nodari et al., 2007). In addition, integrin linked kinase 
(ILK), an important regulator of integrin and growth factor–mediated signaling, is 
also required for extension and stabilization of Schwann cell processes by negatively 
regulating Rho/Rho kinase signaling (Pereira et al., 2009). Interestingly, ErbB 
signaling, in addition to promoting Schwann cell proliferation, also plays a direct 
role in process extension in the sorting process in zebrafish (Raphael et al., 2011). 
1.1.4.1b- Schwann cell proliferation during radial sorting 
Preceding myelination, establishment of the 1:1 relationship between Schwann cells 
and axons is associated with extensive Schwann cell proliferation (Martin and 
Webster, 1973; Stewart et al., 1993). Interaction with axons stimulates Schwann cell 
proliferation. NRG1 is a major mitogenic factor, as has been shown in Schwann cell-
DRG co-cultures in vitro (Morrissey et al., 1995). Transforming growth factor- 
(TGF-) also induces Schwann cell proliferation both in vitro and in vivo. Specific 
ablation of type II TGF- receptor in Schwann cells compromises Schwann cell 
proliferation (D'Antonio et al., 2006). In addition, Notch drives Schwann cell 
proliferation. Conditional deletion of Notch signaling components in immature 
Schwann cells reduces Schwann cell proliferation. In contrast, enforced expression 
of active Notch intracellular domain upregulates cell cycle markers and induces a 
mitogenic effect on Schwann cells (Woodhoo et al., 2009).  
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1.1.5-6 SCHWANN CELL MYELINATION 
Following radial sorting, a Schwann cell in a 1:1 association with an axon, is 
described as the promyelinating Schwann cell, which will exit the cell cycle and 
initiate myelination. The progressive changes in the morphology and molecular 
profiles of promyelinating Schwann cells at the onset of myelination are governed by 
multiple signaling pathways activated by Schwann cell-axon and Schwann cell-basal 
lamina interactions. These pathways converge onto the nucleus to regulate the 
transcriptional programs directing myelination. Myelination is controlled by a 
balance between positive and negative transcriptional programs (Svaren and Meijer, 
2008). In the next sections, recent understanding of the regulation of myelination by 
Schwann cell-axon communication (section 1.1.5) and the transcriptional control of 
myelination (section 1.1.6) will be reviewed. Schwann cell-basal lamina interactions 
will be reviewed in section 1.2. 
1.1.5 Regulation of Schwann cell function by axonal signals  
As described already, throughout development, Schwann cells are in close 
association with axons and communication between neuron and glia is necessary for 
regulating different steps of Schwann cell development and myelination. 
1.1.5.1 Neuregulin-1/ErbB signaling 
Neuregulins (NRGs) are a family of structurally related proteins that share an 
extracellular epidermal growth factor (EGF)-like signaling domain for activation of 
their receptors, ErbB receptor tyrosine kinases (Birchmeier and Nave, 2008). These 
proteins act as survival, growth and differentiation factors in various tissues. Four 
distinct neuregulin genes (Nrg1-4) are present in mammals, with Nrg1 being the 
best-characterized member of the family in mice (Nave and Salzer, 2006).  
NRG1 generates six types of protein (I–VI) and comprises at least 31 
isoforms due to multiple transcription start sites and alternative mRNA splicing of 
the nrg1 gene (Mei and Xiong, 2008). The NRG1 isoforms are classified into 
different subtypes based on their distinct N-terminal domains. NRG1 type I (initially 
identified as neu differentiation factor, heregulin or acetylcholine receptor-inducing 
activity (ARIA)) and type II, also known as glial growth factor (GGF) are generated 
as single pass transmembrane proteins and harbor N-terminal immunoglobulin-like 
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domains. Type I differs from Type II in that Type I has a glycosylation domain, 
whereas Type II contains a kringle-like domain. NRG1 type III (sensory and motor 
neuron-derived factor) has a unique cysteine-rich domain (CRD), which acts as the 
second transmembrane domain (Fig. 3). Other isoforms include NRG1 Type IV-VI, 
which contain shorter amino termini, but they have not been well-studied (Nave and 
Salzer, 2006).  
NRG1 isoforms transduce cellular signals by binding to transmembrane 
receptor tyrosine kinases, ErbB proteins, which are members of the EGF receptor 
superfamily. In the PNS, the ErbB2/ErbB3 heterodimer is the major NRG1 receptor 
expressed by Schwann cells (Morrissey et al., 1995; Nave and Salzer, 2006).  
1.1.5.1a- Proteolytic processing of NRG1 
Most NRG1 isoforms are anchored in the membrane. Proteolytic cleavage of these 
membrane-bound NRG1 isoforms at the juxtamembrane region C-terminal to the 
EGF-like domain is required for the binding of the secreted NRG1 fragment to ErbB 
receptors. NRG1 Types I-III that share stalk, transmembrane and C-terminal 
sequences undergo proteolytic cleavage by proteases at the stalk region (Fig. 3). 
Upon proteolytic processing, soluble forms of NRG1 (Type I and II) are shed from 
the axonal surface and able to diffuse or adhere with heparan sulfate-rich cell 
surfaces in the extracellular matrix via the N-terminal heparan-binding domains. 
NRG1 Type III, however, remains bound to the axonal membrane after cleavage 
through the N-terminal cysteine rich domain (Birchmeier and Nave, 2008; Mei and 
Xiong, 2008).  
The proteases involved in proteolytic processing of NRG1 subtypes have 
been partly characterized, which include membrane-anchored metalloproteases 
known as ‘a disintegrin and metalloprotease’ ADAM proteins, and type I 






Figure 3. Schematic representation of the six types of neuregulin-1 (NRG1) 
isoforms (Mei and Xiong, 2008). 
A. NRG1 isoforms are classified according to their distinct N-terminal 
sequences. An EGF-like domain is present in all isoforms. Types I, II, IV and 
V have an Ig-like domain between the N-terminal sequence and the EGF 
domain, whereas the N-terminal region of Types III and VI is directly 
connected to the EGF domain. A signal peptide and a kringle-like domain are 
present in Type II isoform. In Type III isoform, the specific N-terminal 
sequence contains a unique cysteine-rich domain (CRD) that has a 
transmembrane domain (TMn).  
B. Proteolytic cleavage generates mature NRG1s as paracrine signals that are 
soluble, with the exception of Type III NRG1, which remains tethered 
through its CRD and functions in a manner that requires cell contact. The 
processing of Type IV, Type V and Type VI pro-NRG1s is less well 
characterized.  
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The ADAMs family 
Metalloproteases ADAM10, ADAM17 (also known as TACE) and ADAM19 
(meltrin-) function as -secretases for NRG1 processing (Blobel, 2005; La Marca et 
al., 2011; Luo et al., 2011; Shirakabe et al., 2001). Mouse mutants deficient for these 
ADAM proteins have been studied. Despite active participation in NRG1 cleavage, 
altered expression of ADAM10 in mice does not influence myelination (Freese et al., 
2009). Consistently, myelination is unaffected by inhibition or knockdown of 
ADAM10 expression in vitro (Jangouk et al., 2009; Luo et al., 2011). Mice deficient 
for ADAM19 also myelinate normally, but exhibit a delay in remyelination due to 
delayed activation of myelin-inducing transcription factor Krox20 and myelin-related 
proteins (Wakatsuki et al., 2009). Interestingly, conditional deletion of neuronal 
TACE (ADAM17) in mice results in hypermyelination and aberrant myelination of 
Remak fibers (La Marca et al., 2011). TACE regulates myelination by controlling the 
amount of active membrane-bound NRG1 type III, and is a negative regulator of 
peripheral myelination. 
Another important member of the ADAM family implicated in myelination is 
ADAM22, which is expressed on the axon surface. Neuronal ADAM22 acts as a 
receptor and binds leucine-rich glioma-inactivated 4, Lgi4 expressed and secreted by 
Schwann cells in developing nerves to promote Schwann cell differentiation 
(Ozkaynak et al., 2010). Mutation of Lgi4 in claw paw mice leads to retention of 
Lgi4 mutant protein within Schwann cells, which contributes to delayed axonal 
sorting and the hypomyelinating phenotype of claw paw mice (Bermingham et al., 
2006). Similarly, mice lacking ADAM22 also display hypomyelinated nerves 
(Sagane et al., 2005). However, since ADAM22 does not have a catalytic-site 
consensus sequence, and thus lacks metalloprotease activity, it is not likely to 
participate in NRG1 Type III processing (Yang et al., 2006). Recently, Ozkaynak et 
al. showed that NRG1 expressed on axonal membranes of ADAM22-deficient 
neurons normally activate downstream PI3K and ERK signaling pathways in 
Schwann cells in vitro, suggesting that ADAM22-Lgi4 is not required for NRG1 




BACE1 is a type I transmembrane aspartyl protease, known for processing amyloid 
precursor protein for the generation of amyloid- peptide in Alzheimer’s disease and 
its expression is preferentially enriched in neurons. Mice lacking BACE1 accumulate 
unprocessed NRG1 in the brain. These animals display hypomyelination of 
peripheral nerves and abnormal axonal segregation of sensory axons (Hu et al., 2008; 
Willem et al., 2006), reminiscent of defects in mice haploinsufficent for NRG1 Type 
III or lacking Schwann cell-specific ErbB2 receptor (Michailov et al., 2004; 
Woldeyesus et al., 1999). Moreover, in vitro inhibition of BACE1 activity reduces or 
delays myelination in Schwann cell-DRG co-cultures (Luo et al., 2011). 
Nevertheless, BACE1 processing is not required for NRG1 Type III-stimulated 
myelination since overexpression of neuronal full-length NRG1 type III in BACE1-
null mutants causes hypermyelination, suggesting that NRG1 type III can function 
normally even in the absence of BACE1 (Velanac et al., 2011). 
Recently, the cleavage sites of NRG1 Type I and III by ADAM10 and 
BACE1 have been identified. ADAM10 processes NRG1 at a distinct but adjacent 
site to that of BACE1. Cleavage of NRG1 by BACE1 and ADAMs mediate 
differential effects on myelination (Luo et al., 2011). 
1.1.5.1b- Regulation of Schwann cell myelination by NRG1 signaling 
NRG1 levels determine whether axons are ensheathed or myelinated 
Studies on the function of NRG1 on the ensheathment fate of axons by Taveggia et 
al. suggest that the amount of NRG1 type III on the axon surface, rather than axon 
size, instructs whether the axon is to be myelinated. Small caliber axons such as 
sympathetic neurons of the superior cervical ganglia (SCG) are not myelinated due to 
low expression levels of NRG1. Conversely, large caliber axons such as BDNF- and 
NT3-dependent neurons from the DRG, express high levels of NRG1 and are heavily 
myelinated (Taveggia et al., 2005). Mouse DRG neurons lacking NRG1 Type III co-
cultured with Schwann cells are poorly ensheathed, incompletely sorted, and fail to 
be myelinated. Myelin proteins, P0 and MBP or myelin-related transcription factors, 
such as Oct-6 are not expressed in the co-cultures. In addition, mice haploinsufficient 
for NRG1 Type III have a higher proportion of unmyelinated fibers. Forced 
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expression of NRG1 Type III in normally unmyelinated SCG neurons promotes 
myelination of these small caliber axons. These findings suggest that whether 
Schwann cells myelinate is dependent upon the threshold levels of NRG1 Type III 
on the axon surface (Fig. 4) (Taveggia et al., 2005). 
NRG1 regulates myelin sheath thickness   
The optimal myelin sheath thickness determined by the g-ratio (the ratio of axon 
diameter to fiber diameter of a myelinated axon) is approximately 0.68 in peripheral 
axons in most vertebrates. In general, the thickness of myelin changes according to 
the diameter of the axon: larger axons have thicker myelin sheath and vice versa 
(Nave and Salzer, 2006). Achieving optimal myelin thickness is essential for rapid 
action potential propagation. The correct number of myelin wraps produced by 
Schwann cells is quantitatively controlled by the amount of membrane-bound NRG1 
Type III on the axon surface. Axons from NRG1 Type III heterozygous mouse 
mutants, which contain about half of the normal levels of NRG1, are hypomyelinated 
and conduct considerably more slowly than normal mice (Michailov et al., 2004; 
Taveggia et al., 2005).  
Similarly, mice mutant for Schwann cell-specific ErbB2 or ErbB3, and mice 
that express a dominant-negative ErbB receptor in Schwann cells suffer from 
hypomyelination (Chen et al., 2006; Garratt et al., 2000b). However, NRG1 appears 
to be the limiting factor in determining myelin thickness. The amounts of ErbB 
receptors on Schwann cells appear saturated since mice heterozygous for the ErbB2 
receptor make normal myelin (Michailov et al., 2004). On the contrary, transgenic 
overexpression of NRG1 Type III, but not Type I, in postnatal motor neurons and 
DRG neurons in mice results in hypermyelination with a striking increase in the 
number of myelin wraps in axons, suggesting that NRG1 Type III is a critical 
regulator of myelin thickness (Fig. 4) (Michailov et al., 2004).  
The NRG1-ErbB receptor system may regulate myelin thickness by 
stimulating Schwann cell cholesterol biosynthesis. In vitro, cholesterol depletion 
activates ErbB receptors, which may function as a sensing mechanism for plasma 
membrane cholesterol levels. Expression of recombinant NRG1 in cultured Schwann 
cells enhances the transcription of the 3-hydroxy-3-methylglutarylcoenzyme A 
reductase, the rate-limiting enzyme for cholesterol biosynthesis (Pertusa et al., 2007). 
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Addition of exogenous cholesterol into Schwann cell-DRG cocultures accelerates 
myelination. Moreover, mice lacking cholesterol biosynthesis in Schwann cells show 
severe hypomyelination in peripheral nerves (Saher et al., 2009).  
The extent of myelin production may also be determined by other signaling 
mechanisms, for example BDNF and receptor P75
NTR
. Axon size and myelin 
thickness in transgenic mice overexpressing BDNF are both increased but the level 
of enhanced myelination exceeds the overall increase in axon caliber, resulting in a 
reduction in the g-ratio of myelinated fibers (Tolwani et al., 2004). 
NRG1 signaling in myelin sheath maintenance   
Although NRG1 is crucial in many stages of Schwann cell development and 
myelination, it appears that NRG1/ErbB signaling is dispensable for myelin sheath 
maintenance. This is supported by in vivo analysis of mice deficient of Nrg1/ErbB 
signaling in adult myelinating glia. When the ErbB2 receptor gene is ablated in adult 
myelinating Schwann cells, the myelin sheath remains normal (Atanasoski et al., 
2006). Similarly, tamoxifen-inducible conditional inactivation of NRG1 in the adult 
nerve also does not alter the myelin sheath (Fricker et al., 2011). However, NRG1 
signaling may be important for remyelination in injury. NRG1 deletion in the adult 
nerves results in hypomyelination or lack of remyelination of axons after sciatic 




Figure 4. Regulation of Schwann cell development and myelination by axonal 
NRG1. 
A. Schwann cells (in blue) are derived from neural crest precursor cells (in green) 
and interact with both large and small diameter axons of spinal motor and 
sensory neurons. NRG1 on the axon regulates Schwann cell development by 
interacting with ErbB2/3 receptors on the Schwann cell and activating 
downstream signaling cascades. The amount of NRG1 type III on the axon 
detected by Schwann cells, which is a function of axon size and NRG1 levels, 
then instructs them either into segregating single axons and myelination (top), or 
into a non-myelinating phenotype and formation of a Remak bundle (bottom). 
NRG1 type III signals axon size to myelinating Schwann cells to regulate the 
thickness of the myelin sheath. 
B. In NRG1-null mice, in heterozygous NRG1 (+/−) mice, and in transgenic NRG1 
overexpressing mice, instead of varying according to axon size, the amount of 
myelin made by Schwann cells changes directly as a function of axonal NRG1 




1.1.5.1c- NRG1/ErbB signal transduction in Schwann cells 
NRG1/ErbB signaling promotes survival, proliferation and differentiation of 
Schwann cell precursors, as well as their migration along the axon. At later 
developmental stages, NRG1/ErbB2/3 signaling also regulates myelination 
(Newbern and Birchmeier, 2010) One important question is how can the same 
receptor heterodimer and ligand (NRG1 via ErbB2/3) regulate specific cellular 
processes at distinct stages of Schwann cell development in a temporal and spatial 
manner. 
Following NRG1 binding, heteromeric ErbB2/3 receptors mediate their 
effects on Schwann cell development through activation of multiple downstream 
signaling cascades, including Phosphatidylinositol-3-Kinase (PI3K)/AKT, 
Ras/Extracellular Signal Regulated Kinase 1/2 (ERK 1/2), FAK and Rac1/cdc42, and 
the regulation of calcium-dependent Protein Kinase C (PKC) for calcineurin/NFAT 
activation (Newbern and Birchmeier, 2010).  
The PI3K/ AKT signaling pathway 
Binding of NRG1 Type III to ErbB receptors activates the PI3K/AKT signaling 
pathway (Taveggia et al., 2005) that is indispensable for cellular responses including 
survival, proliferation and differentiation. Inhibition of PI3K/AKT signaling 
components pharmacologically in Schwann cells prevents NRG1-evoked Schwann 
cell survival and proliferation, and subsequently myelination induced by axonal 
NRG1 (GGF) and neurites (Maurel and Salzer, 2000). Selective activation of the 
PI3K pathway in vitro enhances Schwann cell differentiation and promotes myelin 
sheath formation (Ogata et al., 2004). Surprisingly, constitutive activation of AKT in 
Schwann cells in vivo does not alter peripheral myelination (Flores et al., 2008).  
Enforced PI3K signaling in Schwann cells by conditional ablation of the 
negative regulator, PTEN (phosphatase and tensin homolog deleted on chromosome 
10) results in increased myelin thickness for small caliber axons and focal 
hypermyelination in the form of myelin foldings and tomacula (Goebbels et al., 
2010). Interaction of mammalian disc-large Dlg1 and PTEN has been suggested to 
act as a myelination brake to prevent peripheral nerve overmyelination via the 
PI3K/AKT signaling pathway (Cotter et al., 2010). 
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The calcineurin-NFAT signaling pathway 
Another way in which NRG1/ErbB2/3 signaling is likely to regulate myelination 
independently of PI3K is by increasing Ca
2+
 levels in Schwann cells, which activates 
calcineurin/NFAT signaling. Specific deletion of calcineurin B1 subunit in the neural 
crest leads to severe defects in myelination but does not affect Schwann cell 
development (Kao et al., 2009). Exposure of NRG1 to Schwann cell precursors in 
vitro increases cytoplasmic Ca
2+
 for activation of phosphatase calcineurin, which 
dephosphorylates and activates the transcription factors NFATc3 and c4, promoting 
their nuclear translocation. Kao et al. showed that NFAT complexes with the 
transcription factor Sox10 in the nucleus to activate Krox-20, which globally 
regulates genes essential for myelination. 
The Ras/ERK1/2 signaling pathway 
Previous studies have shown that activation of the ERK1/2 pathway in Schwann cells 
in vitro suppresses Schwann cell differentiation by opposing PI3K/AKT activity 
(Maurel and Salzer, 2000; Ogata et al., 2004). Some evidence also shows that high 
doses of exogenously added soluble NRG1 Type II or III to Schwann cells 
suppresses myelination mediated via MEK/ERK activation (Syed et al., 2010), 
rendering ERK1/2 signaling as a negative regulator of Schwann cell myelination 
(Harrisingh et al., 2004; Maurel and Salzer, 2000; Ogata et al., 2004). However, 
recent genetic evidence based on conditional inactivation of ERK1/2 in the neural 
crest has revealed important functions of ERK1/2 in Schwann cell development and 
myelination. Specific ablation of ERK1/2 in the neural crest results in peripheral 
nerves lacking SCPs and subsequently axon defasciculation, loss of peripheral 
projections and sensory neuron death. SCP-specific inactivation of ERK1/2 inhibits 
differentiation and myelination, leading to hypomyelination (Newbern et al., 2011). 
Moreover, absence of ERK1/2 in glial progenitors blocks NRG1-induced survival in 
vitro. These data highlight the importance of ERK1/2 in transducing NRG1/ErbB 
signals.  
A key activator and regulator of NRG1/ErbB-mediated signaling of 
Ras/ERK1/2 pathway is protein tyrosine phosphatase Shp2 (Grossmann et al., 2009). 
A Schwann cell-specific Shp2 mutation inhibits sustained ERK1/2 activation, but not 
PI3K/AKT activity. Conditional deletion of Shp2 in neural crest cells and in 
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myelinating Schwann cells results in severe perturbations in Schwann cell 
development, including peripheral nerves devoid of SCPs and marked 
hypomyelination of axons, respectively. The deficits in myelination are similar to the 
phenotypic changes seen in NRG1 or ErbB2/3 mutant mice (Grossmann et al., 2009). 
Therefore, the ERK1/2 pathway acts downstream of NRG1 signaling and can 
positively regulate myelination. 
The FAK signaling  
Focal adhesion kinase (FAK) acts downstream of NRG1/ErbB signaling. It has been 
shown that FAK is rapidly induced to bind to the Schwann cell ErbB2/ErbB3 
complex upon NRG1 stimulation in vitro (Vartanian et al., 2000). In cultured Shp2-
mutant Schwann cells, activity of FAK and Src, which phosphorylates FAK, is 
dramatically reduced in response to NRG1. Similar to decreased FAK activity seen 
in Schwann cell-specific ErbB2 mutants, activated FAK is also reduced in mice with 
a specific Shp2 mutation in myelinating Schwann cells (Grossmann et al., 2009). 
Specific ablation of FAK in Schwann cells severely impairs myelination, which is 
essentially caused by decreased proliferation, but not reduced process extension 
associated with radial sorting (Grove et al., 2007). 
1.1.5.2 Notch signaling 
The recent discovery of several neuronal signals has provided insights on other 
signaling cascades that may modulate the outcome of NRG1/ErbB signaling in 
Schwann cells. Other mechanisms involved in cooperatively regulating Schwann cell 
development and myelination with NRG1 signaling include Notch, Gpr126 and 
laminin/integrin (reviewed in section 1.2) signaling cascades (Fig. 5).  
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Figure 5. Diagram showing the main signaling pathways that regulate Schwann 
cell myelination. 
The figure shows a promyelinating Schwann cell. The pathways illustrated are not 
comprehensive, but focus on signaling that converges on the nucleus. Dashed lines 
indicate signals with uncertain targets. Major signaling pathways regulating PNS 





The Notch signaling is known for mediating cell-cell signaling between 
neighboring cells. Single-pass transmembrane Notch receptors interact with ligands 
that belong to the Delta and Jagged gene families. Upon ligand binding, cleavage of 
Notch releases from the plasma membrane the active intracellular domain of Notch 
(NICD), which translocates to the nucleus and complexes with other proteins to 
promote transcription of target genes. In addition, active NICD may also act through 
cytoplasmic Deltex but pathways are yet to be identified (D'Souza et al., 2008). In 
the PNS, Notch has been shown to suppress the neuronal lineage and hence promote 
glial differentiation from neural crest cells but its role in gliogenesis is still unclear 
(Kubu et al., 2002; Morrison et al., 2000).  
Recently, Woodhoo et. al showed that Notch signaling regulates multiple 
stages of Schwann cell progression during development (Woodhoo et al., 2009). In 
the study, the authors demonstrated that Notch promotes SCP differentiation to 
immature Schwann cells via canonical signaling by maintaining elevated levels of 
ErbB2 receptors in SCPs. As a consequence, NRG1 signaling is enhanced, which 
promotes SCP survival and likely stimulates differentiation. In addition, Notch also 
accelerates Schwann cell formation and proliferation. In contrast to the stimulating 
effects of myelination by NRG1 signaling in perinatal nerves, Notch inhibits 
myelination by opposing the positive myelination regulator Krox-20 through non-
canonical pathways independent of RBPJ effects. In adult injured nerves, it also 
induces demyelination and dedifferentiation of myelinating Schwann cells 
(Woodhoo et al., 2009). 
1.1.5.3 Gpr126-cAMP signaling 
Myelination is initiated by Schwann cell-axon contact. NRG1 and cyclic adenosine 
monophosphate (cAMP) are both essential myelin-related signals. Elevation of 
cAMP in Schwann cells drives myelin sheath formation (Morgan et al., 1991). In 
vitro, cAMP can mimic the effects of axonal contact in regulating the expression of 
transcription factors such as Oct-6 and Krox-20 necessary for induction of 
myelination (Monuki et al., 1989; Scherer et al., 1994). Monk et al. have recently 
identified a major role of an orphan G-protein coupled receptor Gpr126 in regulating 
cAMP levels required for initiation of myelination in zebrafish. In the absence of 
Gpr126 in zebrafish, axons are sorted normally but Schwann cell development is 
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arrested at the promyelinating state. Interestingly, this Schwann cell surface receptor 
induces the elevation of cAMP levels at the onset of myelination, and hence activates 
Oct-6 and Krox-20 expression. Treatment with forskolin that raises cAMP levels 
restores myelin protein MBP expression and myelination in Gpr126 fish mutants. 
Gpr126 expression and function does not depend on NRG1/ErbB signaling since 
NRG1 Type III and ErbB3 expression in Gpr126 mutants is not altered (Monk et al., 
2009).  
Mice lacking Gpr126 display severe hypomyelination and reduced expression 
of myelin markers. In addition to the myelin phenotype, Gpr126-null nerves also 
show delayed radial axonal sorting by Schwann cells and absence of Remak bundles. 
Failure of Gpr126
-/-
 Schwann cells in providing trophic support to associated axons 
leads to a reduction in axon number in postnatal sciatic nerves. Moreover, absence of 
Gpr126 causes abnormal organization of the perineurium and ectopic fibroblast 
formation in the endoneurium (Monk et al., 2011). 
Interestingly, NRG1 signaling synergizes with the cAMP pathway to drive 
myelination in cultured mouse Schwann cells (Arthur-Farraj et al., 2011). Elevated 
cAMP levels and the presence of NRG1 are required to synergistically trigger the 
expression of myelin-associated markers Krox-20 and P0. Neither cAMP nor NRG1 
alone is sufficient to induce myelin protein expression in mouse Schwann cells. 
NRG1 promotes cAMP-dependent myelin differentiation. cAMP levels determine 
the outcome of NRG1 signaling, whether it is to induce proliferation or 







1.1.6 TRANSCRIPTIONAL CONTROL OF MYELINATION  
1.1.6.1 Positive transcriptional regulators of myelination 
A number of cell-intrinsic factors in Schwann cells that drive myelination have been 
identified, which include transcription factors Tst-1/SCIP/Oct-6 and Brn2, Krox-
20/Egr2, Sox10, NFB, YY1 and NFAT (He et al., 2010; Jessen and Mirsky, 2008; 
Kao et al., 2009; Svaren and Meijer, 2008).  
1.1.6.1a- Oct-6 
The POU homeo-domain transcription factors Tst-1/SCIP/Oct-6 and, to a lesser 
extent, Brn2 are important regulators for the transition of Schwann cells from the 
promyelinating stage to the myelinating stage (Bermingham et al., 1996; Jaegle et al., 
2003; Jaegle et al., 1996). In the absence of Tst-1/SCIP/Oct-6, Schwann cell 
differentiation is transiently retarded at the promyelinating stage. By P8, more than 
80% of wild-type Schwann cells have started elaborating a myelin sheath around 
axons. However it takes nearly 4 weeks for the same number of Schwann cells 
lacking Oct-6 to enter the myelinating phase, although once this stage is achieved, 
myelination appears to proceed as normal (Jaegle et al., 1996). The levels of P0 and 
MBP mRNAs in mice deficient of Oct-6 remain normal (Bermingham et al., 1996), 
indicating that Oct-6 is not required to regulate these genes. Mice lacking both Brn2 
and Oct-6 exhibit a more severe hypomyelinating phenotype. In these mice, 
promyelinating Schwann cells are still detected in adult nerves up to 4 months old. 
These data suggest that Oct-6 and Brn2 are essential for the correct timing of 
myelination (Jaegle et al., 2003).  
In vitro, Oct-6 is strongly induced by the elevation of cAMP in Schwann 
cells, via the activation of protein kinase A (PKA). PKA phosphorylates immediate 
downstream targets including cAMP response element binding protein, Crebp and 
nuclear factor-kappaB, NFB (Svaren and Meijer, 2008). 
1.1.6.1b- Sox10 
SRY-related HMG box (SOX) family member Sox10, expressed in multiple 
consecutive stages of the Schwann cell lineage, plays a key role in Schwann cell fate 
specification and is crucial throughout the myelination process. Mutations in the 
transcription factor Sox10 cause Waardenburg syndrome, Hirschsprung disease and 
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peripheral neuropathies in humans (Inoue et al., 2004). This is partly due to the 
essential role of Sox10 in neural crest cells for survival and cell lineage specification. 
Recently, the role of Sox10 in immature Schwann cells and in adult nerves has been 
deciphered. Immature Schwann cells lacking Sox10 fail to transform into non-
myelinating and myelinating cells, and results in thinned and unsorted peripheral 
nerve axon bundles (Finzsch et al., 2010). Furthermore, the persistent expression of 
Sox10 in adult nerves is important for myelin sheath maintenance. Tamoxifen-
inducible conditional ablation of Sox10 in adult Schwann cells results in 
demyelination, axon degeneration and neuroinflammation (Bremer et al., 2011).  
Early embryonic expression of the Mpz/P0 gene requires binding of Sox10 to 
multiple response elements in its promoter (Peirano et al., 2000). Subsequent 
induction of P0 expression in myelinating cells also depends on Sox10 binding 
(Schreiner et al., 2007). Sox10 is required for activating Oct-6 expression in 
immature Schwann cells. Dimeric binding of Sox10 to the Oct-6 Schwann cell 
enhancer element drives Oct-6 expression in Schwann cells (Jagalur et al., 2011). As 
a result of Oct-6 activation, Sox10 and Oct-6 synergistically activate the expression 
of an immediate target, zinc finger transcription factor Krox-20/Egr2 (Svaren and 
Meijer, 2008).  
1.1.6.1c- Krox-20 
Krox-20, activated by both Sox10 and Oct-6, is required for normal development of 
myelinating Schwann cells. Unlike the transient arrest of Schwann cells at the 
promyelinating stage in Oct-6-deficient mutants, Schwann cell-specific inactivation 
of Krox-20 causes a differentiation block arresting Schwann cells permanently at a 
promyelinating phase. Krox-20-null Schwann cells normally form a 1:1 relationship 
with axons, but wrap only one and a half turns of myelin around the axon. Krox20-
null Schwann cells also fail to express mature myelin proteins such as P0 and MBP, 
although they express the early myelin marker, myelin-associated glycoprotein 
(MAG) (Topilko et al., 1994). The temporal profiles of the expression of Oct-6 and 
Krox-20 are different. Expression of Oct-6, induced by axonal contact, peaks in 
promyelinating Schwann cells around birth when myelination is initiated, and is 
downregulated as myelination progresses in the sciatic nerve; whereas Krox-20 
expression is evident approximately 24-36 hours after Oct-6 appearance, parallels 
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other myelin-related genes and persists in mature myelinating Schwann cells 
(Blanchard et al., 1996; Jaegle and Meijer, 1998; Monuki et al., 1989; Zorick et al., 
1996b). Krox-20 may repress Oct-6 expression since Oct-6 expression is sustained in 
Krox20-null mice (Zorick et al., 1999). 
Sustained expression of Krox-20 in adult nerves is required for maintaining 
the peripheral myelin sheath. Demyelination and Schwann cell dedifferentiation 
results when Krox-20 is removed from adult Schwann cells (Decker et al., 2006). In 
humans, mutations in the Krox-20/Egr2 gene lead to various human hereditary 
peripheral neuropathies including Charcot Marie Tooth disease and Dejerine-Sottas 
Syndrome (Suter and Scherer, 2003). 
An upstream regulator of Krox-20 expression in response to NRG1 signaling 
is the zinc finger protein Yin Yang 1 (YY1). Schwann cell-specific YY1-null mice 
display severe hypomyelination. Schwann cells lacking YY1 express reduced levels 
of Krox-20 and myelin markers, and fail to activate Krox-20 upon exposure to NRG1 
in vitro. YY1 activation upregulates Krox-20 expression, which initiates expression 
of myelin-related genes (He et al., 2010). 
Analyses of myelin gene expression regulated by Krox-20 in primary 
Schwann cells and in mice with a hypomorphic Krox-20/Egr2 allele (Egr2Lo) have 
identified myelin genes including Mpz/P0, Pmp22, Periaxin (Prx), Connexin 32 and 
Mag (Le et al., 2005; Nagarajan et al., 2001). Importantly, convergent regulation by 
both Sox10 and Krox-20 is essential for activation of the myelination program in 
Schwann cells. The promoters of these myelin-related genes contain binding sites for 
both Krox-20 and Sox10, and myelin gene expression depends on activation by both 
Krox-20 and Sox10 (Svaren and Meijer, 2008). Regulatory elements in regions other 
than the promoter that control myelin gene expression have also been described. For 
example, Krox-20 and Sox10 act synergistically to activate a conserved composite 
module within the first intron of the Mpz/P0 gene comprising binding sites for both 
Sox10 and Krox-20 to regulate Mpz/P0 expression. This conserved element has also 
been identified in other major myelin genes (Jones et al., 2007; LeBlanc et al., 2006; 
LeBlanc et al., 2007). 
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1.1.6.1d- Nuclear factor B (NFB) 
Transcription factor nuclear factor B (NFB), which functions as a downstream 
mediator of cAMP signaling, is crucial for activation of Oct-6 and myelination. 
Specifically, phosphorylation of the p65 subunit of NFB by cAMP-dependent PKA 
activates NFB during myelin formation. Inhibition of PKA-mediated NFB 
transcriptional activation attenuates Schwann cell differentiation and myelin 
formation in response to elevated cAMP or in DRG cocultures (Yoon et al., 2008). 
The same group also identified that axonal NRG1 Type III, signalled through its 
cognate receptor ErbB2/3, regulates NFB transcriptional activation during 
myelination in addition to cAMP. Furthermore, co-stimulation by both NRG1 Type 
III and cAMP considerably augments NFB activation in Schwann cells (Limpert 
and Carter, 2010).  
1.1.6.2 Negative transcriptional regulators of myelination 
Myelinating Schwann cells display remarkable plasticity throughout life. In injured 
nerves or in demyelinating neuropathies, Schwann cells dedifferentiate into the 
immature-like phenotype and proliferate. Myelin protein expression is 
downregulated and expression of non-myelin markers is induced. Various signaling 
pathways that inhibit myelin differentiation must be suppressed to allow myelination. 
These pathways are activated in injury conditions. Among these negative regulatory 
pathways are transcription factors that act to oppose myelin formation (Jessen and 
Mirsky, 2008).  
1.1.6.2a- c-jun 
c-Jun is a basic leucine zipper transcription factor and a key component of the AP-1 
transcription factor complex. c-Jun is constitutively expressed in cultured Schwann 
cells from perinatal nerves and promotes proliferation prior to the onset of 
myelination (Monuki et al., 1989; Parkinson et al., 2004). Its expression is 
suppressed by Krox-20 at the start of myelination. In hypomyelinating Krox-20-
deficient mice, c-Jun expression is sustained (Parkinson et al., 2004). Persistent 
expression of c-Jun has been shown to abolish Krox-20 expression in response to 
cAMP elevation, and to inhibit Krox-20-mediated induction of myelin proteins P0 
and Periaxin expression in cultured Schwann cells. Conversely, conditional 
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inactivation of c-Jun in Schwann cells promotes myelin gene expression (Parkinson 
et al., 2008).  
After injury c-Jun is potently induced and antagonizes Krox-20 expression in 
Schwann cells to promote conversion of a myelinating to promyelinating phenotype 
(Parkinson et al., 2008). Since Krox-20 downregulation in adult nerves results in 
myelin degradation (Decker et al., 2006), c-Jun may promote dedifferentiation and 
trigger myelin sheath breakdown by suppressing Krox-20 activity. In the absence of 
c-Jun, Schwann cell dedifferentiation and myelin breakdown is considerably delayed 
after nerve transection, suggesting that c-Jun actively drives Schwann cell 
dedifferentiation during injury (Parkinson et al., 2008). Interestingly, c-Jun acts in 
conjunction with the transcription factor Sox2, which inhibits myelination (Le et al., 
2005). Sox2 is co-expressed with c-Jun in immature Schwann cells, suppressed in 
myelination and reexpressed during injury. In vitro, enforced Krox20 expression or 
upregulation of cAMP inhibits Sox2 (Parkinson et al., 2008). 
1.1.6.2b- Other negative myelin transcription factors  
Other negative transcription factors of myelination include Pax-3, Id2, Krox-24 and 
Egr3. Their expression resembles that of major negative myelination regulators such 
as c-Jun. They are expressed in immature Schwann cells and/or mature non-
myelinating Schwann cells, but are downregulated in the myelinating phenotype. 
Upon injury, their expression is rapidly upregulated (Jessen and Mirsky, 2008). 
1.1.6.3 Epigenetic regulation of myelination 
Schwann cell myelination is also dependent on epigenetic regulation of myelin gene 
transcription by histone deacetylases HDAC1 and 2 (Chen et al., 2011; Jacob et al., 
2011). Recent studies suggest that HDACs may orchestrate concerted expression of 
myelin-specific transcription factors, and hence myelin gene expression. Selective 
ablation of HDAC1 or HDAC2 in Schwann cell precursors does not affect Schwann 
cell development or myelination, indicating compensatory mechanisms between the 
functions of the two HDACs. However, deletion of both HDAC1 and HDAC2 results 
in defects in radial axonal sorting. Large caliber axons that are segregated fail to be 
myelinated. Disruption of myelination induction is correlated with a remarkable loss 
of Schwann cells after birth. Expression of Sox10 and Krox-20 is reduced, but Oct-6 
is markedly increased. There is also a reduction in the expression of the myelin 
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proteins, MAG, MBP and P0. Interestingly, overexpression of HDAC2, but not 
HDAC1, upregulates expression of myelin genes (Chen et al., 2011; Jacob et al., 
2011). HDACs associate with Wnt signaling mediator -catenin to regulate Schwann 
cell survival (Jacob et al., 2011). HDACs also interact with the Sox10 promotor 
region, and NFB is a crucial intermediate in Sox10 activity regulation. In the 
absence of HDAC1 and HDAC2 in Schwann cells, the p65 subunit of NF-κB is 
heavily acetylated, resulting in suppression of mRNA expression of positive myelin 
regulators and induction of differentiation inhibitors such as Id2 and Id4 (Chen et al., 
2011). 
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1.2 REGULATION OF SCHWANN CELL FUNCTION BY THE 
EXTRACELLULAR MATRIX  
The importance of interactions between Schwann cells and axons for correct 
myelination in the developing PNS has been described in the previous section. 
Across the compact myelin sheath, the communication between the abaxonal 
Schwann cell plasma membrane with the extracellular matrix is equally essential for 
controlling the process of ensheathment and radial sorting, and modulating 
myelination. These secreted extracellular molecules may regulate Schwann cell 
myelination independently of, or in conjunction with axon-derived signals, such as 
NRG1 (Mirsky et al., 2008).  
1.2.1 SCHWANN CELL POLARIZATION 
The myelin sheath must achieve the optimal thickness and length for maximal nerve 
conduction efficiency. Up until now, how the radial and longitudinal extension of the 
myelin sheath is controlled is only partially understood.  
An important feature of differentiated cells is cell polarization, which is a 
process of organizing membrane components and cytoskeletal structures in different 
parts of the cell, establishing distinct membrane domains. A simple system for cell 
polarization is seen in epithelial cells, which are polarized along an apical-basal axis. 
Epithelial polarization involves formation of cell-cell contact followed by 
establishment of cellular junctions and segregation of apico-basolateral membrane 
domains (Drubin and Nelson, 1996).  
The Bunge group proposed that Schwann cells resemble epithelia in that they 
separate Schwann cell-axon units from mesenchymal tissues by forming a basal 
lamina (Bunge and Bunge, 1983). Schwann cells are highly polarized, with the outer 
abaxonal membrane domain apposing the basal lamina characterized as a basolateral-
like domain, and the inner adaxonal surface contacting the axon and Schmidt-
Lanterman incisures as an apical-like domain (Ozcelik et al., 2010). Moreover, 
myelin-forming Schwann cells develop a more complex geometric organization than 
epithelia with distinct subcellular domains asymmetrically organized on the radial 
and longitudinal axes (Salzer, 2003).  
Radial polarity in a myelinating Schwann cell includes the adaxonal 
membrane of the Schwann cell adjacent to the axon, which harbors adhesion 
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molecules that may mediate axo-glial interactions, such as MAG. Across the 
compact myelin sheath is the abaxonal surface of the Schwann cell surrounded by 
the basal lamina. This domain harbors ECM receptors including integrins and 
dystroglycan (Fig. 6A).  
Longitudinal polarization of the Schwann cell involves the internodal 
elongation of the myelin sheath, which extends from one node to another (Salzer, 
2003).  Longitudinally, a Schwann cell-axon unit is organized into distinct domains 
each containing a specific subset of junctional proteins. The node of Ranvier is 
contacted by cytoplasmic extensions formed by the Schwann cell called microvilli. 
Immediately adjacent to the node are the paranodal loops, which form septate 
junctions with the axon. The juxtaparanodes separate the paranode from the 
internode (Fig. 6B) (Salzer et al., 2008). Compact myelin is composed of alternating 
apposed layers and contains myelin proteins such as P0 and MBP. Junctional proteins 
that form adherens, tight and gap junctions are found in non-compact myelin. 
Connecting the Schwann cell cytoplasm at the outer and inner margins of the myelin 
internode are cytoplasmic channels known as Schmidt-Lanterman incisures (Salzer, 
2003).  
In addition, along the abaxonal surface of the myelinating Schwann cell 
internode, the Schwann cell cytoplasm is compartmentalized into specialized 
domains, called Cajal bands, which harbor different dystrophin-glycoprotein 
complexes (DGCs) that are believed to segregate the Schwann cell plasma 
membrane into appositions between the outer surface of the myelin sheath and the 
cytoplasmic face of the Schwann cell plasma membrane (Albrecht et al., 2008; Court 
et al., 2004). Cajal bands, named after their initial description by the Spanish 
neuroanatomist Santiago Ramon y Cajal  are cytoplasmic channels traversing the 
internode (Court et al., 2004). Compartmentalization of the Schwann cell cytoplasm 
has been associated with internodal length regulation, although this still remains 





Figure 6. Polarized domains of a myelinated fiber. 
 
A. Schematic representation of Schwann cell polarization on a radial axis. The 
adaxonal Schwann cell membrane contacts the axon, where the outer abaxonal 
membrane apposes the basal lamina. Between the abaxonal and adaxonal 
membranes of the Schwann cell is the compact myelin sheath. From (Berti et al., 
2006). 
B. The diagram depicts the longitudinal polarity of the Schwann cell. It illustrates a 
cross-section through a myelinated axon (gray) wrapped by myelin (blue). The 
node of Ranvier is shown in (red), to which Schwann cell microvilli project. The 
paranodal loops and junctions are in green. The juxtaparanodal region (purple) is 
separated from the node by the paranode. Schmidt-Lanterman incisures, which 
form tight junctions, are cytoplasmic channels that connect the outer and inner 








Figure 7. Compartmentalization of cytoplasm in the abaxonal region of the 
Schwann cell 
A. Silver staining of a nerve fiber by Spanish neuroanatomist Santiago Ramón y 
Cajal (Ramón y Cajal, 1933) reveals Schwann cell cytoplasm as longitudinal 
bands (now known as Cajal bands) along the Schwann cell. These longitudinal 
domains are connected by transverse trabeculae. 
B. Immunostaining of a teased fiber with an antibody against DRP2 (green) and 
fluorescent-conjugated phalloidin (red). DRP2-labeled regions denote 
appositions that are sites between the abaxonal Schwann cell membrane and the 
outermost layer of the myelin sheath, whereas phalloidin labeling reveals 
Schwann cell cytoplasmic domains termed Cajal bands. Note that Cajal bands 
are excluded from DRP2+ patches. 
C. An electron micrograph of the transverse section of a myelinated fiber with 




1.2.2 POLARITY PROTEINS REGULATE SCHWANN CELL 
MYELINATION 
Epithelial-like cell polarity may allow proper establishment of the myelin sheath. 
Indeed, Par-3, a component of the Par polarity complex, accumulates at the adaxonal 
Schwann cell membrane contacting the axon, and plays a crucial role in initiation of 
myelination (Chan et al., 2006). Myelination is impaired when Par-3 localization is 
disrupted. Par-3, which complexes with Par-6 and atypical protein kinase C (aPKC), 
regulates myelination by interacting via its first PDZ domain with the neurotrophin 
receptor p75
NTR
 that binds axonal BDNF, and recruiting the receptor to the axo-glial 
interface at the onset of myelination. Consequently, the targeting of p75
NTR
 by the 
Par polarity complex ensures that Schwann cells efficiently respond to BDNF for 
activating signaling events that lead to myelin formation.  
Par-3 is deacetylated by NAD+-dependent deacetylase Sir-two-homolog 2 
(Sirt2), which in turn blocks aPKC activation. Par-3 deacetylation by Sirt2 
temporally regulates the availability of the Par polarity complex for normal 
peripheral myelination (Beirowski et al., 2011). Similarly, adhesion molecules that 
mediate axo-glial interactions, such as nectin-like protein Necl-4 are found at the 
adaxonal membrane of the Schwann cell along the internode. Necl-4 is highly 
upregulated in premyelinating Schwann cells, and interacts with Necl-1 on the 
axonal surface to mediate axo-glial adhesion in the early stages of myelination 
(Maurel et al., 2007; Spiegel et al., 2007). In vitro knockdown of Necl-4 inhibits 
myelin formation. Disruption of the interaction between Necl-4 and Necl-1 also 
impairs myelination. Moreover, submembranous cytoskeletal proteins, spectrins (II 
and II) that are polarized at axon-glia contact sites in premyelinating Schwann cells, 
modulate myelination via regulation of actin cytoskeleton organization and Necl-
mediated axon-glial interaction. In vitro silencing of spectrin reduces Necl-4 levels 
and disrupts the polarized localization of Necl-4 on the Schwann cell surface (Susuki 
et al., 2011). 
Additionally, recent reports have identified the importance of other polarity 
proteins such as Pals1 and Dlg1 on the regulation of myelin assembly and production 
(Cotter et al., 2010; Ozcelik et al., 2010). Importantly, manipulation of these proteins 
affects the assembly of the myelin sheath, but does not result in Schwann cell 
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dysfunction. In vivo silencing of Pals1 in myelinating Schwann cells results in 
thinner myelin sheaths and formation of myelin infoldings in the sciatic nerve. The 
authors have also reported a defect in the longitudinal extension of the myelin sheath 
(Ozcelik et al., 2010). Dlg1 silencing affects the radial growth of myelin, resulting in 
overmyelination (Cotter et al., 2010).  
1.2.3 INTERACTIONS BETWEEN SCHWANN CELLS AND THE 
EXTRACELLULAR MATRIX 
The extracellular matrix (ECM) is composed of the basal lamina surrounding 
Schwann cells and endoneurial collagen. Basal lamina components typically include 
collagens, heparan sulfate proteoglycan, and non-collagenous glycoproteins, namely 
laminin, fibronectin, entactin (Bunge, 1993). It is a thin sheet of organized ECM as a 
three-layered structure, consisting of lamina fibroreticularis closest to the cell 
membrane, lamina lucida and lamina densa (Bunge and Bunge, 1983). Both non-
myelinating and myelinating Schwann cells are enveloped by a basal lamina, which 
is in close association with the abaxonal Schwann cell membrane. Components of 
the ECM, such as laminins interact with their receptors, integrin and dystroglycan in 
the Schwann cell membrane (Feltri and Wrabetz, 2005). The interactions of Schwann 
cells with these extracellular modulators translate into intracellular signaling events 
that regulate many cellular responses including migration, proliferation and survival, 
differentiation and polarization. Schwann cell development and myelination depends 
on the interactions with ECM molecules such as laminins and collagens (Chernousov 
et al., 2008). Schwann cells require axonal contact for basal lamina assembly (Clark 
and Bunge, 1989), and a basal lamina, at least laminin signals, is necessary for 
Schwann cells to properly ensheathe and myelinate axons (Feltri and Wrabetz, 2005; 
Podratz et al., 2001). 
1.2.3.1 Laminins and their functions 
Laminins are heterotrimeric proteins formed by α-, β-, and γ-subunits. Five α-
subunits, four β-subunits, and three γ-subunits have been identified so far, and 15 
isoforms have been reported (Chernousov et al., 2008). Laminins are expressed in 
the CNS, PNS and the neuromuscular junction. In mature peripheral nerves, laminin-
2 (α2β1γ1), the major isoform, and low levels of laminin-8 (α4β1γ1) are present in 
the endoneurium, whereas laminin-1 (α1β1γ1), -9 (α4β2γ1), and -11 (α5β2γ1) are 
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found in the basal lamina of perineurial cells (Feltri and Wrabetz, 2005). Both 
laminin-2 and laminin-10 (α5β1γ1) are abundant in the Schwann cell basal lamina 
surrounding nodes of Ranvier and paranodes (Occhi et al., 2005).  
1.2.3.1a- Laminin-α2 chain 
In humans and mice, mutations in the Laminin-α2 gene, coding for the α2-laminin 
chain, cause congenital muscular dystrophy 1A, MDC1A, and the phenotype of the 
dystrophic (dy/dy and dy2J/dy2J) mouse. In the absence of laminin-α2 chain 
expression, mutant mice show hypomyelinated axons and defects in radial sorting in 
peripheral nerves characterized by the presence of naked axon bundles lacking 
ensheathment and remaining unmyelinated, most notable in spinal roots and 
proximal region of the nerve, but to a lesser extent in distal peripheral nerves 
(Bradley and Jenkison, 1973; Stirling, 1975). Schwann cells lacking laminin-α2 form 
patchy, discontinuous basal laminas both in roots and peripheral nerves (Madrid et 
al., 1975). Interestingly, in laminin-α2 mutant sciatic nerves, laminin-α1 is 
upregulated in the endoneurium (Previtali et al., 2003b). Schwann cells defective for 
laminin-α2 have shorter internodal lengths (Bradley and Jenkison, 1973; Court et al., 
2009). These mutant mice have poorly formed microvilli, widened nodes of Ranvier 
and reduced sodium channel density (Occhi et al., 2005). Nerve conduction velocity 
is also reduced in mutant peripheral nerves (Rasminsky et al., 1978).  
1.2.3.1b- Laminin-α4 chain 
Mice lacking laminin-α4 chain, which forms laminin-8 in peripheral nerves, display 
a similar hypomyelinating phenotype as described in dy and dy2J mice (Wallquist et 
al., 2005; Yang et al., 2005). However, whereas laminin-α2 mutant nerves show 
more severe hypomyelination in spinal roots than distal nerves, laminin-α4 deficient 
nerves have normally myelinated roots, but more affected distal region of peripheral 
nerve (Yang et al., 2005). In addition, most small bundles of unsorted axons in 
laminin-α4 mutant nerves are ‘myelinated’ forming polyaxonal myelinated bundles, 
which are rarely seen in laminin-α2 dystrophic mice. Interestingly, unlike in laminin-
α2 mutants, the composition and integrity of endoneurial basal lamina is not affected 
in the absence of laminin-α4. These differences may be attributed to compensatory 
mechanisms of other laminin isoforms. In the absence of both laminin-α2 and α4, 
mutant mice exhibit a more severe neuropathy with virtually complete amyelination 
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in distal nerves and a lack of basal lamina in both premyelinating and promyelinating 
Schwann cells, but paradoxically improved radial sorting in the spinal root (Yang et 
al., 2005). Laminin-α2 (laminin 2) and laminin-α4 (laminin 8) are required for 
Schwann cell proliferation during radial sorting. Moreover, transgenic expression of 
laminin-α5 chain of laminin-10 in the double knockouts rescues the sorting defect 
and promotes myelination (Yang et al., 2005). These results may indicate distinct 
roles of different laminin isoforms in various regions of the PNS during 
development. 
1.2.3.1c- Laminin-1 chain 
Schwann cells with specific disruption of laminin-1 subunit lack all laminin 
expression. Laminin-1 mutant mice have severely hypomyelinated axons, and 
mutant Schwann cells fail to extend processes to interdigitate axons resulting in 
impaired radial sorting (Yu et al., 2009a). Furthermore, proliferation of mutant 
Schwann cells required for radial axonal sorting is also severely compromised, 
leading to a remarkable reduction in Schwann cell number (Yu et al., 2005). The 
transcription factor Oct-6 is not downregulated and Krox-20 levels remain low in 
Schwann cells with complete ablation of laminin expression, arresting mutant 
Schwann cells at the premyelinating stage. Elevated Schwann cell apoptosis is also 
seen in postnatal mutant nerves due to decreased PI3K activity and activation of 
caspase cascades (Yu et al., 2005).  
Schwann cells integrate signals from axons and the basal lamina for 
myelination. Laminins may influence Schwann cell proliferation during sorting 
through regulation of NRG1/ErbB signaling. Impaired axon-Schwann cell 
interactions due to impaired axonal sorting in laminin-deficient nerves result in a 
reduction in ErbB2 and ErbB3 receptor phosphorylation that is usually stimulated by 
NRG1, hence a reduction in proliferation (Yu et al., 2005). Laminins positively 
regulate proliferation and survival of Schwann cells via activation of PI3K, FAK and 
the Rho GTPase cdc42 (Benninger et al., 2007; Grove et al., 2007; Yang et al., 2005; 
Yu et al., 2005). Moreover, mice lacking all laminin expression display severe 
abnormalities in sodium channel clustering at the nodes (Occhi et al., 2005). 
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1.2.3.2 Laminin receptors 
In the PNS, laminin receptors consist of integrins, dystroglycan and members of the 
collagen superfamily. During distinct stages of development, Schwann cells 
differentially express laminin receptors. Before birth, SCPs and immature Schwann 
cells express α61 integrin and low levels of α2β1 and α3β1. At the promyelinating 
stage, Schwann cells abundantly express α61 and α64 integrins, as well as non-
integrin laminin receptor dystroglycan (Feltri et al., 1994; Feltri and Wrabetz, 2005). 
In addition to these laminin receptors, myelinating Schwann cells also express α71 
integrin (Previtali et al., 2003a).  
1.2.3.2a- Integrins and their functions 
Integrins are type I transmembrane dimeric proteins made up of non-covalently 
bound α- and β-subunits (Feltri and Wrabetz, 2005). Schwann cell-specific ablation 
of 1-integrin in mice results in impaired radial axonal sorting, which recapitulates 
the phenotype described in laminin-1 mutants (Feltri et al., 2002). Cytoplasmic 
process formation during axonal sorting is defective in 1-integrin null Schwann 
cells, suggestive of 1-integrin’s function in regulating actin cytoskeletal dynamics. 
Indeed, activation of the Rho GTPase Rac1 by 1-integrin receptor is essential for 
Schwann cell process formation and stabilization (Benninger et al., 2007; Nodari et 
al., 2007). However, in contrast to the reduced proliferation and increased apoptosis 
of laminin-lacking Schwann cells, the absence of 1integrin results in variable 
effects on proliferation and survival in different mouse strain backgrounds (Berti et 
al., 2011; Feltri et al., 2002). Normal Schwann cell proliferation and survival has 
been reported in β1-integrin mutants in a mixed 129/C57BL6 background (Feltri et 
al., 2002), but reduced proliferation and survival in β1-integrin mutants in congenic 
C57BL6 background (Berti et al., 2011), which underscores the importance of 
reporting results from a defined strain background. 
α6β4-integrin is distinct from other integrins in that β4 has a long 
cytoplasmic tail for binding to intermediate filaments (Feltri and Wrabetz, 2005). 
Whereas integrins are expressed by both neurons and Schwann cells in the PNS, 
α64 integrin is only expressed by Schwann cells at the onset of myelination (Feltri 
and Wrabetz, 2005). Genetic inactivation of α64 integrin does not affect Schwann 
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cell function, and is dispensable for peripheral nerve development, myelin formation 
and regeneration. However, the authors suggest that α64 integrin may play a role in 
myelin sheath maintenance since α64 integrin-deficient nerves display mild 
abnormal myelin folding (Nodari et al., 2008). Ablation of both α64 integrin and 
dystroglycan increases myelin folding, accompanied by acute demyelination 
particularly in the ventral roots, suggesting that they may co-operate to maintain 
myelin sheath stability (Nodari et al., 2008). Similarly, Schwann cell specific 
inactivation of α71 integrin, the last laminin receptor expressed by differentiating 
Schwann cells, also does not affect peripheral nerve development, basal lamina 
formation or myelination (Previtali et al., 2003a). 
1.2.3.2b- Dystroglycan and its function 
Dystroglycan, originally isolated from skeletal muscle, is a key component of the 
dystrophin-glycoprotein complex (DGC) that links the extracellular matrix with the 
cytoskeleton in various tissues (Masaki and Matsumura, 2010). Dystroglycan is 
expressed in the abaxonal membrane of both non-myelin forming and myelin-
forming Schwann cells and in perineurial cells and satellite cells of DRG (Saito et 
al., 1999; Yamada et al., 1996b). Dystroglycan consists of two subunits: extracellular 
α-subunit and transmembrane β-subunit (Ervasti and Campbell, 1993). Both subunits 
are encoded by a single mRNA as a propeptide, which is proteolytically processed 
into two proteins associated by noncovalent bonds. In Schwann cells, extracellular α-
dystroglycan can bind laminin-2 and agrin, and the cytoplasmic tail of 
transmembrane β-dystroglycan is associated with cytoskeletal proteins that are 
members of various DGCs including dystrobrevins, syntrophins, β-, δ-, , and -
sarcoglycans and the dystrophin family members: Dp116, dystrophin-related protein 
2 (DRP-2) and utrophin (Albrecht et al., 2008; Imamura et al., 2000; Saito et al., 
1999; Sherman et al., 2001). 
The molecular composition of DGC varies in spatially distinct compartments 
of the abaxonal Schwann cell membrane. Cajal bands harbor the DGC containing 
utrophin, Dp116, α-dystrobrevin1 and syntrophins, and separate the abaxonal 
membrane and the myelin layers (Albrecht et al., 2008). In appositions/patches, β-
dystroglycan forms a complex with DRP-2 and Periaxin (Fig. 8) (Sherman et al., 
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2001). The DGC found at the node of Ranvier comprises Dp116 and utrophin (Occhi 
et al., 2005).  
In Schwann cells, β-dystroglycan can be cleaved by matrix metalloproteases 
MMP-2 and MMP-9 that yield a 30 kDa fragment unable to bind α-dystroglycan 
(Yamada et al., 2001; Zhong et al., 2006). Recently, it has been proposed that the 
cleaved 30 kDa β-dystroglycan is present in Cajal bands lacking α-dystroglycan, and 
that both subunits (α-, and uncleaved 43 kDa β-dystroglycans) are localized in 
appositions. Excessive dystroglycan cleavage by MMP-2 and -9 may alter the size of 
cytoplasmic compartments (Cajal bands/appositions). Formation of defective 
Schwann cell cytoplasmic compartments due to increased dystroglycan cleavage is 
associated with reduced internodal lengths in laminin-α2-null dy2J/dy2J mouse 
(Court et al., 2011). 
When dystroglycan in Schwann cells is genetically disrupted, mutant mice 
exhibit a late onset neuropathy characterized by an aberrantly folded myelin sheath, 
redundant myelin loops and polyaxonal myelination in mature nerves (Saito et al., 
2003). These morphological changes in the myelin sheath are due to disruption of the 
linkage between the ECM and Schwann cell cytoskeleton contributed by reduced 
laminin binding capacity of dystroglycan-null peripheral nerve membranes (Saito et 
al., 2003). Schwann cells lacking dystroglycan also have shorter internodes (Court et 
al., 2009). During development, the absence of Schwann cell-specific dystroglycan 
arrests sorting predominantly in spinal roots, but not in peripheral nerves (Berti et al., 
2011; Saito et al., 2003). Dystroglycan in Schwann cells functions as a receptor for 
laminin-2, and their interaction is important for axon defasciculation into a 1:1 
relationship during radial axonal sorting (Berti et al., 2011).  
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Figure 8. Molecular components of dystrophin-glycoprotein complexes (DGCs) 
present in Cajal bands and appositions of myelinated Schwann cells.  
DGC complex containing utrophin, Dp116, dystrobrevins and syntrophins are 
formed in cytoplasm-filled channels, termed Cajal bands that lie underneath the 
plasma membrane of the Schwann cell. Utrophin interacts with F-actin at the N-
terminus (top, left).  
While its PDZ domain homodimerizes, Periaxin interacts via its basic domain with 
DRP2, which also associates with β-dystroglycan. This forms a transmembrane 
complex located at appositions between the outer membrane of myelin sheath and 
the cytoplasmic face of the Schwann cell plasma membrane (bottom, right). Image 
modified from (Masaki and Matsumura, 2010; Sherman and Brophy, 2005). 
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 In the absence of dystroglycan, mutant mice also show nodal abnormalities 
such as reduced sodium channel expression and disorganized microvilli, which lead 
to a reduction in conduction velocity of mature peripheral nerves (Saito et al., 2003). 
Dystroglycan may link the basal lamina to the cytoskeleton of microvilli, forming a 
specific molecular scaffold that operates by limiting the lateral movement of sodium 
channels toward the nodes during Schwann cell elongation, and hence clustering 
sodium channels at the nodes (Occhi et al., 2005). 
 α-dystroglycan in the peripheral nerve is glycosylated, and glycosylation is 
important for dystroglycan functions. Mutations of genes encoding fukutin, POMT 
or LARGE glycosyltransferases, which have α-dystroglycan as a substrate, impair α-
dystroglycan glycosylation and thereby attenuate the binding capacity to laminin and 
agrin (Kim et al., 2004; Michele et al., 2002). Glycosylation defects in dystroglycan 
cause human disorders, such as congenital muscular dystrophy 1D and Fukuyama-
type congenital muscular dystrophy. Mice with mutations of fukutin or LARGE 
show sorting defects as revealed by the presence of clusters of naked axons in 
peripheral nerves and spinal roots (Levedakou et al., 2005; Saito et al., 2007). 
Moreover, fukutin-chimeric mutant mice show defective clustering of acetylcholine 
receptor and fragmented neuromuscular junctions (NMJs) (Saito et al., 2007). 
Collectively, these data indicate that regulation of the sugar chain structure of α-
dystroglycan is important for binding with laminin or agrin, and that the linkage 
between α-dystroglycan and its ligands is essential for myelination of the peripheral 




1.3.1 PERIAXIN AND CHARCOT-MARIE-TOOTH (CMT) 4F 
Defects in PNS myelination can cause Charcot-Marie-Tooth disease (CMT), also 
known as hereditary sensory and motor neuropathy (HSMN). CMT is the most 
frequently inherited peripheral neuropathy, with a prevalence of 1 in 2500 people 
(Skre, 1974). The disease is classified into two major groups, namely a 
demyelinating form (CMT1, CMT3 and CMT4) when myelinating Schwann cells are 
primarily affected, and an axonal form (CMT2) when axons are the principal disease 
target (Dyck and Lambert, 1968; Maier et al., 2002). The demyelinating form of 
CMT is characterized by segmental demyelination followed by remyelination and 
onion bulb formations in patient nerves, with a reduction in nerve conduction 
velocities (NCVs). Patients with the axonal form CMT2 often display normal or 
near-normal NCVs, and nerve biopsies show myelinated axonal loss (Young and 
Suter, 2003). 
The major demyelinating CMT disease characteristics include slowly 
progressive muscular atrophy and weakness, with sensory loss in the distal 
extremities of the limbs and absence of deep tendon reflexes (Guilbot et al., 2001). 
Deformed feet and claw toes are common features of the disease, leading to gait 
impairment (Young and Suter, 2003). Modes of inheritance can be autosomal 
dominant or recessive, or X-linked (Guilbot et al., 2001). The underlying gene 
defects affect myelinating Schwann cells thus triggering secondary axonal 
degeneration. Genes mutated in CMT encode proteins that are involved in 1) the 
regulation of myelin sheath development and maintenance of the myelin structure; 2) 
protein biosynthesis, sorting and degradation; 3) vesicular transport, endocytosis and 
mitochondrial morphology and dynamics (Berger et al., 2006). Mutations in genes of 
myelin components including PMP22, P0/MPZ, connexin 32 and Periaxin are 
responsible for various subtypes of CMT.  Some subtypes of CMT are caused by 
mutations in genes encoding myelin gene transcription factors such as EGR2/Krox-
20 (Berger et al., 2006; Scherer and Wrabetz, 2008). 
Autosomal recessive CMT, which is characterized by a severe, demyelinating 
early onset peripheral neuropathy, is defined as CMT4. To date, eight loci and seven 
genes have been implicated in CMT4 (Parman et al., 2004). Subtypes of CMT4 are 
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classified based on the mutations in the following genes (Berger et al., 2006; Parman 
et al., 2004): 
CMT4A Ganglioside-induced differentiation-associated gene 1 (GDAP1)  
CMT4B1 Myotubularin-related protein 2 gene (MTMR2) 
CMT4B2 MTMR13/SBF2 
CMT4C SH3 domain and tetratricopeptide repeats 2 gene (SH3TC2)  
CMT4D N-myc downstream-regulated gene 1 (NDRG1) 
CMT4E Early growth response gene 2 (EGR2) 
CMT4F Periaxin (PRX) 
CMT type 4F neuropathy is caused by mutations in the human Periaxin gene 
(PRX) mapped on chromosome 19q13, which is syntenic with a region of 
chromosome 7 in the murine Prx gene (Delague et al., 2000; Gillespie et al., 1997; 
Guilbot et al., 2001). Amino acid sequence comparison of human, rat and mouse L-
Periaxin reveals that human L-Periaxin shares ~73% and ~78% sequence identity 
with the rat and murine proteins (Boerkoel et al., 2001). Various nonsense or 
frameshift mutations in the PRX gene have been described in patients showing 
autosomal recessive, demyelinating CMT4F and Dejerine-Sottas neuropathy (DSN 
or CMT3) (Boerkoel et al., 2001; Guilbot et al., 2001; Kabzinska et al., 2006; Kijima 
et al., 2004; Marchesi et al., 2010; Otagiri et al., 2006; Parman et al., 2004; 
Takashima et al., 2002).  
CMT4F patients carrying PRX mutations have early onset but in general slow 
disease progression (Marchesi et al., 2010). Delayed motor development with gait 
problems since childhood has been reported in a majority of CMT4F patients. Most 
patients show severe muscle weakness in distal limbs. Pes cavus (deformed feet and 
claw toes) and scoliosis is present in many CMT4F patients. A number of patients 
also show and severe sensory loss, often associated with sensory ataxia. A moderate-
to dramatic reduction of motor NCVs, undetectable sensory nerve action potentials, 
and demyelination with onion bulb formation are common electrophysiological and 
pathological features of the disease (Barankova et al., 2008; Guilbot et al., 2001; 
Kabzinska et al., 2006; Kijima et al., 2004; Marchesi et al., 2010; Otagiri et al., 2006; 
Parman et al., 2004; Takashima et al., 2002).  
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In CMT 4F, all but one of the 16 human PRX mutations identified so far 
occur in the final exon (exon 7), which encodes 91% of the larger Periaxin isoform, 
L-Periaxin (Marchesi et al., 2010). In this case, the mRNA is predicted to be exempt 
from nonsense-mediated mRNA decay. Indeed, interestingly three of the PRX 
mutations identified (S399fsX410, C715X and R1070X) have been reported to 
generate truncated mutant Periaxin proteins revealed by immunofluorescence 
labeling and/or Western blotting of nerve biopsies (Kabzinska et al., 2006; Parman et 
al., 2004; Takashima et al., 2002).  
A notable mutation at R1070X introduces a stop codon at 28 aa upstream of 
the Periaxin acidic domain. This mutation generates a large truncated protein of 
Periaxin lacking the acidic domain and the rest of the C-terminus. Patients display 
severe demyelination and axonal loss contributing to distal muscle weakness and 
sensory ataxia (Parman et al., 2004), confirming the importance of the C-terminus in 
the function of Periaxin. The most downstream mutation reported so far is the 
K1095fsX18 mutation, which causes a frameshift following amino acid lysine at 
codon 1095 and terminates the protein at amino acid 1113. The patient with this 
mutation developed an early-onset but slowly progressive demyelinating CMT 
(Barankova et al., 2008).  
1.3.2 PERIAXIN ISOFORMS 
The murine Periaxin (Prx) gene, which spans 20.6 kilobases, generates two mRNAs, 
of 4.6 and 5.2 kilobases. These two mRNAs encode two protein isoforms, L-Periaxin 
of 147 kDa and S-Periaxin of 16 kDa, respectively. The smaller isoform S-Periaxin 
is generated as a truncated protein bearing a unique 21 amino acid C-terminus due to 
alternative splicing involving the retention of an intron (intron 6) of the pre-mRNA 
(Dytrych et al., 1998). Interestingly, Prx shares a common genetic structure as 
AHNAK, characterized by a large exon flanked by multiple small exons. The L-
Periaxin protein sequence also has a high degree of sequence similarity as AHNAK. 
AHNAK encodes a giant protein (700 kDa) and a small isoform (17 kDa) expressed 
in muscle. In peripheral nerves, AHNAK is localized to Cajal bands in Schwann 
cells (Salim et al., 2009).  
Up until now, the major research focus has been placed on the function of L-
Periaxin in myelinating Schwann cells, but little is known about S-Periaxin. S-
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Periaxin is diffusely distributed in the cytoplasm with a punctated staining in the 
nucleus of Schwann cells (de Morree et al., 2011; Dytrych et al., 1998), and its 
functions have yet to be identified. Studies of the function of the small isoform of 
AHNAK (S-AHNAK) have shown that S-AHNAK traffics between the cytoplasm 
and the nucleus, and localize to the spliceosome to regulate mRNA splicing of its 
own locus. In the same study, recombinant S-Periaxin was also capable of regulating 
AHNAK splicing in the nucleus (de Morree et al., 2011). Whether S-Periaxin also 
regulates mRNA splicing of its own locus remains to be studied. 
Both L-and S-Periaxin contain a protein interacting PDZ domain at the N-
terminal region (PDZ: post-synaptic density protein PSD-95, Drosophila discs large 
(dlg) tumor suppressor gene, tight junction-associated protein ZO-1) (Dytrych et al., 
1998). Proteins with this protein binding domain are often membrane-associated and 
interact with the cytoplasmic tail of plasma membrane proteins and with the cortical 
cytoskeleton; they can also homo- or heterodimerize (Kim and Sheng, 2004). PDZ 
domains have four possible binding modes, including interaction with the carboxyl-
terminal motif of binding partners, recognition of internal motifs in peptides, PDZ-
PDZ dimerization and lipid recognition (Nourry et al., 2003). 
 In addition to functioning as scaffolding proteins that assemble signal 
transducing proteins into functional signaling complexes at the plasma membrane, 
PDZ domain proteins can act as adaptors for tyrosine kinase receptors. For example, 
the PDZ domain protein Erbin plays a role in stabilization and internalization of the 
ErbB2 protein. In the PNS, Erbin-null mice show hypomyelination and aberrant 
axonal ensheathment of unmyelinated small diameter C fibers. More specifically, 
mice lacking the PDZ domain of Erbin reproduce the phenotype seen in Erbin-/- 
mutants (Tao et al., 2009). Proteins containing PDZ domains, such as Dlg1, Par3 and 
Pals1 (see section 1.2.2) have also been implicated in tight junction assembly and the 
development of epithelial-like polarity. Indeed, many PDZ domain proteins are 
found at the synaptic junction between neurons that contain highly polarized 
subcellular compartments. They interact with neurotransmitter receptors for synapse 
signal transduction, examples of which are PSD-95, GRIP and Dlg1/SAP97 (Nourry 
et al., 2003). As for L-Periaxin, its PDZ domain is known to homodimerize 
(Sherman et al., 2001). 
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Downstream of L-Periaxin’s PDZ domain is a highly basic region, which 
contains a nuclear localization signal (NLS) (Sherman and Brophy, 2000). The 
middle part of the protein consists of a series of repeats (432-725 aa), followed by a 
highly acidic domain towards the C-terminus (1036-1163 aa) of the protein (Fig. 9) 
(Dytrych et al., 1998; Gillespie et al., 1994). L-Periaxin is a protein of non-compact 
myelin, first identified at the periaxonal membranes of early postnatal myelin-
forming Schwann cells in the PNS (Gillespie et al., 1994; Scherer et al., 1995). In 
this work L-Periaxin will be described simply as Periaxin. 
 
Figure 9. Domain structure of mouse L- and S- Periaxin.  
Both isoforms contain a PDZ domain at their N-termini. S-Periaxin (16kDa) has a 
unique 21 aa C-terminus. Downstream of the PDZ domain of L-Periaxin is a highly 
basic domain. The middle of the protein is occupied by a series of repeats. Close to 
the C-terminus is an acidic domain. (Amino acid residues are shown). 
1.3.3 PERIAXIN EXPRESSION IN SCHWANN CELLS 
Proteomic analysis of PNS myelin protein content has revealed that Periaxin is the 
second most abundant myelin-related protein, constituting ~16% of all PNS myelin 
proteins (Patzig et al., 2011). Periaxin expression is not specific to the PNS. It is also 
present in cytoskeletal complexes of lens fibers (Straub et al., 2003), and is important 
for hexagonal geometry and membrane stability of lens fibers (Maddala et al., 2011).  
In mature Schwann cells, Periaxin is expressed in the abaxonal membrane 
and the Schmidt-Lanterman incisures, but is absent from compact myelin and 
paranodal loops (Gillespie et al., 1994). During development, Periaxin is localized in 
the nuclei of murine embryonic Schwann cells as early as embryonic age 14.5 days 
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(E14.5) in vivo, in agreement with the presence of a nuclear localization signal in the 
protein. It is initially expressed in the nucleus until E16.5, and is then localized to the 
Schwann cell plasma membrane at E17.5 (Sherman and Brophy, 2000). However, as 
the myelin sheath matures and the spiralization process completes, Periaxin is 
predominantly localized to the abaxonal Schwann cell membrane (Gillespie et al., 
1994; Scherer et al., 1995). 
1.3.4 TRANSCRIPTIONAL REGULATION OF PERIAXIN EXPRESSION 
Periaxin mRNA and protein are highly upregulated in early stages of myelination 
and peak between postnatal days 8 and 20 in peripheral nerves. The time course of 
Periaxin expression is similar to that of the major myelin protein P0 (Gillespie et al., 
1994). Like P0, regulation of Periaxin expression requires axonal contact since levels 
of Periaxin mRNA and protein in myelinating Schwann cells are progressively lost 
from Schwann cell membranes and become associated with myelin debris following 
nerve transection or crush (Scherer et al., 1995).  
The zinc finger transcription factor Krox-20 is an important regulator of the 
myelin program. In vitro, ectopic expression of Krox-20 in Schwann cells induces 
expression of a number of myelin genes, including Mpz, Pmp22, Mbp, Mag, 
Connexin32 and Prx (Nagarajan et al., 2001). Interestingly, during normal nerve 
development, Periaxin expression in Schwann cells detected by immunofluorescence 
precedes that of Krox-20 induction by at least 2 days. Characterization of Periaxin 
expression in peripheral nerves and cultured Schwann cells lacking Krox-20 has 
revealed detectable Periaxin expression, albeit at reduced levels. In addition, in 
cultured Schwann cells lacking Krox-20, Periaxin expression can be elevated by the 
myelin differentiation signal cAMP. These data indicate that initiation of Periaxin 
expression is independent of Krox-20 regulation. Krox-20, however, may function as 
an amplifier of Prx gene expression since forced expression of Krox-20 in Schwann 
cells induces expression of Periaxin mRNA and protein in the absence of cAMP 
(Parkinson et al., 2003). 
A conserved enhancer element in the first intron of the Mpz gene that consists 
of inverted dimeric Sox10 binding sites and at least one Krox-20/Egr2 binding site 
has been described as a myelin regulatory module (LeBlanc et al., 2006). This 
potential site of Krox20/Sox10 interaction was also identified in the first intron of the 
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Prx gene (Jones et al., 2007). The authors demonstrated binding of Krox20 and 
Sox10 to the conserved composite module in the Prx gene using chromatin 
immunoprecipitation (ChIP) assays, indicating that similar to P0 expression 
regulation, synergistic interactions of Krox-20 and Sox10 to the first intron of the 
Prx gene may mediate an elevation of Periaxin expression in myelinating Schwann 
cells. 
1.3.5 PERIAXIN FORMS A MEMBRANE COMPLEX WITH DRP2 AND 
DYSTROGLYCAN   
In skeletal muscle and the PNS, dystrophin complexes with dystroglycan. The 
dystrophin glycoprotein complex (DGC) plays a significant role in linking 
extracellular matrix proteins such as laminins to the actin cytoskeleton (Ahn and 
Kunkel, 1993; Gee et al., 1993; Yamada et al., 1996a). Periaxin homodimerizes at its 
PDZ domain and associates via its basic domain with DRP2, which interacts with β-
dystroglycan, forming a transmembrane complex (PDG complex) (Fig. 8) (Sherman 
et al., 2001). The complex is localized and clustered at appositions/patches (Court et 
al., 2004; Sherman and Brophy, 2005). As mentioned in the previous section, 
cytoplasmic-rich Cajal bands between appositions contain a specific DGC containing 
utrophin, Dp116, dystrobrevins and syntrophins, and ABC1 cholesterol transporter 
(Albrecht et al., 2008). Cajal bands may have an important role in microtubule-based 
mRNA transport (Court et al., 2004).  
Periaxin is essential for clustering and stabilizing the PDG complex. In mice 
lacking Periaxin, DRP2 is severely depleted and fails to form at the clusters but is 
found diffusely in the cytoplasm (Sherman et al., 2001). In addition, the PDG 
complex is disrupted in Periaxin-null mice, leading to absence of appositions and 
disruption of Cajal bands (Court et al., 2004). Periaxin-deficient Schwann cells also 
have reduced internodal lengths. However, myelin thickness is not affected at 3 
weeks old. A decrease in internodal length of Schwann cells has been proposed to 
result in a reduction in nerve conduction velocity in Prx-null mice (Court et al., 
2004). 
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1.3.6 PERIAXIN-NULL MICE DISPLAY PERIPHERAL NERVE 
DEMYELINATION AND NEUROPATHIC PAIN   
Periaxin-null Schwann cells are capable of ensheathing peripheral nerve axons and 
forming a functionally intact myelin sheath. 3-week-old Prx-null mutant mice exhibit 
a normal behavioral phenotype when tested for neuropathic pain behavior (Court et 
al., 2004). However, by 4-6 weeks of age they start to display a slight tremor and 
later a neuropathic pain behavior phenotype (Gillespie et al., 2000). There is no 
difference in the number of myelinated axons in wild-type and Prx-deficient sciatic 
nerves up to 12 weeks of age, indicating that mice lacking Periaxin have the ability 
to generate normal numbers of myelinated axons. The density of myelinated axons in 
older mice is reduced, and this is reflected in an increase in extracellular matrix 
(Williams and Brophy, 2002). After sciatic nerve crushes in 6-week-old Periaxin-null 
mice, peripheral nerve remyelination takes place in these mice, and the number of 
myelinated axons returns to normal. However, the axon calibers of myelinated fibers 
in the crushed nerve remain smaller than the contralateral uncrushed nerve. Axons 
are also hypermyelinated in regenerated nerves in the absence of Periaxin (Williams 
and Brophy, 2002), suggesting a role of Periaxin in myelin sheath maintenance.  
Older mutant mice (6-9 months old) display hypermyelination with focal 
thickenings of myelin called tomacula, as well as extensive peripheral demyelination. 
This infolding of myelin leads to axon compression. Schmidt-Lanterman incisures, 
which are cytoplasm-filled structures along the length of the internodes, are also 
deranged. Peripheral nerves from these mice display onion bulb formation, a 
pathology indicative of supernumerary Schwann cells attempting to remyelinate 
following demyelination of nerve fibers. This is often associated with the human 
Charcot-Marie-Tooth disease and Dejerine-Sottas disease (Gillespie et al., 2000). In 
the absence of Periaxin in peripheral nerves, mutant animals displayed severe 
behavioral deficits due to instability of the myelin sheath, resulting in the 
development of a late-onset demyelinating neuropathy associated with mechanical 
allodynia and thermal hyperalgesia (Gillespie et al., 2000). Conduction velocities of 
sensory myelinated afferent fibers in Prx-null nerves are severely reduced, which is 
associated with the sensory deficits displayed by the mutant mice. Mutant sciatic and 
saphenous nerves also have significantly reduced conduction velocities by 6 months 
of age. Motor coordination deficits in Periaxin-deficient mice may be contributed by 
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the morphological abnormalities in the preterminal region of motor axons at the 
NMJs associated with demyelination (Court et al., 2008). This indicates that the 
Periaxin-DRP2-dystroglycan complex is essential for the maintenance and 
stabilization of the myelin sheath. Hence, the Periaxin-knockout mouse should be an 
excellent model for studying the development of demyelinating neuropathies. 
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1.4 AIMS OF THE PROJECT 
 
Complete deletion of Periaxin in mouse peripheral nerves perturbs Schwann cell 
elongation and causes a severe demyelinating phenotype. However, the functions of 
the different domain regions of Periaxin remain unclear. In particular, Periaxin 
homodimerizes at its PDZ domain in the Periaxin-DRP2-dystroglycan complex at 
appositions of the Schwann cell membrane (Sherman et al., 2001). Is Periaxin PDZ 
homodimerization essential for stabilization of the Periaxin-DRP2 complex and 
Schwann cell cytoplasmic compartments, and hence Schwann cell function? In order 
to address these questions, this work aims to gain insight into the role of the PDZ 
domain of Periaxin in the following ways: 
 
1. The first aim of the project was to characterize a mouse mutant containing a 
version of Periaxin lacking the PDZ domain in myelinating Schwann cells. 
 
2. Before homodimerization during formation of the PDG complex, it is 
unknown whether the Periaxin PDZ domain has other functions. The second 
objective was to understand the consequences of disrupting the PDZ domain 
dimerization of Periaxin after compartmentalization of the Schwann cell 
cytoplasm is accomplished in adult nerves.  
 
3. Since eliminating the N-terminal PDZ domain (about 10% of the protein) 
from Periaxin might induce changes in the protein folding mechanism; I 
aimed to study whether minimal disruption in the Periaxin PDZ domain 
structure by single amino acid mutations may also result in abrogation of 




2- MATERIALS AND METHODS 
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2.1 ANIMALS 
All animal work conformed to UK legislation (Scientific Procedures) Act 1986 and 
the Edinburgh University Ethical Review policy. All mouse lines used in this work 
were of congenic C57Bl6 background. C57Bl6 strain was chosen due to its 
robustness, easy breeding and availability of knowledge in its physiology and 
genetics. Most importantly, many neurobiological mutations have been generated 
and studied in this strain. 
Generation of P0CreERT mice, which carries a transgene containing the P0 
promoter (specifying Schwann cell specific expression) together with an improved 
variant of the tamoxifen-inducible Cre recombinase CreERT2 (Leone et al., 2003), as 
well as that of Cnp-Cre mice, in which Cre is inserted into the Cnp locus has been 




 transgenic mice: Homozygous Prx
fl/fl
 mouse line was 
generated by Dr. Diane Sherman. The Prx gene contains 7 exons, of which exons 4-7 
are coding exons. 91 % of Periaxin is encoded by exon 7, whereas the PDZ domain 
is encoded by both exons 5 and 6. Two loxP sites were inserted to flank exon 5 of the 
Prx gene (A. Williams, unpublished). Upon Cre-mediated recombination of the loxP 
sites, exon 5 is predicted to be excised and this is predicted to introduce a frameshift 
leading to an in-frame stop codon in exon 6, thus arresting protein translation, or 










Figure 10. Targeting strategy for generating a ”floxed” Periaxin mutant mouse. 
Schematic representation of the genomic Periaxin (WT, wild type), floxed, and 
mutant recombined loci. Two loxP sites were positioned to flank exon 5. Upon Cre-
mediated recombination of the loxP sites, a frameshift stop codon is introduced in 
exon 6, which is predicted to arrest protein translation, or more likely cause 
nonsense-mediated RNA decay. The location of the exons (1-7) and loxP sites (black 
triangles) are indicated. Orange rectangles denote non-coding exons, whereas red 
rectangles protein coding exons. E stands for EcoRI sites.  
Generation of Prx
fl/fl
/Cnp-Cre mice: Targeted ablation of Periaxin in myelinating 
Schwann cells was achieved by crossing homozygous Prx
fl/fl
 mice with mice 
homozygous for the ‘floxed’ allele and heterozygous for Cnp-Cre. In the present 
study, Prx
fl/fl
 mice were defined as wild-type (WT), whereas Prx
fl/fl
/Cnp-Cre mice as 
PDZ-Prx mice.  
Generation of Prx
fl/fl
/P0CreERT mice: homozygous Prx
fl/fl
 mice were crossed with 






2.1.1 Peripheral nerve dissection 
Trigeminal nerves were used for mRNA and protein level analysis because in our 
hands, they provide abundant amounts of proteins and RNA during extraction. 
Following euthanizing with CO2 inhalation, the animal was beheaded, the skull was 
opened and brain removed to expose the trigeminal nerves. The trigeminal ganglion 
and the ophthalmic, maxillary, and mandibular branches of the trigeminal nerve were 
dissected, snap-frozen in liquid N2 and stored at -80
o
C until use. 
Sciatic nerves were used for protein level analysis and cryostat sectioning. 
Sciatic nerves from the proximal region to the sciatic notch were dissected, snap-
frozen in liquid N2 and stored at -80
o
C until use. 
Quadriceps nerves, which are distal and consist mainly of motor nerve fibers, 
were used for all morphometric and electrophysiological analysis because distal 
motor nerves are often affected in CMT4F patients (see section 1.3.1). The nerve was 
dissected from the quadriceps branch of the femoral nerve, from where the 
saphenous and quadriceps branches separate to the distal end where it innervates the 
muscle. Nerves were either fixed for immunofluorescence staining and electron 
microscopy processing, or used fresh for electrophysiology.  
2.2 PCR 
PCR in this study was performed with Go Taq DNA polymerase (1U, Promega), 
unless otherwise stated, in a 25 l reaction containing 1 Go Taq buffer, 1.5 mM 
MgCl2, 0.2 mM dNTPs and 0.5 M of primers. PCR conditions were: 1 cycle of a 1 
min 30 s denaturation at 94
o
C, a 30 s annealing at 57
o
C and a 1min/kb extension at 
72
o
C depending on the product size, followed by 34 cycles of 94
o
C for 40 s, 55
o
C for 
30 s and 72
o
C for 1min/kb. PCR products were resolved on agarose gels, visualized 
by ethidium bromide under UV light in a Uvitec gel documentation system (Uvitec, 
Cambridge). 
2.2.1 Genotyping PCR 
Each ear clip was incubated in 50 l of lysis buffer containing 50 mM Tris pH 8.0, 
50 mM EDTA, 0.25% SDS (w/v) and 0.5 mg/ml Proteinase K (Roche) overnight at 
55
o




l of the diluted genomic DNA was used as PCR template. PCR was 
performed with Go Taq polymerase.  
To identify homozygous Prx
fl/fl 
mice, primers (Peri 27 and Peri 28) were 
designed to flank exon 5. The PCR amplification protocol was: 1 cycle of 94
o
C 
denaturation for 1 min 30 s, 55.6
o
C annealing for 30 s, and 72
o
C extension for 1 min, 
followed by 45 cycles of 94
o
C for 40 s, 55.6
o
C for 30 s and 72
o
C for 1 min. The last 
cycle consisted of 94
o
C for 40 s, 56
o
C for 30 s and 72
o
C for 2 min. PCR products 
were digested overnight at 37
o
C with EcoRI and analyzed by agarose gel 
electrophoresis. Mice homozygous for floxed Prx (Prx
fl/fl
) showed a single band of 
0.5 kb, mice that were heterozygous for floxed Prx (Prx
fl/+
) exhibited two major 
bands at 1.0 and 0.5 kb. Wild-type mice showed a PCR product of 1.0 kb (Fig. 11). 




Figure 11. Genotyping for homozygous Prx
fl/fl
 mice. 
Schematic representation of exons 5-6 (red rectangles) of the genomic Periaxin (WT, 
wild type) and floxed loci. loxP sites (black triangles) and primers used for 
genotyping (Peri 27 and Peri 28) are indicated. E stands for EcoRI sites. An EcoRI 
site is introduced adjacent to the first loxP site (5’-end) in the floxed Periaxin gene. 
Primers Peri 27 and Peri 28 encode a PCR fragment containing the inserted EcoRI 





/P0CreERT mice, transgene was identified by PCR 
amplification using primers P0 CXF and P0 CAR for P0CreERT. The PCR 
conditions included 1 cycle of 94
o
C denaturation for 2 min, 55
o
C annealing for 1 
min, and 72
o
C extension for 1 min, 4 cycles of 94
o
C for 1 min 30 s, 55
o
C for 40 s 
and 72
o
C for 1 min, followed by 28 cycles of 94
o
C for 40 s, 55
o
C for 30 s and 72
o
C 
for 1 min. The last step consisted of 94
o
C for 30 s, 55
o
C for 30 s and 72
o
C for 2 min. 
Cre-positive mice showed a 750 bp PCR product. 
To identify Prx
fl/fl
/Cnp-Cre mice, PCR analysis was performed with primers 
Cre F4 and Cre R6, which yielded a 941 bp product for Cre-positive animals. PCR 
conditions were: 1 cycle of denaturation at 94
o
C for 1 min 30 s, annealing at 55
o
C for 
30 s, and extension at 72
o
C for 1 min, followed by 39 cycles of 94
o
C for 40 s, 55
o
C 
for 30 s and 72
o
C for 1 min. The final step consisted of 94
o
C for 40 s, 55
o
C for 30 s 
and 72
o
C for 2 min. Positive and no template controls were always included. 
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 Table 1. Oligonucleotide primer sequences 
Primer  5’ to 3’ Restriction sites 
BDF F TCATCGGAAGAGAGTAGTAACAAAG  
Cre F4 F ACGAGTGATGAGGTTCGCAA  
Cre R6 R GTTTCACTATCCAGGTTACGG  
CSG 3 R AGCTTGGTGGCTCGCCCAGG  
CSG 26 F TGACTCTCTGCAGAGCTAT  
DLS 29 F GGGATTCGAGGCCAGGAGCCGCAGCGCT EcoRI 
GADPH 
F1 
F ATCACCATCTTCCAGGAGCG  
GAPDH 
R1 
R AGGCCATGCCAGTGAGCTTC  
LMD 7 R AGTTCTCTTTTCCCAAGTTCTCCCGACT  
LMD12 F CAGATTTGCTCTGCCCAAGT  
P0 CAR R TCCGATCCGCCGCATAACC  
P0 CXF F CTGCACAGACATGAGACCATAGG  
Peri 15R R CACCTGGGGCAAAAGAGATAC  
Peri 27 R AAGAAGAGGGGATGAGTAGGCG  
Peri 28 F CCTGTGACTTCCCAAAAAAAC  
Peri 89 F CGAAGATCTGAGATGAAGGGCCCGCGAGC BglII 
Peri 96 F CGGAATTCGCACAGACCGGGGTCAGC EcoRI 
Peri 97 R CGGGATCCTCACCCGGTGGGCACAGTGCGCTTC Stop, BamHI 
Peri 98 R CGGGATCCTCACTCTGCGCATTGCAGCAGGC Stop, BamHI 
Peri 101 F GAGCGGAGTTGGTGGCCATTATCGTGGAGACAG  
Peri 102 R CTGTCTCCACGATAATGGCCACCAACTCCGCTC  
Peri 103 F GAGATTATCGTGGAGGCAGAGGCGCAGACCG  
Peri 104 R CGGTCTGCGCCTCTGCCTCCACGATAATCTC  
Peri 105 F GTTTGCAGGAAGGGGCCCAACTTCTGAGCGC  
Peri 106 R GCGCTCAGAAGTTGGGCCCCTTCCTGCAAAC  
Peri 115 F 5’-ACCGGGGTCAGCGCCTTCAATGTAGCA -3’  
Peri 116 R 5’-CTGCTACATTGAAGGCGCTGACCCCGGT-3’  
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2.3 REVERSE-TRANSCRIPTION PCR (RT-PCR) 
2.3.1 RT-PCR 
RNA was isolated from trigeminal nerves of 3- or 4-week-old wild-type and PDZ-
Prx mice by guanidinium-thiocyanate-phenol-chloroform extraction (Chomczynski 
and Sacchi, 1987; Chomczynski and Sacchi, 2006) with Trizol (TRI-reagent, 
Ambion), precipitated by isopropanol and purified. Briefly, 4-6 nerves were 
homogenized in 400 µl Trizol. 80 µl chloroform (200 µl/ ml Trizol) was added and 
homogenate was incubated for 5 min at room temperature. Following centrifugation 
for 15 min at 13000 rpm at 4
o
C, the aqueous phase containing RNA was transferred 
to a fresh microcentrifuge tube. The phenol/choroform extraction step was repeated 
followed by extraction with chloroform for removal of phenol. Total RNA was 
precipitated from the aqueous phase with an equal volume of isopropanol, purified 
with 70% cold ethanol, and resuspended in RNase-free water. RNA concentration 
was determined by measuring absorbance at 260 nm. RNA was stored at -80
o
C.  
5 µg total RNA in a 20 µl reaction was transcribed into first strand cDNA at 
42
o
C for 1 h using Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase 
(200 units, Promega) with random hexanucleotide primers (Gibco). The reverse 
transcription reaction was terminated by increasing the temperature to 80
o
C for 20 
min. cDNA was amplified by PCR using Go Taq polymerase with forward primer 
CSG 26 encoding exon 4 and reverse primer LMD 7 encoding exon 7 of the Prx 
gene, at an annealing temperature of 57
o
C and a 35 s extension at 72
o
C. Reverse 
transcription efficiency was evaluated by amplifying a 400 bp fragment of 
housekeeping gene GAPDH using primers GAPDH F1 and GAPDH R1 at an 
annealing temperature of 57
o
C and a 20 s extension at 72
o
C. PCR products were 
resolved on 1.5% agarose gels. 
Predicted DNA fragment sizes: 
PCR amplification of wild-type Prx cDNA would yield a DNA fragment of 513 bp, 
recombined Prx sequence due to Cre-mediated excision of exon 5 (157 bp) would 
give rise to a 356 bp PCR product. If exon skipping of exon 6 (194 bp) in the 
recombined gene occurs, a 162 bp fragment would result. 
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The 356 bp DNA fragment was extracted from an agarose gel, Qiaex-
purified, subcloned into pGEM T-easy (Promega) and sequenced (DNA Sequencing 
& Services, Dundee University). 
2.3.2 Semi-quantitative RT-PCR 
Total RNA was prepared and cDNA synthesized from trigeminal nerves of 3-week-
old WT and PDZ-Prx mice as described. To compare wild-type and mutant 
Periaxin mRNA expression, semi-quantitative RT-PCR was performed by co-
amplification of Periaxin cDNA for a ~400 bp fragment of exon 7 of the Prx gene 
using primers LMD 12 and Peri 15R, and of GAPDH cDNA using primers GAPDH 
F1 and GAPDH R1 as an endogenous control sequence. The relative amount of 
cDNA synthesized from each sample was evaluated by PCR amplification of 
GAPDH using the same primers. Equal quantity of cDNA was used for each 
genotype according to uniform expression of the reference gene. PCR was performed 
using Go Taq polymerase with annealing at 57
o
C and extension at 72
o
C for 20 s. To 
ensure that quantitation was done in the exponential phase of the amplification 
process for both sequences, PCR was performed at 20, 25 and 29 cycles for GAPDH 
and 27, 29 and 32 cycles for Periaxin. 25 cycles for GAPDH and 29 cycles for 
Periaxin were determined for quantitation of mRNA expression levels. PCR products 
were resolved on 1.5% agarose gels, visualized by ethidium bromide under UV light 
and photographed.  
2.4 GST FUSION PROTEIN PULLDOWN ASSAYS 
2.4.1 GST Fusion Protein Production 
GST-DRP2 containing the Periaxin binding domain and GST-fusion protein 
containing the third fibronectin III domain of 4-integrin were generated by Dr. 
Diane Sherman. Briefly, DRP2 (aa 110-390) and 4-integrin 3
rd
 fibronectin III were 
amplified by PCR and subcloned in frame into pGEX-KG for generation of GST 
fusion proteins. GST fusion constructs were transformed into E.coli BL21 
CodonPlus-RIL (DE3) (Stratagene). Recombinant proteins were overexpressed by 
induction of transformed cells at log phase with 1 mM isopropyl-1-thio-D-
galactopyranoside (IPTG) for 3 h at 28
o
C. The bacterial pellet was lysed with 50 mM 
Tris, pH 8.0 and 2 mM DTT containing protease inhibitor cocktail (Roche) by 
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sonication (Branson Digital Sonifier), and the supernatant from a 13000 rpm 
centrifugation (SS34 rotor, Sorvall) was purified on a Glutathione-Sepharose 4B 
(Amersham Pharmacia Biotech) column at room temperature. Recombinant proteins 
were eluted from the column with 10 mM reduced glutathione in 50 mM Tris, pH 
8.0. To remove glutathione, purified fusion proteins were dialyzed against 50 mM 
Tris, pH 8.0 and 100 mM NaCl at 4
o
C. Protein concentration was estimated by 
comparing band intensity with known concentrations of bovine albumin (BSA) on an 
SDS polyacrylamide gel. 
2.4.2 GST Pulldown Assays 
Purified GST fusion proteins were used in GST pulldown assays to be analyzed by 
Western blotting or Coomassie blue stain/proteomics. 
For Western blotting, GST alone or GST-DRP2 (6 g) were coupled to 
Glutathione-Sepharose 4B beads (25 l, Amersham Pharmacia Biotech) by 
incubation for 1 h at room temperature followed by 1 h at 4
o
C in binding buffer (50 
mM Tris, pH 7.5, 200 mM NaCl, 0.5% CHAPS, 1 mM EDTA) containing 
phosphatase (5 mM NaF, 1 mM Na3VO4, 2 mM Na4P2O7) and proteinase inhibitors 
(0.5 mM TLCK, 1 mM benzamidine, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml 
antipain). Beads were washed three times with binding buffer to remove ethanol in 
the storage buffer prior to incubation with GST-fusion proteins. Following binding 
with GST-fusion proteins, beads were washed four times with binding buffer. Sciatic 
nerves of 6-week-old WT and PDZ-Prx mice were homogenized in binding buffer, 
lysed on ice for 20 min, and centrifuged for 20 min at 13000 rpm at 4
o
C. 1/10 
volume of the cleared lysate was removed and used as input for Western blotting. 
The washed beads were incubated with the homogenate in binding buffer for 3 h at 
4
o
C with rotation on a rotating wheel. The beads were washed 6-10 times in binding 
buffer, followed by once with binding buffer lacking detergent. Proteins were eluted 
with SDS-PAGE sample buffer (50 mM Tris pH 6.8, 2% SDS, 0.1% bromophenol 
blue, 10% glycerol) containing 100 mM dithiothreitol (DTT), resolved on 5.5% SDS 
polyacrylamide gels, transferred to nitrocellulose and analyzed by Western blotting 
using anti-Periaxin repeat region (1:30,000). 
For the purpose of N-terminal protein sequencing of mutant Periaxin, GST 
alone or GST-4-integrin 3
rd
 fibronectin III (6 g) were coupled to Glutathione-
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Sepharose 4B beads as described. This pulldown assay was performed by Dr. Diane 
Sherman. Trigeminal and sciatic nerves from 6-week-old PDZ-Prx mice were 
homogenized in binding buffer. The washed beads were incubated with the 
homogenate in binding buffer for 3 h at 4
o
C with rotation. The beads were washed 
extensively in binding buffer, and proteins were eluted with SDS-PAGE sample 
buffer and resolved in 6% SDS polyacrylamide gels. Proteins on SDS gels were 
stained with 0.1% Coomassie Blue G, 45% methanol and 10% glacial acetic acid for 
1 h at room temperature, followed by destaining with 10% glacial acetic acid and 
20% methanol to visualize the mutant Periaxin band. The eluted sample was sent for 
N-terminal Edman degradation sequencing (Aberdeen Proteomics, University of 
Aberdeen).   
2.5 YEAST TWO-HYBRID INTERACTIONS 
2.5.1 Generation of Periaxin PDZ mutant constructs as the bait plasmid 
2.5.1a- Periaxin PDZ domain deletion mutants 
PDZ1 (nt 345-581; aa 25-103) and PDZ6 (nt 276-536; aa 2-88) (Fig. 12) were 
amplified by PCR with introduction of an EcoRI restriction site at the 5’ end and a 
termination codon and BamHI site at the 3’ end. The PCR template was rat L-
Periaxin cDNA in pSPORT (Gibco BRL). PCR reaction was performed using 
Phusion High-Fidelity DNA Polymerase (Finnzymes) with primers Peri 96 and 97 
for PDZ1, and DLS 29 and Peri 98 for PDZ6. PCR conditions were: initial 
enzyme activation at 98
o
C for 30 s; followed by 35 cycles consisting of denaturation 
at 98
o
C for 10 s, annealing at 58
o
C for 30 s and extension at 72
o
C for 8 s. PCR 
products were purified and restriction digested with EcoRI and BamHI, and 
subsequently subcloned in frame into pAS2-1 and pGBKT7 yeast GAL4 DNA 
binding domain vectors (Clontech) to produce GAL-4 binding domain fusion 
proteins. 1U of T4 DNA ligase (Fermentas) with Quick Ligation buffer (New 
England BioLabs) was used for a 15 min ligation at room temperature. Competent 
DH5 cells were transformed (Sambrook and Russell, 2001), and plated on LB agar 
containing 0.1 mg/ml carbenicilin for pAS2-1 constructs or 25 g/ml kanamycin for 
pGBKT7 constructs. Randomly selected colonies were checked for inserts by colony 
PCR using Go Taq polymerase with forward primer BDF in the vector and reverse 
 68 
primer Peri 97. Colony PCR cycling parameters were: 1 cycle of denaturation at 
94
o
C for 1 min 30 s, annealing at 55
o
C for 30 s and extension at 72
o
C for 20 s for a 
400 bp product, followed by 35 cycles of 94
o
C for 40 s, 55
o
C for 30 s and 72
o
C for 
20 s. The final cycle consisted of 94
o
C for 40 s, 55
o
C for 30 s and 72
o
C for 2 min. 
Plasmid DNA containing the insert was purified using Nucleospin Plasmid 
DNA purification kit (MACHEREY-NAGEL) and sequenced (DNA Sequencing & 
Services, Dundee University). 
 
 
Figure 12. Periaxin PDZ domain deletion mutant constructs PDZ1 and 
PDZ6 in yeast. 
2.5.1b- Periaxin PDZ domain single amino acid mutations 
Single amino acid changes in Periaxin PDZ domain were introduced by PCR site-
directed mutagenesis using a Quikchange site-directed mutagenesis kit (Strategene). 
Aspartate 63, glutamate 18, threonine 23 and glycine 31 were substituted by an 
alanine to generate the following PDZ domain mutants (nt 276-581; aa 2-103): PDZ-
D63A, PDZ-E18A, PDZ-T23A and PDZ-G31A. In brief, site-directed mutagenesis 
was performed using PfuUltra II polymerase (1.25 U, Strategene) on rat L-Periaxin 
cDNA in pCB6 (10 kb, from Dr. Diane Sherman) with primers containing the desired 
mutation (see below). The PCR conditions were: 1 cycle of 95
o
C denaturation for 30 
s, 16 cycles of denaturation at 95
o
C for 30 s, annealing at 55
o
C for 1 min and 
extension at 68
o
C for 10 min. The PCR product was treated with DpnI for 1 h at 
37
o
C to digest methylated, non-mutated parental DNA template. The mutated 
plasmid was transformed into DH5 competent cells. Mutations were later 
confirmed by sequencing. Periaxin PDZ domain region (aa 2-103) harboring the 
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desired mutations was amplified by PCR using Phusion polymerase at an annealing 
temperature of 58
o
C and a 9 s extension at 72
o
C, with 5’ EcoRI and 3’ BamHI sites 
introduced. The primers were DLS 29 and Peri 97. Following restriction digestion 
and Qiaex-purification, PCR products were subcloned as described. Plasmid DNA 
was purified using Nucleospin columns and sequenced. All constructs generated by 
PCR were confirmed by DNA sequencing. Positive control PDZ (nt 276-581; aa 2-
103) in pAS2-1 was provided by Dr. Diane Sherman.  
 
Primer sequences: 
PDZ1 (nt 345-581; aa 25-103) 
Peri 96 F 5’-CGGAATTCGCACAGACCGGGGTCAGC-3’ EcoRI 
Peri 97 R 5’-CGGGATCCTCACCCGGTGGGCACAGTGCGCTTC-3’ Stop, BamHI 
 
PDZ6 (nt 276-536; aa 2-88) 
DLS 29 F 5’-GGGATTCGAGGCCAGGAGCCGCAGCGCT-3’ EcoRI 
Peri 98 R 5’-CGGGATCCTCACTCTGCGCATTGCAGCAGGC-3’ Stop, BamHI 
 
PDZ-E18A (nt 276-581; aa 2-103) 
Peri 101 F 5’-GAGCGGAGTTGGTGGCCATTATCGTGGAGACAG-3’ 
Peri 102 R 5’-CTGTCTCCACGATAATGGCCACCAACTCCGCTC-3’ 
 
PDZ-T23A (nt 276-581; aa 2-103) 
Peri 103 F 5’-GAGATTATCGTGGAGGCAGAGGCGCAGACCG-3’ 
Peri 104 R 5’-CGGTCTGCGCCTCTGCCTCCACGATAATCTC-3’ 
 
PDZ-D63A (nt 276-581; aa 2-103) 
Peri 105 F 5’-GTTTGCAGGAAGGGGCCCAACTTCTGAGCGC-3’ 
Peri 106 R 5’-GCGCTCAGAAGTTGGGCCCCTTCCTGCAAAC-3’ 
 
PDZ-G31A (nt 276-581; aa 2-103)                
Peri 115 F 5’-ACCGGGGTCAGCGCCTTCAATGTAGCA -3’ 
Peri 116 R 5’-CTGCTACATTGAAGGCGCTGACCCCGGT-3’ 
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2.5.2 Yeast-two-hybrid interaction assays 
Yeast strain Y190 (Clontech) containing lacZ as a reporter gene was used for yeast 
two-hybrid interactions. Interactions were performed by co-transformation of the bait 
plasmid and the prey plasmid in Y190 or by yeast mating. PDZ (nt 276-764; aa 2-
164) in GAL4 activation domain vector pACT2 (Sherman et al., 2001) was used as 
the prey plasmid in the interaction assays. For yeast mating, the bait in yeast strain 
Y190 was mated with the prey in strain Y187 (Clontech) according to the 
manufacturers’ instructions (Clontech). 
2.5.2a- Yeast transformation 
Yeast transformation was based on the lithium acetate (LiAc)-mediated TRAFO 
method (Gietz and Schiestl., 1995). Frozen glycerol stock of Y190 strain was 
recovered on a YPAD agar plate at 30
o
C for 72 h. 5 ml liquid YPAD was inoculated 
with a 2-3 mm yeast colony and incubated with shaking overnight at 30
o
C. The 
following day, 50 ml liquid YPAD was inoculated with the overnight culture to a cell 
density of 510
6
/ml and incubated at 30
o
C with shaking at 200 rpm until a cell 
density of 210
7
/ml was reached. The yeast culture was centrifuged at 3000  g for 4 
min and cells were resuspended in sterile MiliQ water. After centrifugation, yeast 
cells were resuspended in 1 ml 100 mM LiAc (Sigma) and pelleted again at 13000 
rpm for 15 s. LiAc was removed and cells were resuspended to a final density of 
210
9
/ml in 100mM LiAc. 50 l of resuspended cells was used for one 
transformation. The transformation mix was prepared by adding in sequence: 
240 l polyethylene glycol (PEG, MW 3350, 50 % w/v, Sigma) 
36 l 1M LiAc 
25 l sheared salmon sperm DNA (2 mg/ml, Eppendorf) 
50 l sterile MiliQ water and 1 g plasmid DNA  
The mix was vortexed vigorously for 1 min prior to incubation at 30
o
C for 30 min, 
followed by a 22 min heat shock at 42
o
C. Cells were pelleted at 7000 rpm for 15 sec, 
gently resuspended in sterile water and plated on synthetic minimal (SD) agar 
lacking tryptophan for selection of transformants. The omission of tryptophan from 
SD medium selects for the GAL4-binding domain vectors, pAS2-1 and pGBKT7, 
which contain the TRP1 gene, whereas excluding leucine from SD medium selects 
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for activation domain vector pACT2, which contains the LEU2 gene. Leaving out 
both amino acids from SD medium selects for both vectors. 
Co-transformation of both the bait and prey plasmid was performed as 
described, and co-transformants were selected on SD agar plates lacking both 
tryptophan and leucine. Plates were incubated at 30
o
C for 72 h, and transformant 
colonies were tested for -galactosidase activity by filter-lift assay thereafter.  
2.5.2b- Preparation of yeast protein extracts 
After incubating for 72 h at 30
o
C, a single colony of each transformed yeast strain 
was streaked out and incubated in SD medium without tryptophan at 30
o
C with 
shaking at 200 rpm for 48 h. The culture was vortexed and pelleted at 2500 rpm for 5 
min at 4
o
C. The supernatant was removed and pellet was snap-frozen in liquid 
nitrogen. Subsequently, the pellet was thawed and resuspended in 60
o
C pre-warmed 
cracking buffer consisting of 8M urea, 5% (w/v) SDS, 40 mM Tris-HCl, pH 6.8, 0.1 
mM EDTA, 0.4 mg/ml bromophenol blue, 10 l/ml -mercaptoethanol, 0.1 mg/ml 
pepstatin A, 0.03 mM leupeptin, 145 mM benzamidine, 0.5 mg/ml antipain and 5 
mM PMSF. The cell suspension was transferred to a microcentrifuge tube containing 
glass beads (Sigma), incubated at 70
o
C for 10 min, and vortexed vigorously for 1 
min for yeast cell wall disruption. Following centrifugation at 13000 rpm for 5 min, 
the supernatant was boiled for 5 min and proteins were resolved by SDS-PAGE on 
14% gels. Protein expression of PDZ domain mutants was analyzed by Western 
blotting using anti-Periaxin N-terminus and anti-c-myc antibodies. 
2.5.2c- Yeast mating 
The bait in yeast strain Y190 was mated with the prey in strain Y187 (Clontech) in a 
96-well plate. A single transformant colony of each type was resuspended in YPAD 
medium. Aliquots of cell suspensions containing the bait and prey plasmids were 
incubated in the same well at 30
o
C overnight with shaking at 200 rpm. Next day, the 
mating culture was plated on SD agar without tryptophan and leucine, and tested for 
interaction by filter-lift assay 48 h later.   
2.5.2d- Filter-lift assays 
Interactions were tested for -galactosidase activity by filter-lift assay, which was 
semi-quantitatively assessed by the amount of time taken for the development of blue 
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colonies: +++, <30 min; ++, 30-60 min; +, 60-180 min. In brief, for each plate of 
transformants to be assayed, a sterile filter paper (Whatman No. 5, 70 mm) was pre-
soaked in 1 ml Z buffer (16.1 g/L Na2HPO4, 5.5 g/L NaH2PO4, 0.75 g/L KCl, 0.246 
g/L MgSO4, pH 7.0) containing  1.5 mg X-gal and 2.7 l -mercaptoethanol in a 
clean petri dish. A sterile, dry filter was placed over the surface of the plate of 
transformants and rubbed gently to collect colonies. The filter was snap-frozen for 15 
s in liquid nitrogen, and then thawed at room temperature. This step was repeated. 
The filter containing transformant colonies was placed on the pre-soaked filter, and 
incubated at 37
o
C for development of blue colonies.  
2.6 CELL CULTURE 
2.6.1 General cell culture 
HEK 293 cell line was used for all transfection experiments in this work due to high 
efficiency of transfection and recombinant protein production (Thomas and Smart, 
2005). Most importantly, the cell line, from human embryonic kidney origin, does 
not contain endogenous Periaxin. Therefore, any Periaxin levels detected are solely 
attributed to the exression of recombinant Periaxin. HEK 293 cell line was 
maintained in complete Dulbecco's Modified Eagle's medium (DMEM) containing 
10% fetal calf serum (FCS, Sigma), 2 mM L-glutamine (Sigma), 100 U/ml penicillin 
and 100 g/ml streptomycin (Sigma) at 37
o
C in a humidified CO2-enriched 
incubator. When ~90% confluent, cells were passaged by washing once with sterile 
PBS followed by incubating for 1-3 min in 0.25% (w/v) Trypsin/EDTA. After 
adding complete DMEM medium, the cells were pelleted by centrifugation at 1000  
g for 3 min. Cells were gently resuspended in 1 ml complete medium and plated 
either on glass coverslips or tissue culture Petri dishes (Greiner Bio-one) at the 
appropriate densities for transient transfection experiments. Alternatively, cells were 
frozen in 20% FCS, 10% DMSO in DMEM at -80
o
C overnight, and then transferred 
to liquid nitrogen for long-term storage. 
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2.7 CELL TRANSFECTION 
2.7.1 Generation of constructs for transfection 
2.7.1a- FLAG-tagged and myc-tagged full length Periaxin  
Generation of rat full length L-Periaxin cDNA (nt 268-4421; aa 1-1384) in 
mammalian expression vectors pFLAG-CMV5a (Sigma) with an introduced XbaI 
site and pCB6myc  (gift of D.Russell, University of Texas) was performed by Dr. 
Diane Sherman, as previously described (Sherman et al., 2001). The constructs were 
expressed as full length Periaxin with a C-terminal myc-epitope tag and a C-terminal 
FLAG tag, respectively, and were used as positive controls. 
2.7.1b- FLAG-tagged mutant Periaxin PDZ-Prx lacking the PDZ domain 
To generate PDZ-Prx (nt 618-4421; aa 116-1384) in pFLAG-CMV5a, KpnI site (nt 
1323) in L-Periaxin cDNA and XbaI site upstream of the triple c-myc epitope tag in 
pCB6 were digested and inserted into cloning vector pSP72 to generate Peri-pSP72. 
The 5’end of PDZ-Prx up to downstream of the KpnI site was amplified by PCR 
using Phusion polymerase, with a BglII site introduced at the 5’ end, at an annealing 
temperature of 57
o
C and extension at 72
o
C for 1.5 min. The template was rat L-
Periaxin cDNA in pSPORT using primers Peri 89 and CSG 3. The PCR product was 
purified, restriction digested with BglII and KpnI, and cloned into BglII/KpnI 
digested Peri-pSP72. Correct sequence of the PCR generated region in the construct 
was confirmed by DNA sequencing. PDZ-Prx cDNA was excised from pSP72 by 
BglII and XbaI, and cloned into BglII/XbaI digested pFLAG-CMV5a. This indirect 
strategy was used due to the presence of a KpnI site in pFLAG-CMV5a. The 
orientation of the insert was confirmed by restriction digestion. Plasmid DNA was 
sequenced to check for in frame insertion, and subsequently prepared for transfection 
using the Qiagen midiprep kit with endotoxins removed. 
2.7.1c- myc-tagged full length Periaxin with single amino acid changes in PDZ 
domain 
Single amino acid mutations (T23A, G31A and D63A) in the PDZ domain of full 
length Periaxin in pCB6 were introduced by site-directed mutagenesis as described. 
The 5’end up to the KpnI site in L-Periaxin cDNA containing the desired mutation 
was excised with BglII and KpnI, and subsequently subcloned into BglII/KpnI 
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digested non-mutated L-Periaxin in pCB6. The resulting mutant constructs were 
purified for transfection using Nucleospin columns, and sequenced to check for 
orientation and fidelity of the subcloned region. 
2.7.2 In vitro transient transfection 
HEK 293 cells were either seeded at 2  10
5
 cells/ 35 mm Petri dish containing poly-
D-lysine-coated (80 µg/ml, Sigma) acid-washed 13 mm glass coverslips or  6  10
5
 
cells/60 mm Petri dish 1 day before transfection. FuGENE 6 Transfection Reagent 
(Roche): DNA ratio of 3:1 was used for all transfections. For a 60 mm dish, 9 l 
FuGENE 6 Reagent was incubated in 191 l Opti-MEM I (Gibco) for 5 min at room 
temperature. Plasmid DNA of interest in total of 3 µg was added to the diluted 
FuGENE solution and incubated for 20 min at room temperature before adding to the 
cells. For a 35 mm dish, cells on coverslips were transiently transfected with 100 µl 
Opti-MEM I containing 1 µg DNA and 3 µl FuGENE 6 Reagent. Cells were 
harvested 24 h and 48 h later for immunostaining and co-immunoprecipitation, 
respectively.   
2.8 CO-IMMUNOPRECIPITATION 
2.8.1 Preparation of cell lysates and co-immunoprecipitation 
48 h following transfection, cells were washed once with cold PBS, scraped off the 
dish and lysed with IP buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 
1 mM EDTA, and phosphatase and proteinase inhibitors: 5 mM NaF, 1 mM Na3VO4, 
2 mM Na4P2O7, 0.5 mM TLCK, 1 mM benzamidine, 1 mM PMSF, 10 µg/ml 
leupeptin, 10 µg/ml antipain) for 30 min at 4
o
C on wheel. Following centrifugation at 
13000 rpm for 20 min at 4
o
C, 1/10 of the lysate was set aside as input and the rest 
was incubated with 16 l washed anti-FLAG M2 affinity gel (Sigma) at 4
o
C 
overnight on wheel. Next day, the coupled FLAG M2 beads were pelleted by 
centrifugation at 6000 rpm, and washed 6-10 times with IP buffer and once with the 
same buffer without detergent.  Immunoprecipitated proteins were eluted with SDS-
PAGE sample buffer and resolved on 5.5% SDS polyacrylamide gels. Protein 
interaction was analysed by Western blotting using anti-FLAG M2 monoclonal 
antibody (1:8000, Sigma) and anti-c-myc (9E10), 1:10. The experiment was 
performed at least three times, including transient transfections. 
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2.9 SDS-PAGE AND WESTERN BLOTTING 
2.9.1 Protein extraction from peripheral nerves 
For general immunoblotting (for Periaxin, DRP2, -actin), trigeminal or sciatic 
nerves from 3-week and 4-month-old mice were dissected and homogenized in pre-
warmed 2% SDS by boiling for 5 min. Following centrifugation at 13000 rpm for 5 
min at room temperature, the cleared supernatant was recovered and stored at -80
o
C 
until use. Protein concentration of the homogenate was determined by BCA assay 
(Pierce) according to the manufacturers' instructions. Proteins were diluted and 
denatured by boiling in SDS sample buffer, and separated by electrophoresis on SDS 
polyacrylamide gels. 
For immunoblotting for signal transduction proteins, e.g. AKT, ERK1/2, Dlg-
1 and mTOR, sciatic nerves from mice of various ages were dissected and transferred 
to ice cold PBS containing phosphatase inhibitors: 5 mM NaF, 1 mM Na3VO4, 2 mM 
Na4P2O7. The epineurium and perineurium were removed, and nerves were 
homogenized in RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% 
SDS, 0.5% sodium deoxycholate, 1 mM EDTA) containing phosphatase and 
proteinase inhibitors on ice for 25 min. The supernatant was recovered after 
centrifugation at 13000 rpm at 4
o
C for 20 min. Protein concentration was determined 
and proteins were prepared in SDS sample buffer as described. At least 50 g of 
protein was loaded for detection of Dlg-1, PTEN and phosphorylated signal 
transduction proteins by Western blot. 
2.9.2 Western Blotting 
Following SDS-PAGE, proteins were transferred electrophoretically to nitrocellulose 
membrane (0.45 µm, Schleicher and Schuell) in transfer buffer containing 25 mM 
Tris pH 8.3, 192 mM glycine, and 20% methanol for 4 h (or overnight for signal 
transduction proteins) at 400 mA. Membranes were blocked for 1 h with 5% non-fat 
milk in Tris-buffered saline, 0.1% Tween 20 (TBST), and then probed with primary 
antibodies diluted in 1% non-fat milk in TBST for 1.5 h at room temperature. 
Dilutions of primary and secondary antibodies for Western blotting were specified in 
Table 2. The membranes were washed several times with TBST before incubation 
with HRP-conjugated secondary antibodies for 1 h at room temperature. Subsequent 
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to 4-5 washes of 10 min with TBST, the blots were visualized by 
electrochemiluminescence (ECL) detection (Santa Cruz). 
2.10 INDIRECT IMMUNOFLUORESCENCE 
Immunofluorescence was performed on teased fibers, frozen cryosections and 
cultured cells.  
2.10.1 Teased fiber preparation 
Mouse quadriceps nerves were removed and immersion fixed for 30 min in 4% 
paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4). Nerves were washed 
several times with phosphate buffer and transferred into a 35 mm Petri dish 
containing PBS. The perineurium was removed, and nerve fiber bundles were 
separated and teased into individual fibers with acupuncture needles in a drop of 
phosphate buffered saline (PBS, pH 7.4) on 3-aminopropyltriethoxysilane (TESPA, 




2.10.2 Cryostat sections 
Quadriceps and sciatic nerves from mice were dissected, fixed and washed as for 
teased fiber preparation. Nerves were cryoprotected using a sucrose gradient of 5%, 
10% and 25% in 0.1 M sodium phosphate buffer, and subsequently embedded in 
OCT embedding matrix (CellPath, Ltd) and frozen with isopentane cooled in liquid 
nitrogen. The blocks were stored at -80
o
C until use. Longitudinal sections were cut at 
7 µm, and transverse sections at 10 µm on a Leica CM 3050 S cryostat. Sections 
were collected on TESPA-coated glass slides, dried and stored at -20
o
C until needed. 
Prior to immunostaining, slides were rinsed twice with PBS to remove OCT. 
2.10.3 Immunohistochemistry 
Teased fibers or cryosections were blocked with 5% fish skin gelatin, 0.2% Triton X-
100 in PBS for 1 h, followed by primary antibody incubation in the same blocking 
solution in a humidified chamber overnight at room temperature. Primary and 
secondary antibodies were diluted as shown in Table 2. After washing with at least 
four changes of 0.1% Triton X-100 in PBS, slides were incubated with fluorescent-
conjugated secondary antibodies in blocking solution for 1.5 h in the dark at room 
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temperature. Slides were washed several times with PBS and mounted in Vectashield 
(Vector Labs, Burlingame, California) containing DAPI (Sigma). 
2.10.4 Fixation and immunostaining of cultured cells 
24 h post-transfection, HEK 293 cells grown on poly-D-lysine-coated 13 mm glass 
coverslips were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 20 
min, washed three times with PBS, and blocked for 30 min prior to incubation with 
primary antibodies on parafilm for 1 h at room temperature in a humidified Petri 
dish. To check for expression of transfection constructs, immunolabeling with anti-
FLAG and anti-myc antibodies was performed. Coverslips were washed with four 
changes of PBS and incubated with secondary antibodies in the dark for 1 h at room 
temperature. After washing with PBS, cells on coverslips were mounted in 
Vectashield.  
2.10.5 Image acquisition 
Bright field and fluorescence imaging for morphometric analysis were performed 
using an Olympus BX60 microscope equipped with a Hamamatsu ORCA-ER digital 
camera with assistance of the software OpenLab (version 5.5.2). For confocal laser 
scanning microscopy, a Leica TCL-SL confocal microscope with a 40× or a 63× 
objective, 1.4 NA, and Leica proprietary software was used for acquiring 
fluorescence and phase contrast images of teased fibers and fluorescence images of 
cryosections. FITC- and TRITC-fluorophores were excited with an Argon (488 nm) 
and HeNe (543 nm) laser, respectively. Z stacks were assembled using the maximum 
projection tool of the imaging software. Figures were prepared using Adobe 
Photoshop CS4 extended version 11 (Adobe Systems).  
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Table 2. Reagents used for immunfluorescence and Western blot 
Primary antibodies, secondary antibodies and fluorophore-conjugated dyes used in 
the present study are shown in the following tables. 
(IF: immunofluorescence; WB: Western blot) 
Primary antibodies 
Antibody name Species Source Dilution (IF) Dilution 
(WB) 
Anti- actin Rabbit P.J.Brophy - 1:10000 
Anti-AKT  Rabbit Cell 
Signaling 
- 1:1000 
Anti-c-myc (clone 9E10) Mouse 
(Hybridoma) 
P.J.Brophy - 1:10 
Anti-c-myc (clone 9E10) Mouse Sigma 1:200 - 
Anti-Dlg1 (SAP 97) Mouse Enzo 
Lifesciences 
1:100 1:1000 
Anti-DRP2 2155 Rabbit P.J.Brophy - 1:3000 
Anti-DRP2 2164 Rabbit P.J.Brophy 1:300 - 
Anti-dystrophin 
(MANDRA I) 
Mouse IgG1 Sigma 1:150 - 
Anti-ERK1 (K-23) Rabbit Cell 
Signaling 
- 1:1000 
Anti-FLAG Rabbit Sigma 1:400 - 
Anti-FLAG M2 Mouse IgG1 Sigma - 1:8000 
Anti-Gliomedin (720) Rabbit E. Peles 1:500 - 
Anti-Krox-20 Rabbit Covance 1:200 1:500 
Anti-Kv1.1 channel Rabbit Chemicon 1:200 - 
Anti-MBP (pep7) Rabbit P.J.Brophy 1:400 1:3000 





Rabbit P.J.Brophy 1:1000 - 
Anti-Neurofascin (NF155 
NFC3) 
Sheep P.J.Brophy 1:1000 - 
Anti-Neurofilament  
200 kDa 
Mouse IgG1 Sigma 1:1000 1:10000 
Anti-P0 Rabbit D.Colman - 1:3000 
Anti-P0 Chicken IgY Aves Labs 1:100 - 
Anti-p75 NGFR Rabbit Millipore 1:1000 - 
Anti-pan Na
+
 channel Mouse IgG1 Sigma 1:200 - 
Anti-pan Neurofilament 
R39 
Rabbit D.Dahl 1:400 - 
Anti-Periaxin  
(Repeat region) 
Rabbit P.J.Brophy 1:8000 1:30000 
Anti-Periaxin (C-
terminus) 




Rabbit P.J.Brophy 1:2000 1:20000 



















Anti-PTEN (9552) Rabbit Cell 
Signaling 
- 1:1000 
Anti-Radixin (RAD4) Rabbit P.J.Brophy 1:400 - 






Anti-Sox10 Guinea pig M.Wegner 1:1000 - 
Anti-Tubulin (ICN) Rabbit P.J.Brophy - 1:1000 
 
Secondary Antibodies 
Antibody name Species Source Dilution  
FITC-conjugated anti-rabbit IgG Donkey Jackson 1:100 
FITC-conjugated anti-rabbit IgG Goat Cappel 1:200 
FITC-conjugated anti-mouse IgG1 Goat Southern Biotec 1:200 
TRITC-conjugated anti-mouse IgG1 Goat Southern Biotec 1:200 
TRITC-conjugated anti-chicken IgY Donkey Jackson 1:75 
TRITC-conjugated anti-guinea pig IgG Donkey Jackson 1:200 
Cy3-conjugated anti-rabbit Donkey Jackson 1:500 
HRP-conjugated anti-rabbit IgG Goat Jackson 1:50000 
HRP-conjugated anti-mouse IgG Goat Jackson 1:20000 
Fluorescent-conjugated dyes 
Antibody name 
Source Dilution  
Alexa 568-conjugated phalloidin Invitrogen 1:50 
DAPI, 4',6-diamidino-2-phenylindole Sigma 4 g/ml 
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2.11 ELECTRON MICROSCOPY 
Mice were terminally anesthetized with intraperitoneal injection (i.p.) of 
pentobarbital (0.2 mg/g body weight) and perfused transcardially with freshly 
prepared fixative containing 4% paraformaldehyde, 2.5% glutaraldehyde in 80 mM 
sodium cacodylate buffer, pH 7.4. Quadriceps nerves were dissected and immersion 
fixed in the same fixative for 4 h at room temperature then overnight at 4
o
C. Next 
day, nerves were washed twice with 0.1 M sodium cacodylate buffer, pH 7.4, 
followed by post-fixation in 1% osmium tetroxide (OsO4) in 0.1 M sodium 
cacodylate buffer for 1 h at room temperature. Subsequently, nerves were washed 3 
times with 0.1 M cacodylate buffer prior to dehydration through an ascending series 
of ethanol (50%, 70%, 90%) for 5 min each, three 10-min changes of absolute 
ethanol and finally two changes of propylene oxide for 15 min each. The tissue was 
infiltrated with a 1:1 (v/v) mixture of araldite (araldite CY212 and DDSA, Agar 
Scientific) and propylene oxide for 1 h followed by araldite overnight at room 
temperature. After incubating in fresh araldite containing polymerizer (dibutyl 
phthalate (DBT) and benzyldimethylamine (BDMA), Agar Scientific) for 2 h, nerves 
were embedded in araldite in transverse orientation in flat silicone moulds. Resin 
was polymerized at 60
o
C for 48 h.  
400 nm thick semithin cross sections were cut on a Leica Ultracut UCT 
ultramicrotome, stained with 1% Toluidine in 1% borate buffer, mounted in Cytoseal 
mounting medium (VWR) and examined by bright field microscopy. Images were 
captured at 20, 40 and 100 magnifications using a digital camera with Openlab 
software. Ultrathin sections of 70 nm were stained with uranyl acetate and lead 
acetate and examined on a Philips/FEI CM120 BioTwin electron microscope. EM 
images were acquired using an Orius TEM SC1000 camera (Gatan). Ultrathin 
sectioning and staining were performed by Stephen Mitchell at the EM facility. 
For osmicated teased fiber preparation, following transcardial perfusion 
quadriceps nerves were excised and fixed as described. Nerves were post-fixed in 
1% OsO4 in 0.1 M sodium cacodylate buffer for 1 h at room temperature and 
subsequently washed with 0.1 M sodium cacodylate buffer. Nerve fibers were teased 
into single fibers in a drop of PBS on TESPA-coated slides, mounted in glycerol and 
examined by bright field microscopy. 
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2.12 MORPHOMETRY 
2.12.1 Internodal length measurements 
Teased single fibers isolated from quadriceps nerves of 3-week-old WT, PDZ-Prx, 
Prx KO, and Cnp-Cre
+/-
 were immunostained with monoclonal mouse anti-
dystrophin (Mandra I, Sigma) 1:150, Alexa 568 conjugated-phalloidin and DAPI, 
and imaged at 10 magnification in a camera-equipped fluorescence microscope 
with OpenLab acquisition software. The distance between two nodes of Ranvier was 
measured using the same software. At least 100 Schwann cell internodes were 





/P0CreERT Schwann cells, teased 
fibers were immunolabeled with anti-dystrophin and anti-Periaxin N-terminus or 
anti-DRP2. Internodal lengths of recombined Prx
fl/fl
/P0CreERT fibers lacking 
Periaxin N-terminus immunoreactivity or DRP2 patches were determined. 
For refined internodal length measurements to select for large diameter 
axons, teased fibers from 3-week-, 6-week- and 4-month-old WT and PDZ-Prx 
quadriceps nerves were immunolabeled with anti-dystrophin (Mandra I), anti-pan 
neurofilament R39 and DAPI, and imaged using a 10 objective using a digital 
camera. Axon diameter was estimated as the mean width of each neurofilament-
labeled axon at two positions along the measured internode. To determine the cut-off 
diameter for large caliber axons, 50% of total number of WT fibers at each age 
representing the percentage of large diameter axons, were taken into account. 
Average internodal length for large caliber fibers was computed from internodal 
lengths of myelinated fibers with axon diameter larger than or equal to the cut-off 
diameter. At least 100 Schwann cell internodes were measured per animal (n=3 for 
each group). 
2.12.2 Schmidt-Lanterman incisure analysis 
Quadriceps nerves from 2-month-old WT and PDZ-Prx mice were dissected, fixed 
and teased as described. Teased fibers were stained with rabbit anti-RAD4 1:400 
Alexa 568 conjugated-phalloidin and DAPI. Images were captured using a digital 
camera at 10 magnification with Openlab software. Internodal distance was 
measured as the distance between two RAD4-labeled Schwann cell microvilli. The 
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number of SLIs was counted along each internode in randomly chosen individual 
fibers. At least 100 internodes per animal (n=3 per group) were analyzed. The 
number of SLIs per 100 µm fiber length was presented. 
2.12.3 Ratios of myelinating to non-myelinating Schwann cells 
Cryostat cross sections of sciatic nerves  of 3 weeks and quadriceps nerves from WT, 
PDZ-Prx and Prx KO mice of 4 months were prepared as described. Sections were 
immunolabeled with rabbit anti-Krox20 for Schwann cells committed to myelination, 
and guinea pig anti-Sox10 for both myelinating and non-myelinating Schwann cells. 
Images were acquired with a 20 objective in a fluorescence microscope using a 
digital camera with Openlab software. The numbers of Krox20- and sox10-
immunopositive cells were counted per cross section of each genotype (n=3 for each 
group). 
2.12.4 Apposition and g-ratio analysis 
Quadriceps nerves from 3-week-old WT and PDZ-Prx mice were prepared for 
electron microscopy as described. Digitized electron micrographs of ultrathin cross 
sections of quadriceps nerves were analyzed for apposition numbers and g-ratios. 
Axon area, fiber area and the number of appositions per nerve fiber were measured 
using NIH Image (Image J) software. For apposition counts, at least 100 randomly 
selected nerve fibers were analyzed, excluding those surrounded by a Schwann cell 
nucleus or a Schmidt-Lanterman incisure. For g-ratio analysis, images were 
calibrated based on the scale bar corresponding to the magnification used for each 
micrograph. The axon (without myelin) and fiber areas (including myelin) of 
randomly chosen fibers were measured, except for those surrounded by a Schmidt-
Lanterman incisure. The axon and fiber diameters were estimated as 2(area/) and 
g-ratio was calculated as axon diameter/fiber diameter. At least 100 nerve fibers per 
animal (n=3 for each group) were analyzed. 
2.12.5 Analysis of abnormal myelin profiles, myelinated axon numbers and 
nerve area 
Semithin transverse sections (400 nm) from quadriceps nerves of 2-, 4-, 6- and 9-
month-old WT, PDZ-Prx and Prx KO mice were examined by bright field 
microscopy in a light microscope, and imaged with a 40 oil objective using a digital 
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camera with Openlab software. A series of 40 images were edited into a continuous 
complete quadriceps nerve cross section using Photoshop CS. The total number of 
myelinated axons was counted per cross section. Thinly myelinated or demyelinated 
axons were also counted. The proportion of fibers with tomacula and folded myelin, 
as indicated by redundant myelin loops, was calculated as the percentage of 
abnormal myelin profiles. The proportion of thinly myelinated or demyelinated 
axons surrounded by processes of supernumerary Schwann cells was determined as 
the percentage of onion bulbs. For nerve area analysis, semithin transverse sections 
from quadriceps nerves were imaged at 20 magnification using a digital camera. 
Nerve area was measured by NIH Image software. The area of the nerve cross 
section was measured three times by outlining its outer border and averaged. At least 
3 animals per genotype for each time point were analyzed. 
2.12.6 Analysis of paranodal myelin tomacula 
Osmicated teased fibers of quadriceps nerves from 6-week-old WT and PDZ-Prx 
mice were examined by bright field microscopy. Images were captured with a 20 
objective using a digital camera with Openlab. The proportion of paranodes with 
myelin tomacula was computed as the percentage of paranodal myelin thickenings. 
At least 430 paranodes were examined per animal (n=3) for each genotype.  
2.13 PHYSIOLOGY AND BEHAVIORAL ANALYSIS 
2.13.1 Nerve Conduction Velocity 
Femoral nerves+quadriceps branch were dissected from WT, PDZ-Prx and 
Periaxin-null mice of various ages (3 weeks, 6 weeks, 4 months and 10 months of 
age; n=5-10), and maintained in oxygenated mammalian HEPES physiological 
solution containing 137 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5.5 mM 
D-glucose and 5 mM HEPES, pH 7.2-7.4. For periods of no longer than 10 min, 
nerves were transferred and placed on an array of Ag/AgCl electrodes with 1 mm 
intervals in an isolated chamber and surrounded by liquid paraffin kept at 37
o
C. 
Compound action potentials (CAP) were recorded from the distal end of the 
quadriceps branch by stimulating the proximal end of the femoral nerve with a 
square wave (0.15 ms, 0.1-1.5 V). Depending on the length of the nerves, the 
conduction distance was altered from 3 mm to max. 11 mm by adjusting the position 
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of the stimulating electrode, except for 3-week-old nerves, in which conduction 
distance varied from 2 to 7 mm. The voltage of stimulus was adjusted to ensure 
excitation of the exact active population of nerve fibers. Signals of CAP were 
converted to digitized signals using Scope software (PowerLab data acquisition 
system). Latencies of the onset of CAP were measured from the stimulus artefact to 
the peak of the CAP for all conduction distances. The conduction velocity was 
calculated from the slope of the regression line by plotting conduction distances 
against the corresponding latencies. Recordings were repeated 2-3 times for each 
nerve. The conduction velocity per animal was determined by averaging the mean 
conduction velocities of both nerves. 
2.13.2 RotaRod 
3 week- and 4-month-old WT, PDZ-Prx and Prx KO mice (10-16 per group) were 
trained on a 5-lane mouse RotaRod (Ugo Basile) for two consecutive days before the 
test on day 3. Animals were placed on a rotating RotaRod (3-cm diameter) 
sequentially at 24 rpm and 32 rpm for a maximum of 60s, four times at each speed. 
Each trial run was separated by a 10 min rest period. Mice were removed from the 
RotaRod either when they fell off the rod or at 60s. The mean latency to fall of each 
mouse, which measures the length of time each animal was able to stay on the rod, 
was determined by the mean latency from the four trials for each rotating speed 
obtained on day 3. 
2.13.3 Sensory tests 
WT and PDZ-Prx mice (4-5 months of age; n=9-11) were tested for hindpaw 
withdrawal response to mechanical and noxious thermal stimulation. These tests 
were performed by Dr. Ada Delaney. In brief, conscious animals were tested for the 
threshold of hindpaw withdrawal in response to graded mechanical stimulation with 
von Frey filaments, which provide a calibrated indentation pressure against the 
hairless skin of the hindpaws. The threshold response was defined as the nominal 
bending force of the filament that evoked hindpaw withdrawal 5 times in a 10-time 
application (Chaplan et al., 1994). The withdrawal response to noxious thermal 
stimulation was determined by the time for hindpaw withdrawal in response to 
quantified noxious thermal stimulus by an infrared beam (Hargreaves et al., 1988).  
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2.14 TAMOXIFEN INDUCTION OF RECOMBINATION 
Tamoxifen free base (Sigma, T5648) was dissolved in sunflower seed oil 
(Sigma)/ethanol (10:1) at 10 mg/ml. Sunflower seed oil was pre-warmed at 70
o
C for 
15 min. Tamoxifen was dissolved in the warm oil/ethanol mixture in a sonicating 
water bath for 30 min. 4-week-old mice were administered with tamoxifen via 
intraperitoneal injection (i.p.) at a dose of 1 mg/10g body weight, once per day for 10 
consecutive days. Mice were treated again for 5 days after a 7-day rest period. 
Animals were sacrificed 18 weeks after the last treatment for protein expression and 
morphological analysis.  
2.15 STATISTICS 
All statistical analysis was performed and graphs were produced using GraphPad 
Prism (version 5.0c). All values are expressed as mean  SEM. Unpaired, two-tailed 
Student’s t- test was used to determine statistical significance between 2 groups of 
samples. One-way analysis of variance (ANOVA) followed by Tukey HSD multi-
comparison post-test was used to assess p values between multiple samples (3 or 
more unpaired groups). For non-parametric statistical analysis, Mann-Whitney U test 
was used to determine statistical significance between 2 groups of samples, and 
Kruskal-Wallis test followed by Dunn’s post-test was used for comparing 3 or more 
unpaired groups of samples. For hindpaw withdrawal response to mechanical 




3.1 STUDY OF THE FUNCTION OF THE PERIAXIN PDZ 
DOMAIN IN PERIPHERAL NERVES  
Periaxin forms a transmembrane complex with DRP2 and dystroglycan at distinct 
Schwann cell domains, termed appositions, between the abaxonal surface of the 
myelin sheath and the cytoplasmic face of the Schwann cell membrane (Sherman and 
Brophy, 2005; Sherman et al., 2001). This complex is essential for myelin sheath 
maintenance and stability in the mature PNS.  
 Charcot-Marie-Tooth (CMT) disease type 4F is caused by nonsense or 
frameshift mutations in the Periaxin gene (PRX) mapped on chromosome 19q13 
(Delague et al., 2000; Guilbot et al., 2001). Our laboratory had previously generated 
a Periaxin-null mutant as a mouse model for CMT 4F. Mice deficient for Periaxin 
initially produce compact myelin, but later develop a peripheral nerve demyelinating 
neuropathy (Gillespie et al., 2000). In the absence of Periaxin, the Periaxin-DRP2-
dystroglycan (PDG) complex is disrupted leading to the disruption of Cajal bands, 
which are longitudinal and transverse bands of cytoplasm along Schwann cell 
internodes formed between appositions. Prx KO Schwann cells have reduced 
internodal lengths, resulting in decreased nerve conduction velocities (Court et al., 
2004). In the mature PNS, peripheral nerves display extensive demyelination, 
followed by remyelination, causing severe sensory and motor deficits (Gillespie et 
al., 2000).  
Although the consequences of complete ablation of Periaxin in peripheral 
nerves have been well characterized, the functions of the different domain regions of 
Periaxin remain elusive. One of the most important mutations in the human PRX 
gene R1070X introduces a stop codon 28 amino acids upstream of the acidic domain 
of Periaxin, leading to the production of a large truncated protein lacking the acidic 
domain and the rest of the C-terminus. Periaxin without the C-terminal acidic 
domain causes severe demyelination, onion bulb formation and axonal loss in human 
patients. Patients diagnosed with this type of early onset demyelinating neuropathy 
display severe clinical symptoms such as unsteady gait contributed by distal muscle 
weakness and impaired sensory modalities (Guilbot et al., 2001; Kabzinska et al., 
2006; Kijima et al., 2004; Otagiri et al., 2006; Parman et al., 2004; Takashima et al., 
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2002). This highly implicates the importance of the specific domains within Periaxin 
for its various regulatory roles.  
At the N-terminus of Periaxin is a PDZ domain, which has been speculated to 
play a chief role in recruiting proteins to a cortical scaffold for transmembrane 
signaling (Dytrych et al., 1998). Indeed, Periaxin homodimerizes at the PDZ domain 
in the PDG complex. However, the functional importance of the Periaxin PDZ 
domain, particularly its dimerization, has not been addressed. The study presented 
here examines the functions of the PDZ domain of Periaxin in the regulation of 
apposition formation and maintenance, Schwann cell elongation and stability of the 
myelin sheath, in a conditional mouse mutant expressing a version of Periaxin 
lacking the first 116 amino acids at the N-terminus, i.e. the PDZ domain in 
peripheral nerves.   
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PART A. GENERATION OF A CONDITIONAL MUTANT MOUSE 
LACKING THE PERIAXIN PDZ DOMAIN IN PERIPHERAL NERVES 
Mice in which exon 5 of the Prx gene was floxed had originally been generated in 
order to ablate Periaxin protein expression in the adult. However, as will be 
described here, these mice produced after Cre-mediated recombination a form of 
Periaxin lacking the N-terminal PDZ domain. Therefore, these mice proved to be 
extremely useful. In order to study the mutant Periaxin lacking the N-terminal PDZ 
domain, mice carrying the ‘floxed’ Prx gene, which contain normal amounts of wild-
type Periaxin (Fig. 13A), were crossed with a Cnp-Cre line (Lappe-Siefke et al., 
2003). This system provides a robust and complete recombination of the loxP sites in 
the early embryonic PNS. In this study, Prx
fl/fl
 mice are defined as wild-type (WT). 
3.1.1 Expression of a mutant Periaxin protein in Prx
fl/fl
/Cnp-Cre mice 




/Cnp-Cre mice by 
Western blotting. The absence of wild-type Periaxin in Prx
fl/fl
/Cnp-Cre mice 
analyzed by immunoblotting for the Periaxin N-terminus indicated complete deletion 
of the wild-type form upon Cre excision of the ‘floxed’ gene. A mutant form of 
Periaxin lower in molecular weight than the WT form was detectable in sciatic nerve 
homogenate using specific Periaxin antibodies against the repeat region or the C-
terminus. This mutant version was not recognized by the anti-Periaxin N-terminus 
antibody (Fig. 13B). In most Prx
fl/fl
/Cnp-Cre mice examined, the mutant Periaxin 
expression generally appeared to be lower than that of the WT form in control 
nerves. These data suggested the generation of a Periaxin form containing a large 
part of the protein without the N-terminus. 
Immunostaining of transverse sections of sciatic nerves from mutant animals at 
3 weeks old revealed a lack of immunoreactivity for the N-terminus of Periaxin, 
indicating the absence of the wild-type Periaxin and that no fibers escaped 
recombination (Fig. 13C). The mutant protein was localized at the abaxonal 
Schwann cell membrane, as identified by the Periaxin antibody against the repeat 
region, though perhaps slightly reduced in levels, compared with the wild-type form 























A. By Western blot analysis, sciatic nerve homogenates from homozygous 
Prx
fl/fl
 and WT mice showed comparable amounts of Periaxin detected by 
anti-Periaxin N-terminus antibody. 
B. Wild-type Periaxin was not detected in nerve homogenates from 3-week-old 
Prx
fl/fl
/Cnp-Cre mice by the N-terminus antibody. However, a mutant 
Periaxin form, lower in molecular weight than the wild-type form, was 
identified by both the repeat region and C-terminus antibodies in the mutant 
animals. -Actin and -tubulin were used as loading controls.  
C. Transverse sections of sciatic nerves from 3-week-old Prxfl/fl and Prxfl/fl/Cnp-
Cre mice immunolabeled with Periaxin antibodies against the repeat region 
and the N-terminus show an absence of immunoreactivity for the N-terminus 
but positive staining for the repeat region in the abaxonal Schwann cell 
membrane Prx
fl/fl
/Cnp-Cre mouse. MAG is localized correctly to the 
periaxonal membrane of the Schwann cell. Scale bar, 15 m. 
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3.1.2 mRNA expression of the mutant Periaxin remains unaltered 
To determine whether mRNA levels of the mutant Periaxin in Prx
fl/fl
/Cnp-Cre mice 
were comparable to WT, Periaxin transcript levels were compared between 3-week-
old WT and PDZ-Prx mice using semi-quantitative RT-PCR with a set of primers 
hybridizing to exon 7 of the Prx gene and are specific for both the wild-type and 
mutant Periaxin. The transcript level of mutant Periaxin was similar to that of the 




Figure 14. The mRNA expression of mutant Periaxin is unaltered.   
Semi-quantitative RT-PCR using primers encoding exon 7 of the Prx gene shows 
that the mRNA expression of the mutant Periaxin in PDZ-Prx trigeminal nerves at 
3 weeks old is similar to that of wild-type Periaxin in WT nerves. GAPDH was used 




3.1.3 The hypotheses of exon skipping and translation reinitiation 
The conditional system had been predicted to generate a glial specific knockout of 
Periaxin. However, analysis of protein expression by region-specific antibodies of 
Periaxin revealed the generation of a mutant Periaxin form (see section 3.1.1).  
In order to account for this surprising result, I came up with two hypotheses. 
First, there might be an exon skipping event in the mutant mice with Cre-mediated 
recombination. Exon skipping is the most common alternative splicing mechanism in 
mammals, contributing to the diversity of mammalian proteins (Miriami et al., 2003). 
Nonsense and missense mutations can cause skipping of exons (Cooper and Mattox, 
1997; D'Souza et al., 1999; Vuillaumier-Barrot et al., 1999). Cre-mediated excision 
of exon 5 in the Prx gene might therefore result in an exon skipping event. In the Prx 
gene, exon 4 is in frame with exon 7, skipping of exon 6 in the recombined Prx gene 
would give rise to a Periaxin mutant form lacking the PDZ domain (~10-14 kDa 
shorter).  
To study this further, I isolated RNA from trigeminal nerves of 4-week-old 
Prx
fl/fl
/Cnp-Cre mice since abundant amounts of RNA could be extracted from 
trigeminal nerves, and performed reverse transcription-PCR (RT-PCR). If exon 
skipping had taken place, amplifying the N-terminal region between exons 4 and 7 
using specific primers would yield a DNA fragment that lacks both exon 5 (due to 
Cre-mediated excision) and exon 6 due to a skipping event (Fig. 15A). However, the 
RT-PCR and DNA sequencing results did not reveal a sequence due to exon skipping 
(expected fragment size ~160 bp), but a PCR product lacking exon 5 alone at ~350 
bp, as predicted to result from Cre-mediated recombination of the ‘floxed’ Prx gene 
(Fig. 15B). Based on this and in light of the fact that part of exon 4, which should 
still be present after exon skipping, was not detectable by the N-terminal Periaxin 
antibody, it seemed unlikely that exon skipping was the reason for the generation of 
the mutant Periaxin form. 
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Figure 15. Generation of the mutant Periaxin is not attributed to exon skipping 
as revealed by RT-PCR analysis in mice with Cre-mediated recombination. 
A. Schematic representation of the PCR amplification strategy for identification 
of an exon skipping event in the Prx gene. Exons are numbered. Arrows 
marked with P1 represent the forward primer in exon 4 of the Prx gene, and 
P2 the reverse primer in exon 7. PCR amplification of wild-type Prx cDNA 
would give rise to a product of 513 bp, and of the recombined Prx sequence 
would yield a 356 bp fragment. Skipping of exon 6 in the recombined gene 
would generate a 162 bp fragment by PCR.  
B. Trigeminal nerve cDNA from reverse transcription was amplified by PCR 
using primers P1 in exon 4 and P2 in exon 7 of Prx, yielding a 500 bp 
product for WT and a 350 bp product indicative of the predicted 
recombination in the ‘floxed’ allele for Prx
fl/fl
/Cnp-Cre mice (Figure 17B 
shows the actual sequence). No signs of a 160 bp product predicted to be 
from exon skipping of the recombined gene were found. NT, no template. 
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Figure 16. Kozak consensus sequencing surrounding the start codon ATG.  
A start codon is in a strong context optimal for translation initiation if a purine (A or 
G) is in positions -3 and +4 (Harhay et al., 2005). 
 
A second mechanism by which a putative mutant protein lacking the N-
terminus might be generated is reinitiation at an internal AUG start codon during 
protein translation, as proposed in other contexts by Marilyn Kozak. According to 
the scanning mechanism for initiation of translation in eukaryotes, the 40S ribosomal 
subunit along with Met-tRNA and various initiation factors, binds to the 5’-end of 
mRNA and subsequently migrates in a 5’ to 3’ direction until it encounters the first 
AUG codon in a favorable context for translation initiation (Kozak, 1978). The ‘first 
AUG rule’ applies in more than 90% of vertebrate mRNA sequences studied thus far 
(Kozak, 1987a). Selection of the initiation site depends on the position and context of 
the initiation codon. An AUG codon is considered to be in a strong context provided 
that a purine (A or G) is in positions -3 (3 nucleotides upstream from the AUG) and 
+4 (preferably G) (Fig. 16) (Kozak, 1989).  
Translation initiation is not entirely limited to the first AUG codon closest to 
the 5’- proximal end. Ribosomes advancing from the 5’ end may initiate at 
downstream AUG codons in certain mRNAs under three specific conditions (Kozak, 
1987b; Kozak, 1989). First, when the 5’ cap and the first AUG codon are separated 
by fewer than 10 nucleotides, initiation may take place at the first and second AUG 
codons (Kelley et al., 1982; Peterson and Piatigorsky, 1986; Strubin et al., 1986). 
Secondly, ribosomes can reach an internal AUG codon by ‘leaky scanning’, when 
the first AUG lies in an unfavorable context for initiation (i.e. when position -3 is a C 
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or U). In such cases, ribosomes may bypass the first AUG and continue to scan along 
the mRNA sequence for a downstream AUG in a strong context (Kozak, 1986b). 
Another mechanism by which access to internal AUG codons is allowed is 
reinitiation, which operates when the upstream AUG lies in a favorable context, thus 
ruling out leaky scanning, but is followed shortly by an in-frame stop codon (Kozak, 
1984; Kozak, 1986a; Kozak, 1987b). Under such a circumstance, ribosomes may 
reinitiate translation at the next downstream AUG codon. Interestingly, Marilyn 
Kozak observed that selection of the reinitiation site is not restricted to the next 
downstream AUG. She predicted that 40S subunits must attain a certain level of 
competency for reinitiation to occur. The subunits that are not yet competent when 
they reach the first AUG codon downstream should continue scanning, skipping over 
the first AUG and initiating at AUG codons further downstream when they become 
competent (Kozak, 1987b). 
During the generation of Prx
fl/fl
/Cnp-Cre mice, we predict that exon 5 in the 
floxed Prx gene is excised upon Cre-mediated recombination, thus introducing an in-
frame termination codon in exon 6, aborting normal translation of the WT Periaxin 
protein. By the mechanism of reinitiation, 40S ribosomal subunits may remain bound 
to mRNA and continue to scan for a downstream AUG codon in a favorable context. 
As noted in Figure 17B, which illustrates the recombined Prx sequence lacking exon 
5, there are 4 potential AUG codons (in red and underlined) downstream of the in-
frame termination codon. The first three internal AUG codons are either in a weak 
context (C, a non-purine in +4 position) resulting in ‘leaky scanning’ or would 
encounter another termination codon that follows shortly if translation were to 
reinitiate at them, giving rise to other minicistrons (Kozak, 1987b). Therefore these 
AUG codons are likely not suitable initiation codons for the translation of the mutant 
protein.  
The fourth AUG codon located in exon 6 downstream of the in-frame stop 
codon lies within a favorable context, precluding ‘leaky scanning’. Considering the 
fact that it is in-frame with the WT Prx sequence (Fig. 17A), I predicted that 
reinitiation might take place at this AUG codon, resulting in translation starting from 
the basic domain of Periaxin, omitting the PDZ domain.  
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The efficiency of reinitiation gradually improves as the distance between the 
translated sequences initiated at the first AUG and an internal AUG is lengthened. 
However, the yield of the initiated protein due to reinitiation may decline when the 
intercistronic distance further increases (Kozak, 1987b). Since the translated 
sequence initiated at the first AUG in Prx gene and that initiated at the fourth AUG 
codon is 150 nucleotides apart, this might explain the slight reduction in levels of the 
mutant Periaxin in Prx
fl/fl
/Cnp-Cre mice compared to that of the wild-type protein in 


















Figure 17. The hypothesis of translation reinitiation for the generation of the 
mutant Periaxin. 
A. The wild-type Prx cDNA sequence from exon 4 to the beginning of exon 7. 
The ATG codon highlighted in pink denotes the start codon closest to the 5’ 
end and is the normal initiator codon for wild-type Periaxin. The ATG (red 
font and highlighted in yellow), in-frame with the first ATG, is the internal 
initiator codon suspected to be reinitiated at by 40S ribosomal subunits. The 
red arrowheads mark the position of the start of an exon. 
B. The 350 bp recombined floxed Prx sequence obtained from DNA 
sequencing. Exon 5 was deleted by Cre recombination causing a frameshift 
and introducing a stop codon in exon 6 (denoted in gray). We hypothesize 
that 40S subunits remain bound to the mRNA after encountering the first 
AUG, scan along and reinitiate translation at a downstream AUG codon. 
From the cDNA sequence, the first 3 ATGs (in red font) downstream of the 
stop codon are either in a weak context or would generate short cistrons, we 
believe that reinitiation takes place at the fourth ATG (in red and highlighted 
in yellow), which will generate a mutant protein lacking the PDZ domain.  
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3.1.4 N-terminus sequencing supported the reinitiation theory 
To further verify the hypothesis, with the help of Dr Diane Sherman, we pulled down 
the mutant Periaxin protein using a GST-fusion protein containing the third 
fibronectin III domain of 4-integrin, which strongly interacts with the C-terminus of 
Periaxin. The N-terminus of the mutant protein was then sequenced by the Edman 
degradation method (Aberdeen Proteomics, University of Aberdeen). The N-
terminus amino acid sequence from proteomics analysis, despite some ambiguity 
among the first 7 residues, was consistent with the predicted sequence suggested 
above: 
 
This showed that the mutant Periaxin lacked the first 116 amino acids of the N-
terminus, and strongly confirmed that translation of the mutant Periaxin lacking the 
PDZ domain, potentially due to reinitiation, started at the predicted downstream 
AUG in exon 6.  
3.1.5 Periaxin does not homodimerize in the absence of the PDZ domain 
In the absence of the PDZ domain, homodimerization is predicted to be prevented in 
the Periaxin-DRP2-dystroglycan complex (Fig. 18). To test whether mutant Periaxin 
lacking the N-terminal PDZ domain was able to bind full-length Periaxin, FLAG-
tagged mutant Periaxin PDZ-Prx lacking the first 116 amino acids and myc-tagged 
full-length Periaxin were expressed in HEK 293 cells (Fig. 19A). Expression of each 
construct was confirmed by immunofluorescence staining of the transfected cells 
using anti-FLAG and anti-myc antibodies (data not shown). By co-
immunoprecipitation, mutant FLAG-tagged Periaxin could not bind full-length myc-
tagged Periaxin in vitro, in contrast to the control full-length FLAG-tagged Periaxin, 
which was co-immunoprecipitated with myc-tagged Periaxin (Fig. 19C). This 
suggests that homodimerization does not occur without the PDZ domain in Periaxin. 
To ensure the specificity of anti-FLAG M2 affinity gel and the antibodies used for 
co-immunoprecipitation, mutant FLAG-tagged Periaxin and full-length myc-tagged 
Periaxin were individually expressed in HEK 293 cells. FLAG-tagged mutant 
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Periaxin was immunoprecipitated using anti-FLAG M2 beads, but was not detected 





/Cnp-Cre mice harbor a large truncated Periaxin protein lacking 116 amino 
acids at the N-terminus, i.e. the PDZ domain, which comprises less than 10% of the 
protein. Hence, I thought it would be of interest to study this mutant mouse as 
homodimerization of the PDZ domain would not occur. For characterization of the 
mutant mouse in this work, Prx
fl/fl




Figure 18. Diagrams show the Periaxin-DRP2-dystroglycan complex in the wild-
type (left) and in the PDZ-Prx mutant (right). 
Periaxin homodimerizes at the N-terminal PDZ domain and interacts via the basic 
domain with DRP2, which associates with -dystroglycan, forming a membrane-
associated complex in the Schwann cell cortex. Note that dimerization of Periaxin’s 






















Figure 19. Periaxin without the PDZ domain does not homodimerize. 
A. Domain structure of full-length wild-type Periaxin (upper panel) and mutant 
Periaxin (bottom panel) proteins. Periaxin protein from the PDZ-Prx mutant 
lacks 116 amino acids including the PDZ domain at the N-terminus. Amino 
acid residues are shown. 
B. A control experiment showing single expression of FLAG-tagged mutant 
Periaxin PDZ-Prx or myc-tagged full-length Periaxin confirms the 
specificity of anti-FLAG M2 affinity gel and antibodies used in co-
immunoprecipitation. HEK293 cells transiently expressing FLAG-tagged 
mutant Periaxin PDZ-Prx alone or myc-tagged full-length Periaxin alone 
were lysed in a buffer containing 1% Triton X-100, and both were 
immunoprecipitated using anti-FLAG M2 beads. Immunoprecipitates were 
analyzed by immunoblotting with anti-FLAG or anti-myc antibodies. The 
input lanes contain samples of cell lysate.  
C. Mutant Periaxin lacking the PDZ domain does not homodimerize with full-
length Periaxin in transfected HEK 293 cells. By co-immunoprecipitation, 
full-length FLAG-tagged Periaxin binds full-length myc-tagged Periaxin. In 
contrast, mutant FLAG-tagged Periaxin fails to bind full-length myc-tagged 
Peraxin in vitro. The input lanes show comparable expression levels of the 
respective transfected constructs in the cell line detected by anti-FLAG or 
anti-myc antibodies. 
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PART B. CHARACTERIZATION OF PDZ-Prx MICE CONTAINING 
PERIAXIN WITHOUT THE PDZ DOMAIN IN PERIPHERAL NERVES 
3.1.6 DRP2 is depleted and DRP2-positive patches are absent in PDZ-Prx nerves 
In Prx-knockout animals, Periaxin/DRP2 rich patches in Schwann cells fail to form and 
appositions are disrupted. The internodal lengths of Schwann cells in these animals are 
reduced thus affecting nerve conduction velocity (Court et al., 2004). To investigate 
whether DRP2-patches were still present in PDZ-Prx mice, I analyzed the peripheral 
nerves of these animals by immunostaining and Western blotting. First, mutant Periaxin 
was expressed at reduced levels as indicated by a decrease in immunoreactivity detected 
by the anti-Periaxin repeat region antibody. It remained membrane-associated but was 
no longer localized in cobblestone-like patches. In the presence of mutant Periaxin (Fig. 
20A), DRP2 was diffusely expressed, severely depleted and failed to localize at spheroid 
domains. This was similar to the DRP2 expression in the Prx-null mice (Sherman et al., 
2001). DRP2 appears mostly in the phosphorylated form in WT animals, and is non-
phosphorylated in the absence of Periaxin in Prx-null mutants (Fig. 20B). To study 
whether DRP2 was phosphorylated in PDZ-Prx mice, I analyzed sciatic nerve 
homogenates for DRP2 expression by Western blotting. In contrast to the wild-type 
control, DRP2 mainly appeared in the non-phosphorylated form and was reduced in 
levels in these mice (Fig. 20B). 
 Since the PDZ domain of Periaxin is not required for association with DRP2 
(Sherman et al., 2001), it is interesting that DRP2 was not properly targeted to patches 
despite the presence of the DRP2-binding basic domain in the mutant Periaxin. In order 
to test whether the mutant Periaxin interacted with DRP2, a GST-pull down assay was 
performed. A GST-DRP2 fusion protein (aa 110-390 of DRP2) containing the Periaxin-
binding region co-precipitated with mutant Periaxin from PDZ-Prx sciatic nerve 
lysates. However, the degree of binding to the DRP2-fusion protein by mutant Periaxin 




Figure 20. DRP2-patches are absent and Cajal bands disrupted in PDZ-Prx 
Schwann cells. 
A. Confocal immunofluorescence analysis of teased fibers of quadriceps nerves 
from 4-week-old WT and PDZ-Prx mice immunolabeled for Periaxin, DRP2 
and the Cajal band marker S100. Periaxin detected by the repeat region antibody 
is present at a reduced level in PDZ-Prx mouse (top panels). When stained for 
DRP2, WT fibers display distinct patches, which are absent in the mutant fibers 
(middle panels). In addition, Cajal bands are disrupted in the mutant fibers. 
Unlike WT Schwann cell cytoplasm, which is arranged in longitudinal and 
transverse bands, the cytoplasm in PDZ-Prx Schwann cells appears continuous 
along the internode (bottom panels). Scale bar, 20 m. 
B. Western blot analysis shows that DRP2 is depleted in the PDZ-Prx sciatic 
nerve homogenates at 3 weeks of age, compared with WT nerves. The DRP2 
expression in PDZ-Prx nerves is similar to that in Prx KO nerves. 
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Figure 21. Biochemical evidence showing binding of DRP2 with mutant Periaxin 
lacking the PDZ domain. 
GST or GST-fusion protein of DRP2 (aa 110-390) were incubated with sciatic nerve 
lysates from 6-week-old WT and PDZ-Prx mice. GST-DRP2 fusion protein interacts 
with mutant Periaxin in PDZ-Prx nerves, but at reduced levels. The input lanes confirm 
the presence of the wild-type Periaxin in WT nerves and the mutant Periaxin in PDZ-
Prx nerves. The Coomassie-blue-stained gel (bottom panel) shows equal amounts of 




3.1.7 Cajal bands are disrupted and appositions absent in PDZ-Prx Schwann cells 
I further examined whether Cajal bands were present in the mutant Schwann cell by 
labeling quadriceps nerve teased fibers with an antibody directed against the Schwann 
cell cytoplasmic protein S100, and found that Cajal bands were disrupted. Instead of 
arranging in distinct longitudinal and transverse bands as in the WT Schwann cell, 
cytoplasm of the mutant Schwann cell appeared continuous shown by S100 
immunostaining (Fig. 20A). 
 As mentioned in the ‘Introduction’ section, the Schwann cell is 
compartmentalized into discrete domains (Albrecht et al., 2008; Court et al., 2009; Court 
et al., 2004). Upon the completion of myelin compaction, the cytoplasm of the Schwann 
cell is restricted to the outer ring of the fiber and is separated by close appositions 
between the abaxonal membrane of the Schwann cell and the outermost layer of the 
myelin sheath. To address whether appositions were present in the PDZ-Prx Schwann 
cell, ultrastructural analysis of the Schwann cell-axon unit was performed by electron 
microscopy. In transverse sections of 3-week-old quadriceps nerves, WT Schwann cells 
showed distinct regions of cytoplasm restricted by appositions. In sharp contrast, most 
PDZ-Prx Schwann cells contained no appositions and the cytoplasm appeared 
continuous around the myelin sheath (Fig. 22A). By counting the number of appositions 
per Schwann cell from randomly selected fields of electron micrographs of WT and 
PDZ-Prx quadriceps nerves, it was obvious that all WT Schwann cells had appositions, 
with the highest percentage of Schwann cells containing 2-3 appositions. However, the 
majority of mutant Schwann cells harbored no appositions, with a small proportion of 
fibers showing only one or two (Fig. 22B). These results suggest that appositions are 




Figure 22. Appositions are absent in PDZ-Prx Schwann cells. 
A. Electron micrographs of transverse sections of WT and PDZ-Prx quadriceps 
nerves. WT Schwann cell cytoplasm is separated by appositions (asterisks) 
between the abaxonal Schwann cell membrane and the underlying myelin sheath 
(left). In PDZ-Prx Schwann cells, the absence of appositions results in a 
concentric ring of cytoplasm around the myelin sheath (right). Scale bar, 1 m. 
B. The quantification of appositions per Schwann cell in 3-week-old quadriceps 
nerve transverse sections (n=3 and 100 fibers for WT and PDZ-Prx) shows that 
most PDZ-Prx Schwann cells have no appositions (right), compared with the 
WT (left). 
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3.1.8 Axon diameters and myelin sheath thickness are normal in peripheral nerves 
of PDZ-Prx mutant mice 
Prior to the development of myelin abnormalities, Periaxin-null peripheral nerves have 
normal axon diameters and myelin thickness at 3 weeks old (Court et al., 2004). To 
address whether these parameters were altered in PDZ-Prx nerves, axon diameters and 
myelin sheath thickness were measured in transverse EM micrographs of 3-week-old 
WT and PDZ-Prx quadriceps nerves. The distribution of axon diameters was 
comparable between WT and PDZ-Prx mice (Fig. 23B). Myelin sheath thickness 
determined by g-ratio analysis (axon diameter/ fiber diameter) was also similar between 
WT and PDZ-Prx quadriceps nerves (Figs. 23A and C). The mean g-ratio of the 
mutant nerves at 3 weeks of age was 0.608  0.016, compared with 0.636  0.011 for the 
WT (p = 0.2351), which did not differ significantly (Fig. 23C). 
3.1.9 Longitudinal elongation of PDZ-Prx Schwann cells is impaired  
Periaxin is important for the regulation of Schwann cell elongation. In the absence of 
Periaxin, Prx KO Schwann cells have shorter internodal lengths because the rate of 
Schwann cell internodal growth fails to match up with that of nerve length (Court et al., 
2004). Despite the seemingly normal capacity of myelin assembly in PDZ-Prx 
peripheral nerves, I asked whether abrogation of Periaxin dimerization might influence 
Schwann cell elongation. To address this question, PDZ-Prx Schwann cell internodal 
lengths were compared with those of the WT and Prx KO at 3 weeks and 6 weeks of 
age. Teased fibers from quadriceps nerves were immunolabeled with anti-dystrophin, a 
microvillus marker, for identification of the locations of nodes of Ranvier. At 3 weeks 
old, the average internodal length of PDZ-Prx Schwann cells was significantly shorter 
than that of the WT (WT, 455.3  6.7 m, n=8; PDZ-Prx, 328.7  2.4 m, n=8; p < 
0.001), but was comparable with that of the Periaxin-null Schwann cells (302.7  3.9 
m, n=5; Fig. 24A). Schwann cells displayed a heterogeneous distribution of internodal 
distances in each genotype analyzed. The distributions of internodal lengths at 3 weeks 
showed that the majority of WT internodes were in the range of 400-599 m, with only 
a small proportion of internodes shorter than 400 m. On the contrary, most Schwann 
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cells of PDZ-Prx and Prx KO mice were only 200-399 m in length (Fig. 24B). 
Consistently, at 6 weeks old, PDZ-Prx Schwann cells remained shorter than that of the 
WT (WT, 559.3  18.1 m, n=3; PDZ-Prx, 415.6  3.7 m, n=6; p < 0.001; Fig. 24C).  
To test whether the internodal lengths of PDZ-Prx Schwann cells would 
eventually catch up with that of the WT control as nerve growth continues with age, I 
measured WT and PDZ-Prx Schwann cell internodal lengths in adult quadriceps nerves 
at 4 months of age. The mean internodal length of PDZ-Prx Schwann cells was 479.4  
11.9 m (n=4), compared with that of the WT controls at 713.9  6.8 m (n=5), and was 
statistically different from the WT values (p < 0.001; Fig. 24D), suggesting that 
Schwann cells elongated as nerve length increased with age, but the rate of longitudinal 
growth of mutant Schwann cells remained slower than that of WT Schwann cells. 
PDZ-Prx mutants were generated by crossing homozygous Prx
fl/fl
 mice with 
Cnp-Cre animals, in which Cre was inserted into the Cnp locus (Lappe-Siefke et al., 
2003). PDZ-Prx mice were heterozygous for CNPase expression. To ensure that the 
reduction in the mean Schwann cell internodal distance of PDZ-Prx mice was specific 
for the mutation resulting in the absence of Periaxin’s PDZ domain but not due to 
reduced levels of CNPase, the average internodal lengths were compared between 3-
week-old WT and mice heterozygous for both the ‘floxed’ Periaxin and Cnp-Cre, 




 Schwann cells had normal internodal lengths, 
ruling out the possibility of decreased CNPase levels leading to defective Schwann cell 
elongation in PDZ-Prx mutants (Fig. 24E). In addition, the decrease in internodal 
lengths of PDZ-Prx Schwann cells was not due to a reduction in the mutant Periaxin 
amounts reported in this work. By immunoblotting, the levels of mutant Periaxin in 
PDZ-Prx sciatic nerves were similar to the amounts of wild-type Periaxin in Prx
+/-
 
nerves, which had no obvious phenotype shown by Dr Diane Sherman (unpublished 




Figure 23. Axon diameters and myelin sheath thickness are normal in quadriceps 
nerves from 3-week-old PDZ-Prx mice. 
A. Scatter plot depicts g-ratios of myelinated nerve fibers from WT (blue circles) 
and PDZ-Prx quadriceps nerves (red squares) at 3 weeks old, in relation to the 
axon diameter based on electron micrographs of ultrathin cross sections (n=3; 
100 fibers per group).  
B. In 3-week-old PDZ-Prx quadriceps nerves, axons displayed a normal size 
distribution compared with that of WT axons (n=3; 100 fibers per genotype). 
C. The mean g-ratio of nerve fibers from PDZ-Prx quadriceps nerves is not 














Figure 24. PDZ-Prx Schwann cells lacking the Periaxin PDZ domain have 
reduced internodal lengths. 
A. Internodal length measurements of teased quadriceps nerve fibers from WT 
(n=8), PDZ-Prx (n=8), and Prx KO mice (n=5) at 3 weeks. The average 
Schwann cell internodal lengths of PDZ-Prx and Prx KO fibers are 
significantly shorter than WT values (p <0.0001; one-way ANOVA with Tukey’s 
HSD post-test). 
B. Distributions of Schwann cell internodal lengths from WT, PDZ-Prx and Prx 
KO mice at 3 weeks. The majority of PDZ-Prx and Prx KO Schwann cells are 
shorter in length, compared with WT Schwann cells. 
C. The mean internodal length of PDZ-Prx Schwann cells remains shorter than 
that of WT Schwann cells at 6 weeks old (n=3-6 per genotype; p <0.0001; one-
way ANOVA with Tukey’s HSD post-test), and at 4 months old (n=4-5 per 
genotype; p < 0.0001; Student’s t-test) in D. 
E. The average internodal lengths are similar between 3-week-old WT and mice 
heterozygous for both the ‘floxed’ Periaxin and Cnp-Cre, defined as CNP
+/-
 (n=3 
per group; p =0.1596; Student’s t-test), suggesting that the reduction in the mean 
Schwann cell internodal distance of PDZ-Prx mice is due to the absence of 
PDZ domain homodimerization but not the reduced levels of CNPase. 
F. Western blot analysis reveals that the amounts of mutant Periaxin in PDZ-Prx 
sciatic nerves are similar to the amounts of wild-type Periaxin in Prx
+/-
 nerves, 
which have normal internodal lengths, indicating that the reduction of PDZ-Prx 
Schwann cell internodal lengths is not because of a decreased amount of the 
mutant Periaxin. -actin was the loading control. 
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Shorter internodal lengths in PDZ-Prx Schwann cells would suggest an increase in 
the number of myelinating Schwann cells forming a 1:1 relationship with axons per unit 
length of nerve fiber. To determine whether Schwann cell number in PDZ-Prx nerves 
differed from that in the WT, I quantified the number of myelinating Schwann cells and 
Schwann cells in general, immunostained for the transcription factors Krox-20 and 
Sox10, respectively, in WT and PDZ-Prx sciatic nerve transverse sections at 3 weeks 
of age. In agreement with a one-third reduction in PDZ-Prx internodal lengths 
compared with the WT controls, the number of myelinating Schwann cells in PDZ-Prx 
sciatic nerves was proportionately augmented by 42.2  6.7% (Fig. 25A). Additionally, 
there was also an increase of 38.8  5.7% in total Schwann cells, labeled as Sox10-
immunopositive cells, in the mutant nerves. However, in comparison with the WT 
nerves, the proportion of myelinating Schwann cells, determined by the ratio of Krox-
20+ to Sox10+ cells, remained unchanged, suggesting that myelination was not affected 
at this age (Fig. 25B). The expression level of Krox-20 was also elevated in 3-week-old 
PDZ-Prx sciatic nerves as demonstrated by immunoblotting, further confirming the 
increase in quantity of myelinating Schwann cells in the mutant nerves, as a result of a 
reduction in internodal lengths (Fig. 25C). 
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Figure 25. An increase in Schwann cell number is consistent with a decrease in 
internodal lengths in PDZ-Prx peripheral nerves. 
A. Sciatic nerve transverse sections from 3-week-old WT and PDZ-Prx mice were 
immunolabeled with anti-Krox-20 antibody for myelinating Schwann cells, and 
anti-Sox10 antibody for all Schwann cells. PDZ-Prx sciatic nerves have 
significantly more Schwann cells than WT nerves. The numbers of Krox-20+ 
cells per cross section of WT and PDZ-Prx sciatic nerves are 283.0  11.0 and 
401.0  7.0, respectively (n=3 per genotype; p = 0.0009), and the numbers of 
Sox10+ cells are 377.0  8.7 and 522.7  13.9 (p = 0.0008; Student’s t-test). 
B. The proportion of myelinating Schwann cells (ratio of Krox-20+ to Sox10+ 
cells) is similar between WT and PDZ-Prx sciatic nerves (75.1  2.2 vs 76.9  
2.3%; p = 1.000; Mann-Whitney test). 
C. Western blot analysis shows that the levels of Krox-20 in PDZ-Prx sciatic 
nerves at 3 weeks old are increased corresponding to an increase in myelinating 
Schwann cells. -actin was used to normalize loading. 
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3.1.10 Myelin abnormalities in PDZ-Prx mice 
The structure of the myelin sheath has been well studied in the Periaxin-null mice, which 
displayed focal thickenings, termed tomacula, and onion bulb pathology indicative of 
supernumerary Schwann cells attempting to remyelinate following demyelination 
(Gillespie et al., 2000). I asked whether the myelin sheath was also affected in PDZ-
Prx nerves at later stages.  
The quadriceps nerves of PDZ-Prx mice were examined by light microscopy 
and electron microscopy at various ages. One of the prominent features of the mutant 
nerves was the enlargement of the endoneurial space resulting in an increase in the nerve 
cross-sectional area (Fig. 26A). In contrast to the closely arranged axons in the WT 
nerves, myelinated axons in both the PDZ-Prx and Prx KO quadriceps nerves were 
less densely packed due to an accumulation of extracellular matrix (ECM) in the 
endoneurial and perineurial space. At 2 months of age, the cross-sectional area of PDZ-
Prx quadriceps nerves was slightly larger than that of the WT. However, by 4 months of 
age, the area of the mutant nerves remarkably increased by more than two fold, 
compared with that of the WT nerves (WT, 32.5  10
3
  1078 m
2
; PDZ-Prx, 68.1  
10
3
  5770 m
2
; p < 0.01). Prx KO nerve area was also significantly enlarged at this age 
(57.7  10
3
  4985 m
2
; p < 0.05). Whereas the WT nerve area remained constant at 
older ages, there was a tendency of a progressive increase in the size of both PDZ-Prx 
and Periaxin-null nerves with age (Fig. 26B).  
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Figure 26. PDZ-Prx mice have enlarged quadriceps nerves due to an increase in 
endoneurial and perineurial space. 
A. Semithin transverse sections of WT, PDZ-Prx and Prx KO quadriceps nerves at 
4 months of age were examined by light microscopy at 20 magnification. The 
cross-sectional areas of both the PDZ-Prx and Prx KO nerves are increased, 
compared with that of control nerves. Myelinated axons are less densely 
arranged because of an increase level of ECM in the endoneurium of PDZ-Prx 
and Prx KO nerves.  Scale bar, 30 m. 
B. Cross-sectional area measurements of WT, PDZ-Prx and Prx KO sciatic nerve 
semithin sections at 2, 4, 6 and 9 months show an enlargement of nerve area in 
both the PDZ-Prx and PrxKO nerves, compared with the WT (n=3-4 per 
genotype per age; *p < 0.05, **p < 0.01 and ***p < 0.001; one-way ANOVA 
with Tukey’s HSD post-test for each age). 
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At 3 weeks, the myelin sheath in PDZ-Prx nerves appeared morphologically 
indistinguishable from that of WT littermates (Fig. 22A, section 3.1.8). However, in the 
adult, mutant peripheral nerves displayed hypermyelination with focally folded myelin 
and tomacula, as revealed by light microscopy of transverse semi-thin PDZ-Prx 
sections (Fig. 27A). In affected Schwann cell-axon units, aberrant loops of myelin 
arranged around myelinated, usually large diameter axons. Such infolds and outfolds of 
myelin often drastically altered the axon profile by causing axon compression. 
Quantitation of abnormal myelin profiles (Fig. 27B) showed that the proportion of fibers 
containing myelin foldings and tomacula increased progressively in the mutant 
quadriceps nerves examined at 2 months (15.5  1.4%), 4 months (32.5  2.0%), 6 
months (44.2  3.2%) and 9 months (51.3  0.6%). The shape of myelin foldings 
became more complex with age as demonstrated by transverse EM micrographs of 8-
month-old mutant nerves. Focal redundant myelin loops inside a myelinated axon 
leading to severe constriction of axon cytoplasm were frequently observed (Figs. 28A-
C). Within these infolds, axonal material was found in the gap between the inner and 
outer myelin infolding. Some outfolds consisted of single or multiple recurrent myelin 
loops that appeared as satellite myelinated axons around a larger myelinated axon 
ensheathed by the Schwann cell plasma membrane (Figs. 28D-E). Focally folded myelin 
was also visible in small caliber axons (Fig. 28B).  
In PDZ-Prx quadriceps nerves at older ages (6-9 months), a small proportion of 
Schwann cell-axon units were thinly myelinated and associated with supernumerary 
Schwann cells and processes loosely in contact with axons, surrounded by a basal 
lamina, forming onion bulbs (Figs. 27A and 28F). This provided another line of 
evidence for progressive myelin morphological abnormalities in the mutant nerves with 
age. Nevertheless, in comparison with the quadriceps nerves from Periaxin-deficient 
mice, PDZ-Prx nerves showed a less severe demyelinating phenotype. Additional to 
myelin tomacula and foldings, Prx KO nerves also displayed severe demyelination as 
revealed by extensive onion bulb pathology at 4 months and 6 months (Fig. 27A). Prx 
KO fibers had a significantly higher percentage of onion bulbs than PDZ-Prx nerves at 
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all ages analyzed (Fig. 27B). The observation that the proportions of myelin foldings and 
tomacula in Prx KO fibers were lower than PDZ-Prx values at all ages may suggest 
that aberrant folding of the myelin sheath occurs prior to demyelination.  
Apart from myelin sheath abnormalities, in some Prx KO fibers, degeneration of 
the entire Schwann cell-axon unit was detectable and was characterized by vacuolation 
of the axoplasm with disruption of the myelin sheath (Fig. 29A). Naked axons 
surrounded by processes of supernumerary Schwann cells were also evident. While the 
number of myelinated axons in PDZ-Prx quadriceps nerves (~530-550) did not differ 
significantly from that of the WT at all ages examined, Prx KO nerves showed a gradual 
reduction in myelinated axon number with age. At 9 months, Prx KO quadriceps nerves 
had 411  20 myelinated axons, compared with 554  9 and 550  4 in WT and PDZ-
Prx nerves, respectively. These results further confirm that PDZ-Prx mice develop a 





















Figure 27. Myelin foldings in PDZ-Prx peripheral nerves. 
A. Semithin cross sections of quadriceps nerves from WT, PDZ-Prx and Prx KO 
mice at 4 months (top panels) and 6 months (bottom panels) were compared. At 
4 months of age, PDZ-Prx nerves contain numerous nerve fibers with myelin 
foldings and redundant myelin loops (red arrows) leading to axon compression. 
In addition to myelin foldings and thickenings, Prx KO nerves show features of 
onion bulb pathology (red arrowheads) indicative of demyelination followed by 
attempts of remyelination by supernumerary Schwann cells. At 6 months, thinly 
myelinated onion bulbs (red arrowheads) are noted in PDZ-Prx nerves, 
indicating a progressive increase in abnormal myelin profiles with age. PDZ-
Prx nerves display a less severe demyelinating neuropathy than Prx KO nerves 
as revealed by fewer onion bulb formations in PDZ-Prx mice. Scale bar, 15 
m.  
B. Quantification of the proportion of hypermyelinated nerve fibers containing 
focally folded myelin or myelin thickenings (tomacula) in WT, PDZ-Prx and 
Prx KO quadriceps nerves at 2, 4, 6 and 9 months. At all ages examined, PDZ-
Prx nerves contain a significantly higher percentage of myelin foldings and 
thickenings than WT nerves (n=3-5 per genotype for each age; *p < 0.05, **p< 
0.01; Kruskal-Wallis test with Dunn’s post-test). 
C. The proportions of onion bulb formations are substantially higher in Prx KO 
nerves than in PDZ-Prx or WT nerves at all ages examined (n=3-5 per 




















Figure 28. Ultrastructural analysis of Schwann cell-axon units in 8-month-old 
PDZ-Prx quadriceps nerves.  
A, C. Electron micrographs show excessive and aberrant myelin loops inside a 
myelinated axon severely affecting the axonal shape, leading to axon compression. 
Axonal material is found in the gap between the inner and outer myelin infolding. B. 
Small caliber fibers also contain myelin infoldings and outfoldings. Single (D) and 
multiple (E) redundant myelin loops appear as satellite myelinated axons around a larger 
myelinated axon surrounded by the Schwann cell membrane. F. A thinly myelinated 
Schwann cell-axon unit is surrounded by processes of Schwann cells forming an onion 






















Figure 29. Myelinated axon number is normal in PDZ-Prx quadriceps nerves. 
A. In 4-month-old semithin quadriceps nerve cross sections, PDZ-Prx nerves 
display myelin foldings and redundant loops of myelin, but do not show signs of 
axon degeneration indicated by vacuolation of the axoplasm as in Prx KO nerves 
(red arrowheads). A naked axon surrounded by processes of supernumerary 
Schwann cells is seen (asterisk) and complex abnormal myelin morphologies are 
detectable in Prx KO quadriceps nerves. Scale bar, 10 m. 
B. Quantitation of myelinated axon numbers in WT, PDZ-Prx and Prx KO 
quadriceps nerves at 2, 4, 6 and 9 months. The number of myelinated axons in 
PDZ-Prx nerves is comparable with that in control nerves at all ages, indicating 
no axonal loss. However, myelinated axon number progressively decreases with 
age in Prx KO nerves, compared with the WT values (n=3-5 per group for each 
age; *p < 0.05 and ***p < 0.0001; one-way ANOVA with Tukey’s HSD post-
test for each age) 
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Tomacula are a pathological hallmark of hereditary demyelinating neuropathies 
and are predominantly located in the nodal and paranodal regions (Amici et al., 2006; 
Amici et al., 2007; Bolino et al., 2004). By examining single teased fiber preparations 
from osmicated quadriceps nerves of the PDZ-Prx mice, it became evident (earliest age 
examined was at 6 weeks) that myelin foldings or thickenings were preferentially 
formed at the paranodes of mutant nerve fibers. Whereas the WT fibers showed 
regularly shaped myelin with nodes of Ranvier spaced between adjacent Schwann cells, 
most PDZ-Prx myelinated fibers contained redundant loops of myelin at the paranode 
(Fig. 30A). 71.1  1.2% of paranodal regions in mutant nerve fibers examined showed 
focal axonal constrictions encased by tomacular swellings (Fig. 30D). Occasionally, 
focal myelin thickenings were detected near the nuclei of mutant Schwann cells at 6 
weeks (Fig. 30B).  Consistently, focal overproduction of myelin progressed with age, as 
revealed by multiple myelin tomacula along the internodal or at paranodal regions in 
most teased fibers from 4-month-old PDZ-Prx quadriceps nerves (Fig. 30C). 
Interestingly, despite pronounced focal hypermyelination, levels of compact myelin 
proteins, MBP and myelin protein zero (P0), were not altered in PDZ-Prx sciatic nerves 
both at 2 months and 6 months, suggesting normal myelin compaction (Fig. 30E). 
To test whether the localizations of voltage-gated ion channels were altered 
because of paranodal myelin thickenings, voltage-gated potassium channels and sodium 
channels in PDZ-Prx teased fibers at 4 months old were immunolabeled with anti-
Kv1.1 and anti-pan Na
+ 
channel antibodies. Kv1.1 was localized in the juxtaparanodal 
regions of the axon between the paranodes and internodes, and at the inner mesaxon in 
WT fibers, as described in (Peles and Salzer, 2000). Although Kv1.1 was present in 
PDZ-Prx fibers, it was not properly localized in some mutant fibers and often appeared 
diffuse, intruding into the internode due to a paranodal tomaculum. However, normal 
appearance and correct localization of Kv1.1 was also found in fibers with myelin 
thickenings at the paranodes. Sodium channels were correctly localized to the nodes of 

















Figure 30. Paranodal myelin thickenings are evident in teased fibers of PDZ-Prx 
quadriceps nerves at 6 weeks of age. 
A. Myelin tomacula are predominantly formed at the paranodal regions in 
osmicated teased fibers of PDZ-Prx quadriceps nerves at 6 weeks old. Black 
arrowheads denote the nodes of Ranvier. Scale bar, 50 m. 
B. Occasionally, myelin thickenings are detected around the nuclei of PDZ-Prx 
Schwann cells (red arrowheads) at 6 weeks of age. Scale bar, 30 m. 
C. In 4-month-old PDZ-Prx quadriceps nerves, multiple myelin depositions are 
visible along the internodes (red arrows), in addition to paranodal tomacula. 
Black arrowheads: nodes of Ranvier. Scale bar, 50 m. 
D. Quantitation of the proportion of paranodal myelin thickenings in 6-week-old 
WT and PDZ-Prx fibers reveals that over 70% of paranodes in PDZ-Prx 
fibers contain a tomaculum (n=3 per genotype). 
E. Western blot analysis of P0 and MBP on sciatic nerve homogenates from WT and 
PDZ-Prx mice at 2 and 6 months old. At both ages, P0 and MBP levels in WT 
and PDZ-Prx nerves are similar. -actin was used to normalize loading. 










Figure 31. Voltage-gated potassium channels Kv1.1 are abnormally localized in a 
proportion of PDZ-Prx quadriceps nerves fibers. 
Teased fibers from quadriceps nerves of 4-month-old WT and PDZ-Prx mice were co-
labeled with anti-Kv1.1 and anti-NaV antibodies. Sodium channels are correctly 
localized to the node of Ranvier in both WT and PDZ-Prx fibers. Kv1.1 channels are 
localized to the juxtaparanodes in WT teased fibers. In contrast, it appears diffuse and 
mislocalized in some mutant fibers due to the presence of paranodal tomacula. 
Arrowheads denote nodes of Ranvier. Scale bar, 20 m. 
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3.1.11 Abnormally myelinated PDZ-Prx nerve fibers are prone to mechanical 
stress leading to shifted localization of nodal proteins 
In teased fiber preparations of adult PDZ-Prx nerves, displacement of the nodes of 
Ranvier was occasionally detectable. Figure 32A shows the paranodal region, labeled for 
glial Neurofascin (Nfasc155), together with the node of Ranvier, of the left fiber 
invaginating into the paranode on the right. Similarly, in the mutant fiber in Figure 32B, 
despite normal expression of Neurofascin, the paranode, alongside the gliomedin-stained 
microvilli, in one Schwann cell-axon unit shifted into the paranodal region of the 
apposing hypermyelinated PDZ-Prx fiber that was surrounded by an abnormal and 
apparently multi-layered basal lamina. This phenomenon was rarely seen in WT teased 
fibers. 
To determine whether this observation was due to an artifact caused by mechanical 
stretching during fiber teasing, I examined the localizations of the nodes and paranodes 
in longitudinal cryostat sections of the quadriceps nerves. Unlike in single teased fibers, 
nodal displacement was not noted in PDZ-Prx nerve fibers on longitudinal sections 
(data not shown), suggesting that this phenomenon did not occur normally in vivo, but 
was a teasing artifact, likely attributed to unstable anchorage of the paranodal myelin 





Figure 32. Abnormally folded myelin in PDZ-Prx fibers is unstable leading to 
shifted localization of nodal proteins during fiber teasing. 
A. Immunostaining of quadriceps nerve teased fibers from 4-month-old WT and 
PDZ-Prx mice for voltage-gated sodium channels and paranodal marker 
Neurofascin. In the PDZ-Prx teased fiber, the node of Ranvier appears 
displaced, with the paranode on the left fiber shifted into the apposing Schwann 
cell-axon unit on the right. Background staining shows myelin thickenings at the 
paranodal regions in mutant fibers. Arrowheads denote nodes of Ranvier. Scale 
bar, 10 m. 
B. Immunofluorescence labeling of WT and PDZ-Prx quadriceps nerve teased 
fibers at 4 months for gliomedin in Schwann cell microvilli and paranodal 
Neurofascin are overlayed with transmitted light images of teased fibers, 
revealing shifted localization of nodal and paranodal proteins in mutant nerve 
fibers. Phase contrast images show a thin sheet of regularly shaped basal lamina 
surrounding the Schwann cell membrane in normal fibers. However, in mutant 
fibers, basal lamina appears irregular in shape and in multiple layers. 
Arrowheads denote nodes of Ranvier. Scale bar, 10 m. 
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3.1.12 Non-myelinating Schwann cell number is increased in adult PDZ-Prx 
quadriceps nerves 
Mature PDZ-Prx peripheral nerves characterized by extensive myelin folding are 
enlarged in size due to ECM accumulation in the endoneurium. Indeed, upregulation of 
ECM molecules such as collagens, fibronectin and laminin has been reported in the 
nerve biopsies of Charcot-Marie-Tooth disease type 1 patients (Palumbo et al., 2002). In 
the twitcher mouse, the activation and proliferation of supernumerary Schwann cells in 
response to demyelination is associated with excessive ECM in the endoneurial space 
(Kagitani-Shimono et al., 2008). To assess whether there was an elevation in Schwann 
cell number, which might be responsible for the increase in endoneurial space in adult 
PDZ-Prx peripheral nerves, despite limited demyelination, I immunostained 4-month-
old PDZ-Prx quadriceps nerve transverse sections with anti-p75
NGFR
 antibody for non-
myelinating Schwann cells. In normal nerves, p75
NGFR
-immunopositive non-myelinating 
Schwann cells predominantly associated in clusters, presumably with Remak bundles, 
found between myelinated axons with compact myelin uniformly labeled with anti-P0 
antibody. However, in enlarged PDZ-Prx and Prx KO nerves, p75
NGFR
 
immunoreactivity was detected ubiquitously in the endoneurium throughout the entire 
quadriceps nerve cross sections (Fig. 33A). At higher magnification, numerous p75
NGFR
-
immunopositive Schwann cells and processes enveloped thinly myelinated axons or 
even hypermyelinated axons indicated by irregular P0 staining (Fig. 33B), suggesting an 
increase in non-myelinating Schwann cells in the PDZ-Prx and Periaxin-null nerves. 
 The augmentation of Schwann cell number was further confirmed by 
quantification of the number of myelinating Schwann cells and total Schwann cells by 
Krox-20 and Sox10 immunolabeling per cross section of the quadriceps nerves from 
WT, PDZ-Prx and Prx KO mice at 4 months old (Fig. 34A). PDZ-Prx and Prx KO 
nerves had two and three times higher the number of Krox-20-positive cells per cross 
section than WT nerves, respectively. Remarkably, the total number of Schwann cells 
labeled for Sox10 was significantly elevated by three-fold in PDZ-Prx nerves and five-




















Figure 33. An increase in non-myelinating Schwann cells in mature PDZ-Prx 
quadriceps nerves 
A. Confocal immunofluorescence analysis of quadriceps nerve cross sections from 
4-month-old WT, PDZ-Prx and Prx KO mice doubled-labeled with anti-
P75
NGFR
 and anti-P0 antibodies. In WT nerves, P75
NGFR
 immunoreactivity is 
detected in distinct clusters representing Remak bundles located between 
myelinated axons. However, in PDZ-Prx and Prx KO nerve sections, P75
NGFR
-
positive non-myelinating Schwann cells are ubiquitously localized between 
myelinated axons. Scale bar, 50 m.  
B. At higher magnification, thinly myelinated and also hypermyelinated axons are 
surrounded by non-myelinating Schwann cells labeled for P75
NGFR
 in both 




















Figure 34. Quantification of Schwann cell numbers shows a significant elevation in 
non-myelinating Schwann cells in adult PDZ-Prx quadriceps nerves. 
A. Double labeling of quadriceps nerve cross sections from 4-month-old WT, 
PDZ-Prx and Prx KO with anti-Krox-20 and anti-Sox10 antibodies shows an 
increase in the number of myelinating Schwann cell nuclei labeled for Krox-20 
and Schwann cell nuclei for Sox10. Scale bar, 50 m. 
B. Quantitation of the numbers of Krox-20- and Sox10-positive cells per cross 
section of WT, PDZ-Prx and Prx KO quadriceps nerves at 4 months old reveals 
that there is a two- and three-fold increase in the number of Krox-20-positive 
myelinating Schwann cells in PDZ-Prx and Prx KO nerves, respectively, 
compared with WT nerves (n=3; *p < 0.05 and ***p < 0.001; one-way ANOVA 
with Tukey’s HSD post-test). The number of Sox10-positive Schwann cells is 
considerably increased by three times in PDZ-Prx nerves and five times in Prx 
KO nerves (n=3; p < 0.0001; one-way ANOVA with Tukey’s HSD post-test). 
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3.1.13 Schmidt-Lanterman incisures are morphologically normal in myelinated 
PDZ-Prx fibers 
Schmidt-Lanterman incisures (SLIs) are cytoplasmic channels within compact myelin 
that connect the Schwann cell abaxonal cytoplasm to the adaxonal cytoplasm. They have 
been implicated in facilitating transport of metabolic substances across the myelin sheath 
via gap junctions (Ghabriel and Allt, 1981; Gould et al., 1995). SLIs become fully 
mature at 2 months of age in mice (Tricaud et al., 2005). To determine whether SLIs 
were affected in PDZ-Prx nerves, teased fiber preparations from quadriceps nerves at 2 
months were labeled with phalloidin, and the number of SLIs was counted. Similar to 
the WT teased fibers, the morphology of SLIs in PDZ-Prx fibers appeared grossly 
normal (Fig. 35A). In agreement with our published data (Gillespie et al., 2000), SLIs in 
Prx KO nerve fibers were deranged. PDZ-Prx fibers contained slightly fewer SLIs per 
internode than WT fibers (WT, 13.72  0.33; PDZ-Prx, 11.95  0.27; p < 0.05; Fig. 
35C). However, due to a reduction in Schwann cell internodal lengths, SLIs in PDZ-
Prx nerves appeared more densely arranged along the internode than the WT controls. 
The number of SLIs per 100 m fiber was slightly elevated in PDZ-Prx fibers 




Figure 35. SLIs are morphologically normal in PDZ-Prx peripheral nerve fibers. 
A. Quadriceps nerve teased fibers were stained with phalloidin for SLIs in 2-month-
old mice. PDZ-Prx fibers harbored SLIs, which were morphologically similar 
to those in the WT control (arrowheads). In contrast, the incisures were 
completely deranged in Prx KO nerves. Scale bar, 50 m. 
B. SLIs appeared more densely arranged in PDZ-Prx teased fibers due to reduced 
Schwann cell internodal lengths. Hence, the number of incisures per 100 m 
internode is modestly higher in PDZ-Prx fibers than in the WT (n=4 per 
genotype; p < 0.05; Mann-Whitney U-test). 
C. The number of SLIs per internode in PDZ-Prx fibers is decreased (n=4 per 
genotype; p < 0.05; Mann-Whitney U-test). 
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3.1.14 Electrophysiological investigations of peripheral nerves in PDZ-Prx mice 
Our laboratory has previously demonstrated experimentally that nerve conduction 
velocity is sensitive to changes in internodal lengths in 3-week-old Periaxin-null mice, at 
which age parameters known to influence nerve conduction velocity, including myelin 
sheath thickness, axon diameter and localization of sodium channels are normal (Court 
et al., 2004). In PDZ-Prx mice, Schwann cell elongation was impaired leading to a 
decrease in internodal lengths both in young ages and in the adult (section 3.1.9). It was 
of particular interest to address whether nerve conduction velocity was reduced with 
respect to a shortening of Schwann cell internodal distance in PDZ-Prx nerves, given 
that other parameters mentioned above are not affected (section 3.1.8). 
3.1.14a- Conduction velocity of PDZ-Prx nerves is reduced at 3 weeks, but 
normal at 4 months 
I measured nerve conduction velocity from acutely isolated femoral nerves with the 
quadriceps branch from 3-week- and 4-month-old WT, PDZ-Prx and Prx KO (n=5-10 
per group for each age). From isolated nerve preparations, latencies of the onset of 
compound action potentials at varying conduction distances were measured from an 
active population of the fastest conducting and largest caliber Group A fibers, namely 
the A and A fibers. Nerve conduction velocities were determined as described in 
methods (section 2.12.1). At 3 weeks, the conduction velocity of PDZ-Prx nerves was 
dramatically reduced compared with the WT (Fig. 36). This was in agreement with the 
Prx KO values, which also showed a significant reduction in nerve conduction velocity 
(WT, 20.9  1.7 m/s; PDZ-Prx, 8.5  0.5 m/s; Prx KO, 12.6  1.1 m/s; p < 0.001). 
Intriguingly, despite shorter Schwann cell internodal lengths and myelin abnormalities 
(sections 3.1.9 and 3.1.10), 4-month-old PDZ-Prx nerves had normal conduction 
velocity, similar to the control values. Due to severe demyelination, the conduction 
velocity of adult Prx KO nerves was considerably reduced compared with both the WT 





Figure 36. Nerve conduction velocity is reduced at 3 weeks but normal at 4 months 
in PDZ-Prx mice. 
Nerve conduction velocities were measured from WT, PDZ-Prx and Prx KO 
quadriceps nerves at 3 weeks and 4 months. At 3 weeks old, nerve conduction velocity is 
reduced, in concurrence with a decrease in internodal length in both PDZ-Prx and Prx 
KO mice. Interestingly, the conduction velocity of 4-month-old PDZ-Prx nerves is 
similar to the WT values. Adult Prx KO nerves have considerably reduced conduction 
velocity (n=5-10 per genotype for each age; ***p < 0.0001; one-way ANOVA with 









3.1.14b- By 4 months old, PDZ-Prx Schwann cells are sufficiently long to 
support normal nerve conduction  
PDZ-Prx peripheral nerves contained focally folded myelin and tomacula, but limited 
onion bulb formation suggestive of a low degree of demyelination (section 3.1.10). The 
observation that PDZ-Prx peripheral nerves were able to conduct normally prompted 
me to hypothesize that in mature mutant peripheral nerves, Schwann cells have 
elongated sufficiently to support normal conduction of axons when mild demyelination 
only minimally affects nerve conduction. To test this, the conduction velocities of WT 
and PDZ-Prx nerves at 6 weeks, an age intermediary of 3 weeks and 4 months, were 
measured. The conduction velocity of WT quadriceps nerves at 6 weeks was 38.3  1.5 
m/s, which was not significantly different from that in normal adult nerves. PDZ-Prx 
nerves at 6 weeks had a conduction velocity of 29.4  1.1 m/s, which was between those 
of PDZ-Prx nerves at 3 weeks and 4 months (Fig. 38B).  
Whereas the conduction velocity of PDZ-Prx nerves at 3 weeks was reduced to 
half the WT values, PDZ-Prx nerve conduction velocity at 6 weeks of age was only 
slower than that of WT nerves by about 25%. A tendency towards an increase in nerve 
conduction velocity was evident with Schwann cell longitudinal growth over time in 
PDZ-Prx nerves, highly supportive of the notion that mutant Schwann cells had 
reached a threshold length to support normal nerve conduction in the adult, alongside an 
increase in axon diameters with nerve growth.  
Next, I decided to estimate the threshold internodal lengths in mutant Schwann 
cells. Since nerve conduction velocity was measured from the largest caliber Group A 
fibers using the current set-up, internodal lengths of the largest diameter fibers were 
selectively determined from quadriceps nerve teased fibers of WT and PDZ-Prx mice 
at 3 weeks, 6 weeks and 4 months of age. Teased fibers were double labeled with an 
anti-neurofilament antibody for the estimation of axon diameters, and an anti-dystrophin 
antibody for internodal length measurements. The distributions of axon diameters of WT 
and mutant fibers were comparable at all ages examined (Fig. 37). The scatter plots in 
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Figure 37 depicted that, with the same axon diameter, the majority of PDZ-Prx 
internodal lengths were shorter than those of the WT.  
Although there have been few quantitative studies of peripheral nerves of the 
mouse reported in the literature, the composition of peripheral nerves has been 
extensively studied in cats, from which the general classification and proportion of nerve 
fibers should apply to other mammals (Boyd, 1968). In cats, the largest caliber A and 
A fibers comprise approximately 60% of all myelinated afferent and efferent nerve 
fibers, thus excluding non-myelinated C-fibers, in nerves to skeletal muscle (Boyd, 
1968). In light of these findings and in order to impose stricter criteria on selection of 
large diameter fibers, I decided to take into account ~50% of all myelinated fibers for the 
estimation of the cut-off diameters for large caliber axons in the quadriceps nerve at 
each age. The cut-off axon diameters at the age of 3 weeks, 6 weeks and 4 months were 
4.2 m, 4.875 m and 6.0 m, respectively (Figs. 37B, D and F).  
The mean internodal lengths of large diameter fibers from WT and PDZ-Prx 
nerves were calculated from the internodal lengths of myelinated fibers with axon 
diameter larger than or equal to the cut-off diameter (Table 3 and Fig. 38A). The average 
internodal length of large diameter fibers at 6 weeks in WT was 575.4  15.5 m, at 
which length and axon diameter nerve fibers were conducting as fast as adult nerves. 
The threshold Schwann cell internodal length for normal nerve conduction in PDZ-Prx 
nerves was in the range of 422.1  15.5 m and 540.4  8.5 m, likely close to the 
higher end, together with an increase in the mean axon diameter with age. 
3.1.14C-PDZ-Prx mice have reduced nerve conduction velocity at 10 months old 
Consistent with a gradual increase in myelin abnormalities and pathological onion bulb 
formations, the nerve conduction velocity of PDZ-Prx mice at 10 months of age, was 
reduced compared with WT values (WT, 43.1  1.2 m/s vs PDZ-Prx, 31.8  1.3 m/s; p 




















Figure 37. Determination of the average internodal lengths of large caliber fibers.  
Quadriceps nerve teased fibers from WT and PDZ-Prx mice at 3 weeks, 6 weeks and 4 
months were co-stained with an anti-neurofilament antibody for axon diameter 
measurements, and an anti-dystrophin antibody for internodal length measurements. The 
distributions of axon diameters are similar between WT and PDZ-Prx myelinated 
axons at all ages examined shown in A, C and F. The scatter plots in B, D and F show 
internodal lengths of individual fibers in relation to axon diameter. For determination of 
the mean internodal lengths of large caliber fibers, fibers with large axon diameters, 
which comprise 50% all myelinated fibers examined, were taken into account for the 
estimation of the cut-off axon diameters. The cut-off diameters for 3 weeks, 6 weeks and 
4 months are 4.2 m, 4.875 m and 6.0 m, respectively. 
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Table 3. The mean internodal lengths (IL) of large caliber fibers and nerve 


















Figure 38. Adult PDZ-Prx Schwann cells are sufficiently long to support normal 
conduction of axons. 
A. The average internodal lengths of large caliber fibers from WT and PDZ-Prx 
nerves at 3 weeks, 6 weeks and 4 months were calculated from the internodal 
lengths of myelinated fibers with axon diameter larger than or equal to the cut-
off diameter (n=5-10 per genotype per age; **p < 0.01 and ***p < 0.001; 
Student’s t-test). 
B. Nerve conduction velocities were measured in WT and PDZ-Prx quadriceps 
nerves at an intermediate age, 6 weeks. The conduction velocity of WT 
quadriceps nerves at this age is similar to that of 4-month-old WT nerves. PDZ-
Prx conduction velocity at 6 weeks is catching up with that of normal nerves and 
is between values at 3 weeks and 4 months of mutant nerves, showing a tendency 
to an increase in conduction velocity with age (n=5-10 per genotype per age; 
***p < 0.0001; one-way ANOVA with Tukey’s HSD post-test).  
C. In agreement with a progressive increase in abnormal profiles and onion bulb 
formation, 10-month-old PDZ-Prx nerves have reduced nerve conduction 
velocities (n=5-7 per genotype per age; p = 0.0001; Student’s t-test). 
 147 
3.1.15 Motor coordination is impaired in 3-week-old but not in 4-month-old PDZ-
Prx mice 
Motor coordination was tested in 3-week- and 4-month-old WT, PDZ-Prx and Prx KO 
animals using a RotaRod. Mice were trained on a rotating RotaRod at two rotating 
speeds, 24 rpm and 32 rpm, for two consecutive days before the test trial. The test was 
terminated when the mice fell from the rod or at 60 s. RotaRod performance was 
evaluated by the mean latency to fall at the two rotating speeds tested. At 3 weeks, 
PDZ-Prx and Prx KO mice performed equally well as WT mice at 24 rpm (n=12-16 
per group). However at 32 rpm, the performance of PDZ-Prx and Prx KO mice was 
substantially poorer than WT controls (Fig. 39), confirming impairment in motor 
coordination consequent to a reduction in nerve conduction velocity at this age.  
In concurrence with the normal conduction velocity in adult mutant mice, RotaRod 
performance of 4-month-old PDZ-Prx mice did not differ significantly from that of 
their WT littermates at 32 rpm (n=10-16 per group). Conversely, Periaxin-null mice, 
which display a more severe demyelinating phenotype performed considerably poorly 
on the RotaRod at the same speed (Fig. 39). 
3.1.16 PDZ-Prx mice display normal sensory reflex behaviors 
I compared sensory behaviors in WT and PDZ-Prx mice by testing mechanoreception 
and thermal nociception that are primarily driven by myelinated A and unmyelinated C 
afferent fibers, respectively (Gillespie et al., 2000). Sensory reflex behavioural tests for 
mechanical withdrawal threshold with von Frey filaments and withdrawal latency from 
noxious heat were performed by Dr. Ada Delaney in WT and PDZ-Prx mice at 4-5 
months old. In both tests, PDZ-Prx mice showed normal mechanical response 
threshold to light tactile stimuli and thermal nociceptive response latency, suggesting 
that mutant animals did not display mechanical allodynia or thermal hyperalgesia (Table 
4 and Fig. 40). These data indicated that in PDZ-Prx nerves, small caliber myelinated 





Figure 39. Motor coordination assessed by RotaRod performance is impaired at 3 
weeks but normal at 4 months in PDZ-Prx mice. 
Motor coordination was evaluated in WT, PDZ-Prx, and Prx KO mice at 3 weeks old 
(left) and 4 months old (right) using the RotaRod test. At 24 rpm, there is no difference 
in RotaRod performance in WT, PDZ-Prx, and Prx KO mice at both ages. However, at 
32 rpm, PDZ-Prx, and Prx KO mice performed significantly poorly, compared with 
WT mice at 3 weeks old (n=12-16 per group; *p < 0.05 and ** p < 0.01). Motor 
coordination of 4-month-old PDZ-Prx mice does not differ significantly from WT 
values at 32 rpm. In contrast, Prx KO mice’s motor coordination is substantially 




Table 4. Hindpaw withdrawal response of mechanical and noxious thermal 
stimulation at 4-5 months of age. 
Figure 40. PDZ-Prx mice display normal sensory reflex behaviors. 
A. Minimum filament indentaton pressure thresholds for repeat paw withdrawal 
responses to mechanical stimulation with von Frey filaments were measured in 
4-5-month-old WT and PDZ-Prx mice. PDZ-Prx animals have normal 
mechanical withdrawal threshold (n=9-11 per group; p = 0.2233; Mann-Whitney 
Rank Sum test). 
B. The thermal nociceptive response latency from an infrared beam was determined 
in WT and PDZ-Prx mice at 4-5 months of age. PDZ-Prx mice have normal 
withdrawal latency from noxious heat, compared with WT littermates ((n=9-11 
per group; p = 0.9648; Student’s t-test). 
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3.1.17 Dlg1 levels are increased in PDZ-Prx quadriceps nerves 
Schwann cell hypermyelination with focally folded myelin and paranodal tomacula, 
often indicative of defective regulation of myelin production, is a common pathological 
feature for peripheral demyelinating neuropathies (Suter and Scherer, 2003). Mice 
deficient for myotubularin-related protein 2 (MTMR2), in which mutations in humans 
cause autosomal recessive Charcot-Marie-Tooth type 4B1, show a dysmyelinating 
phenotype characterized by aberrant myelin outfoldings (Bolino et al., 2004; Bonneick 
et al., 2005). The interaction of MTMR2 with mammalian discs large 1 (Dlg1)/ synapse-
associated protein 97 (SAP-97) has been implicated for the regulation of myelin 
membrane homeostasis in the Schwann cell (Bolino et al., 2004; Bolis et al., 2005; Bolis 
et al., 2009). Disruption of this interaction results in myelin outfoldings and redundant 
myelin loops (Bolis et al., 2009). In a recent study, Cotter et al provided evidence that 
Dlg1 prevents overproduction of peripheral myelin via the interaction with phosphatase 
and tensin homolog (PTEN), which acts by inhibition of AKT activation (Cotter et al., 
2010). 
 In the absence of the PDZ domain of Periaxin, PDZ-Prx mice develop a 
progressive neuropathy with excessive myelin deposition as myelin foldings and 
thickenings. To better understand the potential mechanism for myelin foldings, I 
investigated whether Dlg1/PTEN might be involved in the dysregulation of myelin 
production in PDZ-Prx mutants. The expression of Dlg1 in mature PDZ-Prx 
peripheral nerves was examined by immunostaining and Western blotting. In WT 
quadriceps nerve teased fibers, Dlg1 was enriched in Schwann cell microvilli at the 
nodal region (Bolino et al., 2004) and co-localized with a microvillus marker, radixin 
recognized by anti-RAD4 antibody. Interestingly, enhanced Dlg1 immunoreactivity was 
detected in the microvilli of PDZ-Prx Schwann cells (Fig. 41A). An increased level of 
Dlg1 expression in PDZ-Prx nerves was further confirmed by Western blot analysis of 
sciatic nerve homogenates from mice at 5 weeks and 6 months of age. However, prior to 
the development of myelin abnormalities at 3 weeks old, levels of Dlg1 in PDZ-Prx 
sciatic nerves, when normalized against actin, did not differ from those of WT mice. 
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Sciatic nerves of Periaxin-deficient mice, which develop a more severe phenotype later 
on, contained elevated amounts of Dlg1 at 3 weeks (Fig. 41B). 
 The pattern of PTEN expression studied by Western blot analysis of sciatic nerve 
lysates of 3-week- and 5-week-old PDZ-Prx and Prx KO coincided with that of Dlg1, 
with increased levels of PTEN in Prx KO nerves at both ages, and in PDZ-Prx at 5 
weeks. At 6 months old, however, PTEN levels in PDZ-Prx peripheral nerves appeared 
slightly reduced. 
 Growth factors such as neuregulin and insulin-like growth factor-I (IGF-I) play 
key roles in the regulation of Schwann cell differentiation (Nave and Trapp, 2008; Ogata 
et al., 2004). Effects of these growth factors are mediated through intracellular signaling 
cascades including phosphatidylinositol-3-OH kinase (PI3K) pathways and mitogen-
activated protein kinase (MAPK) pathways (Ogata et al., 2004). Signaling molecules 
including phosphatidylinositol-3-OH kinase (PI3K) and the serine/threonine kinase AKT 
are important for positively regulating myelination (Ogata et al., 2004). Since 
disinhibition of AKT activation due to downregulation of Dlg1/PTEN is associated with 
excessive myelin production (Cotter et al., 2010), I quantified phosphorylated AKT 
levels to investigate the possibility of its involvement in the overproduction of myelin in 
the Periaxin mutants. By immunoblotting, amounts of activated AKT that is 
phosphorylated at serine residue 473 were not altered in PDZ-Prx sciatic nerves at 3 
weeks or 6 months, or in Prx KO sciatic nerves at 3 weeks (Fig. 41C).  
Activation of extracellular signal-regulated kinase 1/2 (ERK1/2), a constituent of 
the MAPK signaling pathways drives the dedifferentiation of Schwann cells in vitro 
(Harrisingh et al., 2004). In addition, studies in mouse models of the demyelinating form 
of CMT type 1 have demonstrated that ERK1/2 activation leads to an upregulation of 
Schwann cell-derived chemokine MCP-1 (CCL2), which mediates macrophage 
activation, promoting myelin degeneration (Fischer et al., 2008; Groh et al., 2010; Kohl 
et al.). To address whether ERK phosphorylation was altered in the Periaxin mutants, I 
examined the levels of phosphorylated ERK1/2. At 5 weeks old, levels of 
phosphorylated ERK1/2 in PDZ-Prx sciatic nerves were not changed compared with 
those in WT nerves. However, in Prx KO nerves, phosphorylation of ERK1/2 was 
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elevated (Fig. 41D). Similar results were obtained at 3 weeks (data not shown). In 
mature PDZ-Prx mice at 6 months old, there was a modest increase in the amounts of 
activated ERK1/2. 
 Since there was an increase in the number of Schwann cells in the Periaxin 
mutants due to reduced internodal lengths, I intended to investigate the Mammalian 
Target of Rapamycin (mTOR) signaling cascade, which regulates cell growth and 
proliferation. Activation of mTOR mediated by AKT signaling has also been implicated 
in the regulation of myelination in the CNS (Narayanan et al., 2009). I evaluated the 
expression levels of mTOR and its downstream substrate, S6 ribosomal protein in sciatic 
nerve homogenates of 3-week-old WT, PDZ-Prx and Prx KO mice. The amounts of 
phosphorylated mTOR and total mTOR in nerves of both Periaxin mutants were similar 
to those in normal nerves. Expression of phosphorylated S6 ribosomal protein, however, 
was markedly augmented in both PDZ-Prx and Prx KO nerves, with a more notable 
increase in Periaxin-null mice, in comparison with WT nerves (Fig. 41E). This suggests 
















Figure 41. Dlg1 levels are increased in PDZ-Prx quadriceps nerves. 
A. Teased fibers from quadriceps nerves of 2-month-old WT and PDZ-Prx mice 
were co-labeled with anti-Dlg1 and anti-RAD4 antibodies. Dlg1 
immunoreactivity enriched at the nodal regions is increased in PDZ-Prx nerve 
fibers. Scale bar, 15 m. 
B. Western blot analysis of Dlg1 and PTEN expression levels in WT, PDZ-Prx 
and Prx KO sciatic nerves at 3 weeks, 5 weeks and 6 months. Amounts of Dlg1 
are elevated in 5-week- and 6-month-old PDZ-Prx nerves. PTEN levels are 
increased in 5 weeks but not at 6 months in PDZ-Prx nerves. -actin was used 
to normalize loading.  
C. The amounts of activated AKT phosphorylated at serine 473 in PDZ-Prx sciatic 
nerves are unaltered, compared with those in WT nerves. 
D. PDZ-Prx sciatic nerves have normal amounts of activated ERK at 5 weeks old. 
Nevertheless, in mature PDZ-Prx peripheral nerves, activated ERK is elevated 
in levels. Prx KO sciatic nerves at 5 weeks contain increased amounts of 
activated ERK, compared with WT nerves. 
E. Phosphorylated mTOR levels in sciatic nerves of 3-week-old PDZ-Prx and Prx 
KO mice are not significantly different from those in WT nerves. Amounts of 
phosphorylated S6, a downstream substrate of mTOR, however, are notably 
increased in PDZ-Prx and Prx KO nerves. -actin was used as a loading 
control.  
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3.1.18 Summary  
In this chapter, I have demonstrated that the PDZ domain of Periaxin is required for 
homodimerization, which is essential for the stabilization of the PDG complex and 
regulation of the formation of discrete Schwann cell domains, termed appositions.  
I have described the generation of a conditional mutant mouse, PDZ-Prx, 
expressing a Periaxin form lacking the N-terminal PDZ domain in peripheral nerves, 
based on the mechanism of translation reinitiation. Dimerization of Periaxin does not 
occur in the absence of the PDZ domain. In PDZ-Prx Schwann cells, DRP2 fails to 
form appositions and Cajal bands are disrupted. Schwann cell internodal distances are 
reduced. This is consistent with an increase in the number of myelinating Schwann cells 
in PDZ-Prx nerves.  
In the mature PNS, PDZ-Prx mice develop a progressive neuropathy marked 
with extensive hypermyelination with focally folded myelin and paranodal tomacula. 
Nevertheless, the PDZ-Prx mice show a less severe demyelinating phenotype, 
compared with the Periaxin-null mice. 
 Consequent to a decrease in Schwann cell internodal lengths, nerve conduction 
velocity of quadriceps nerves from 3-week-old PDZ-Prx mice is reduced, and motor 
coordination impaired. Interestingly, adult PDZ-Prx nerves, with limited 
demyelination, have normal conduction velocity, indicating that mutant Schwann cells, 
albeit defects in longitudinal growth have elongated enough to support normal nerve 
conduction. These findings suggest that the PDZ-Prx mouse serves as a good model 
for studying the sensitivity of nerve conduction velocity to changes in internodal lengths. 
In addition, PDZ-Prx mice show normal nociceptive sensory function.  
 Collectively, these data suggest that the PDZ domain of Periaxin is important for 
regulating apposition stability, Schwann cell internodal lengths, and myelin 
maintenance, through homodimerization or by binding with potential interactors in the 
submembranous cortex of the Schwann cell. In order to study this further, it will be 
necessary to study the downstream signaling mechanisms involved in the regulation of 
Schwann cell growth and myelin production in the Periaxin mutants.  
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3.2 THE ROLES OF THE PERIAXIN PDZ DOMAIN IN 
ESTABLISHED SCHWANN CELL COMPARTMENTS 
 
Abrogation of PDZ domain homodimerization in Periaxin destabilizes the Periaxin-
DRP2-dystroglycan (PDG) complex, leading to the absence of DRP2-patches and 
disruption of appositions and Cajal bands. The absence of the Periaxin PDZ domain in 
Schwann cells also results in a reduction of Schwann cell internodal lengths and an 
excessively folded myelin sheath in peripheral nerves. Whether stabilization of the PDG 
complex, and thus proper maintenance of close appositions in the Schwann cell, is 
responsible for the regulation of internodal growth remains elusive. In addition, Periaxin 
is localized in the Schwann cell plasma membrane before the onset of myelination and 
its association of DRP2 (Sherman and Brophy, 2000). Before homodimerization during 
formation of the PDG complex, it is still unknown whether the PDZ domain has other 
functions such as targeting proteins to the cortical cytoskeleton.  
When myelination is complete, the cytoplasm of the Schwann cell is restricted to 
regions segregated by appositions between the Schwann cell membrane and the 
outermost layer of the myelin sheath, forming distinct compartments. I wished to ask 
what would happen if the PDG complex was disrupted after compartmentalization of the 
Schwann cell is accomplished. I investigated the consequences of disrupting Periaxin 
PDZ domain homodimerization, thus the PDG complex, after the establishment of 
specific Schwann cell compartments, namely appositions and Cajal bands, in tamoxifen-
inducible Prx
fl/fl
/P0CreERT mice. Mutant Periaxin without the N-terminal PDZ domain 
was predicted to be generated by Cre-recombination upon tamoxifen induction. In this 
study, apposition maintenance, Schwann cell internodal lengths and myelin morphology 
were examined in the peripheral nerves of adult Prx
fl/fl
/P0CreERT mice.  
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Tamoxifen was administered to weaned Prx
fl/fl
/P0CreERT mice, 3-4 weeks of age, as 
well as to control littermates Prx
fl/fl
 for 10 consecutive days. After a rest-period of 7 
days, mice were treated again for 5 days. Animals were analyzed for the degree of the 
‘floxed’ Prx gene recombination at various time points (Fig. 42A). The findings 
presented here are from the analysis of mice 12 weeks and 18 weeks after the last 
tamoxifen treatment. Experiments studying non-treated Prx
fl/fl
/P0CreERT mice indicated 
that recombination did not occur without tamoxifen induction (data not shown). Hence, 
tamoxifen-treated Prx
fl/fl
 mice were used as the control in the study. 
Mice treated with tamoxifen were analyzed for Periaxin expression 12 and 18 
weeks following the last treatment. By immunoblotting using a Periaxin antibody 
against the C-terminus, two Periaxin bands were identified from the sciatic nerve 
homogenates of Prx
fl/fl
/P0CreERT mice 12 weeks post-treatment (Fig. 42B). The mutant 
form of Periaxin was expressed as a lower molecular weight protein at reduced levels, 
compared with the wild-type Periaxin in control nerves. This was consistent with the 
mutant version of Periaxin in Prx
fl/fl
/Cnp-Cre mice (known as PDZ-Prx mice in the 
study). Little wild-type Periaxin was expressed in Prx
fl/fl
/P0CreERT nerves at this time 
point (Fig. 42B). At 18 weeks after tamoxifen induction, the amount of wild-type 
Periaxin was negligible in the Prx
fl/fl
/P0CreERT lysates as shown by Western blot 
analysis, indicating that maximum ablation of wild-type Periaxin was achieved by Cre-




Nevertheless, the deletion efficiency of the wild-type Periaxin was variable 
among tamoxifen-treated animals. The extent of wild-type protein deletion in the 
peripheral nerves from Prx
fl/fl
/P0CreERT mice was analyzed in different animals 18 
weeks after treatment by Western blotting and immunofluorescence staining. Peripheral 
nerves of some tamoxifen-treated mice contained both the wild-type and mutant forms 
of Periaxin detected by the Periaxin C-terminus antibody in sciatic nerve homogenates 
by Western blot analysis (data not shown). By immunofluorescence labeling, in contrast 
 158 
to myelinated fibers from treated Prx
fl/fl
 nerves, which were immunopositive for both the 
N- and C-terminal regions of Periaxin, approximately 50% of fibers from the quadriceps 
nerves of Prx
fl/fl
/P0CreERT mice did not harbor the wild-type Periaxin, but the mutant 
Periaxin alone, recognized by the Periaxin C-terminus antibody (Fig. 42C). Although 
residual amounts of the wild-type Periaxin were present in the mutant nerves of some 
animals even after 18 weeks post-treatment, these data suggest that mutant Periaxin 
lacking the N-terminus was generated in this tamoxifen-inducible conditional system. 
Despite only partial ablation of the wild-type Periaxin, the Prx
fl/fl
/P0CreERT quadriceps 
















Figure 42. Generation of mutant Periaxin PDZ-Prx lacking the N-terminus by 
tamoxifen-inducible Cre-recombination in Prx
fl/fl
/P0CreERT mice.  
A. The scheme of the tamoxifen administration protocol. 3-4 weeks old Prxfl/fl and 
Prx
fl/fl
/P0CreERT littermates were treated with tamoxifen at a dose of 1 mg/10 g 
body weight once per day for 10 consecutive days. Mice were treated again for 5 
days following a 7-day rest period and were analyzed 12 or 18 weeks after the 
last treatment.  
B. Immunoblots probed with a Periaxin antibody against the C-terminus show that 
the mutant Periaxin was generated in tamoxifen-treated Prx
fl/fl
/P0CreERT mice 
12 weeks and 18 weeks post-treatment (wpt). Residual amounts of the wild-type 
Periaxin were still present in Prx
fl/fl
/P0CreERT sciatic nerve lysates 12 weeks 
after treatment. Complete ablation of the wild-type Periaxin was achieved 18 
weeks after treatment in this case. When normalized against -actin, the mutant 
Periaxin was expressed at reduced levels, compared with the wild-type Periaxin. 
C. Recombination efficiency was variable among tamoxifen-treated 
Prx
fl/fl
/P0CreERT mice 18 weeks post-treatment. Immunofluorescence images 
show quadriceps nerve cross sections immunolabeled with specific Periaxin 
antibodies against the N-terminus or C-terminus. Nearly 50% of myelinated 
fibers lack wild-type Periaxin identified by the Periaxin N-terminus antibody. 
Deletion of the wild-type Periaxin in this animal was incomplete at this time 
point. Scale bar, 50 m. 
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In the absence of the PDZ domain of Periaxin, DRP2 patches are absent and longitudinal 
and transverse bands of cytoplasm, the Cajal bands, are disrupted, as analyzed in PDZ-
Prx peripheral nerves (see sections 3.1.6 and 3.1.7). I asked whether DRP2 patches and 
Cajal bands were affected when Periaxin’s PDZ domain was removed by the generation 
of the mutant Periaxin after the establishment of appositions. Immunolabeling of teased 
fibers from quadriceps nerves of tamoxifen-treated animals with the Periaxin repeat 
region antibody displayed immunoreactivity for Periaxin in the Schwann cell membrane 
18 weeks after tamoxifen treatment, albeit reduced in levels, compared with the treated 
littermate controls. Mutant Periaxin in Prx
fl/fl
/P0CreERT fibers was membrane-
associated but was not localized to patches. DRP2 levels were reduced and DRP2 
patches were absent in the quadriceps nerves of Prx
fl/fl
/P0CreERT mice, in contrast to 
the distinct patch pattern observed in control teased fibers. Cajal bands immunolabeled 
for S100 were also disrupted and appeared continuous along the internodes, suggesting 
the disruption of appositions (Fig. 43). Due to the variable degree of recombination in 
myelination fibers, DRP2 was not equally depleted in all fibers analyzed per animal. By 
12 weeks post-treatment, at least 50% of total fibers lacked DRP2 patches in all animals 




Figure 43. DRP2 patches are absent and Cajal bands disrupted in tamoxifen-
inducible Prx
fl/fl
/P0CreERT mice 18 weeks post-treatment. 





mice with the Periaxin repeat region antibody shows reduced amounts of Periaxin, 
presumably the mutant form in Prx
fl/fl
/P0CreERT fibers. Note that Periaxin is no longer 
localized in patches. Analysis of DRP2 immunoreactivity demonstrates that DRP2 
appears in patches in control fibers. In contrast, Prx
fl/fl
/P0CreERT teased fibers do not 
display DRP2-patches. Cajal bands immunolabeled for S100 are also disrupted. Scale 




3.2.3 Schwann cell internodal lengths are unaltered in Prx
fl/fl
/P0CreERT mice 
Characterization of PDZ-Prx mice indicated that the mutant Periaxin without the PDZ 
domain failed to homodimerize, resulting in the disruption of the PDG complex and 
Cajal bands. PDZ-Prx mutants also have shorter Schwann cell internodal lengths (see 
section 3.1.9). By postnatal day 21, myelination is essentially complete, and Schwann 
cell compartments were well established. Prior to tamoxifen induction in 3-4-week-old 
Prx
fl/fl
/P0CreERT mice, longitudinal growth of Prx
fl/fl
/P0CreERT Schwann cells was 
predicted to be normal. To address whether disruption of the PDG complex and 
cytoplasmic bands in recombined Schwann cells influenced Schwann cell internodal 
growth, I measured Schwann cell internodal distances of teased quadriceps fibers from 
Prx
fl/fl
/P0CreERT mice 12 weeks following tamoxifen induction.  
Due to the heterogeneity of recombination efficiency in individual fibers, teased 
fibers were co-immunolabeled for dystrophin for internodal length measurements, and 
DRP2 or Periaxin N-terminus to select for fibers with a high degree of recombination. 
Internodal lengths of Schwann cells lacking the Periaxin N-terminus or DRP2 were 
measured. In contrast to PDZ-Prx Schwann cells, which had shorter internodal lengths, 
Prx
fl/fl
/P0CreERT Schwann cells showed normal average internodal length compared 
with the control value at 12 weeks after tamoxifen treatment  (Prx
fl/fl
, 753.1  27.4 m vs 
Prx
fl/fl
/P0CreERT, 730.7  20.7 m; Fig. 44A). Mutant Schwann cells also displayed a 
normal internodal length distribution, similar to control Schwann cells (Fig. 44B), 
indicating that Schwann cell internodal distance was not altered despite the disruption of 
the PDG complex and Cajal bands. This suggested that disrupting the PDG complex 
after the establishment of Schwann cell compartments no longer influences Schwann 
cell elongation.  
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Figure 44. Schwann cell internodal lengths of Prx
fl/fl
/P0CreERT mice are normal.  
A. Teased fibers were immunolabeled with antibodies directed against dystrophin 
and DRP2 or the Periaxin N-terminus. Internodal lengths of Schwann cells with 
depleted DRP2 or without the N-terminus of Periaxin were measured. Unlike 
PDZ-Prx Schwann cells with reduced internodal lengths (p < 0.0001), the 
average internodal distance of recombined Prx
fl/fl
/P0CreERT Schwann cells 
does not differ significantly with the control value (n=3; at least 70 internodes 
per genotype; one-way ANOVA with Tukey’s HSD post-test).  
B. Distributions of Schwann cell internodal lengths from teased fibers of 4.5-
month-old tamoxifen-treated mice analyzed 12 weeks post-treatment shows 
that Prx
fl/fl
/P0CreERT Schwann cells have normal internodal lengths compared 




/P0CreERT nerves display abnormal myelin profiles 
I next examined the peripheral nerves of Prx
fl/fl
/P0CreERT mice by light microscopy to 
determine if the myelin sheath was affected. Due to the variable degree of recombination 
in myelinated fibers by tamoxifen induction, quantitation of abnormal myelin profiles 
was not performed. At 18 weeks after tamoxifen injection, the cross sectional area of the 
Prx
fl/fl
/P0CreERT quadriceps nerves was increased. The endoneurial and perineurial 
space was strikingly enlarged, compared with control nerves (Figs. 45A and B). Mutant 
nerves contained numerous focal thickenings and foldings of the myelin sheath, 
consistent with what was observed in PDZ-Prx nerves. Redundant myelin loops inside 
a myelinated axon appeared as ‘U-shaped’ infolds, and often causing axon compression. 
Aberrant myelin invaginations in axons and myelin outfoldings were evident in the 
mutant nerves (Figs. 45D and F). Additionally, Prx
fl/fl
/P0CreERT nerves also harbored 
thinly myelinated axons enveloped by processes of supernumerary Schwann cells 
forming onion bulbs (Fig. 45D). These data confirm that Periaxin’s PDZ domain is 






















Figure 45. Tamoxifen-treated Prx
fl/fl
/P0CreERT nerves show abnormal myelin 
profiles.  
Semithin transverse sections of quadriceps nerves from 6-month-old Prx
fl/fl
 (A, C and E) 
and Prx
fl/fl
/P0CreERT mice (B, D and F) 18 weeks after tamoxifen injection. A-B. 
Quadriceps nerve area of Prx
fl/fl
/P0CreERT mice is increased due to an increase in 
endoneurial space, compared with the treated control littermates. Scale bar, 65 m. D, F. 
Foldings and focal thickenings of the myelin sheath (red arrows), as well as onion bulbs 
(red arrowheads) are evident in Prx
fl/fl
/P0CreERT nerves after tamoxifen treatment. 
Scale bar, 15 m.  
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3.2.5 Summary 
In this chapter, I have shown that the mutant Periaxin lacking the N-terminal PDZ 
domain was generated by tamoxifen inducible Cre-recombination of the ‘floxed’ Prx 
allele in Prx
fl/fl
/P0CreERT mice. The wild-type Periaxin was replaced by the mutant 
Periaxin in Schwann cells with successful recombination. However, residual amounts of 
wild-type Periaxin were present in some myelinated fibers of mutant nerves analyzed. 
This might be due to incomplete Cre-recombination of the ‘floxed’ Prx allele.  
Although the proportions of Schwann cells containing the mutant Periaxin varied 
among treated animals, recombined myelinated fibers displayed decreased amounts of 
DRP2 and absence of DRP2-positive patches. Schwann cell cytoplasm was no longer 
arranged in longitudinal and transverse bands along the internodes, indicating disruption 
of Cajal bands. Disrupting the PDG complex after the establishment of specific Schwann 
cell compartments does not affect longitudinal elongation of Schwann cells. The absence 
of the PDZ domain of Periaxin leads to hypermyelination in peripheral nerves, revealed 
by extensive myelin foldings indicating dysregulation of myelin production.  
Taken together, these results confirm that the PDZ domain of Periaxin is required 
for the maintenance of appositions and the myelin sheath.  
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3.3 MUTATIONS IN PERIAXIN PDZ DOMAIN ABROGATES 
HOMODIMERIZATION 
 
Periaxin contains a PDZ domain at the N-terminus (Dytrych et al., 1998). PDZ domains 
are peptide-binding domains that are usually 80-100 amino acid residues long. They are 
specialized protein interaction domains known for binding to short peptide motifs at the 
carboxy-termini of ligand proteins, and may be important for interactions with the 
cytoplasmic tail of plasma membrane proteins and with the cortical cytoskeleton (Sheng, 
1996). Canonical PDZ domains contain six -strands (1-6 or A-F) and two -
helices (1 and 2 or A and B), with a short 1-helix formed in the region between 




Figure 46. Three-dimensional structure of a canonical PDZ domain. 
Ribbon diagram of the structure of the second PDZ (PDZ2) domain of PSD-95 (-
helices in purple, -strands in green). PSD-95 PDZ2 contains six β-strands and two α-
helices (labeled), and adopts the canonical PDZ fold that displays a binding groove for 
its target C-terminal peptide (orange). N- and C-termini are indicated. Figure adapted 




 Periaxin is known to homodimerize in the Periaxin-DRP2-dystroglycan (PDG) 
complex localized to the submembranous cortex of the Schwann cell (Sherman et al., 
2001). Like Periaxin, a number of PDZ domain proteins also form dimers with 
themselves as homodimers, or with other PDZ domain proteins as heterodimers (Kim 
and Sheng, 2004; Lee and Zheng, 2010). Several scaffolding proteins localized in the 
postsynaptic terminal have been reported to self-associate to form homodimers such as 
GRIP-1, Shank1, Tamalin and ZO proteins (Chen et al., 2008; Fanning et al., 2007; Im 
et al., 2003a; Im et al., 2003b; Sugi et al., 2007; Utepbergenov et al., 2006; Wu et al., 
2007); and heterodimers such as nNOS/PSD-95 and nNOS/syntrophin (Hillier et al., 
1999; Tochio et al., 2000). Dimerization mechanisms of these PDZ dimers have been 
extensively described as detailed below. 
Structural evidence of PDZ domain homodimerization was first described in the 
PDZ domain of the glutamate receptor-interacting protein (GRIP). GRIP contains 7 PDZ 
domains, in which the sixth PDZ domain PDZ6 homodimerizes through an anti-parallel 
orientation of the N-terminal 1 strands. The dimeric interaction was maintained by 
hydrogen bonds between polar residues and hydrophobic forces between non-polar 
residues in the 1 strands. The 1-4 loop also contributed to mediating dimerization of 
PDZ6 (Im et al., 2003b). Similarly, Shank1, which is important for organization of 
synaptic multiprotein complexes, dimerizes via a conserved 2-3 loop and anti-parallel 
1-1 interactions, supported by hydrogen bonds and van der Waals forces (Im et al., 
2003a). Although the N-terminal 1 strands differ in configuration in the two PDZ 
dimers, the similarity in their dimerization mechanisms through forming anti-parallel 1 
strand may imply that the N-terminal 1 strand anti-parallel dimerization could be a 
common configuration among PDZ dimers. 
The second PDZ domain, PDZ2, of tight junction-associated ZO proteins (ZO-1 
and ZO-2) employs a unique dimeric conformation, stabilized by extensive symmetrical 
domain swapping of -strands (Chen et al., 2008; Fanning et al., 2007; Utepbergenov et 
al., 2006; Wu et al., 2007). Due to domain swapping of 1 and 2 strands, instead of 
orienting in an anti-parallel fashion with 3 strand in each PDZ domain, the 2 strand 
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continues in the same direction connecting to the short 3 strand, allowing -strands to 
cross and pack against each PDZ monomer for dimerization (Fanning et al., 2007).  
PDZ domain dimerization of Tamalin, a regulator of mGluR trafficking, is 
mediated by hydrophobic interactions between 2 and 3 strands from each monomer. It 
is also capable of assembling into a tetramer in crystallized conditions (Sugi et al., 
2007). As mentioned, PDZ domains can form heterodimers. A well-known example is 
the complex formed between neuronal nitric oxide synthase (nNOS) and syntrophin or 
PSD-95 (Hillier et al., 1999; Tochio et al., 2000). The PDZ domain of nNOS has been 
shown to dimerize in a head-to-tail arrangement with that of syntrophin and PSD-95 via 
the insertion of a two-stranded -sheet structure termed ‘-hairpin finger’ into the 
peptide-binding groove of the PDZ domain of syntrophin or PSD-95. A buried salt 
bridge, contributed by hydrogen bonding and electrostatic interactions, between the -
finger and the main body of the nNOS PDZ domain is required for stabilizing the -
hairpin structure, which is required for dimeric interactions. The salt bridge is essentially 
formed between an arginine residue in the  finger and an aspartate in the 4 strand of 
the PDZ domain (Hillier et al., 1999; Tochio et al., 2000).  
Dimerization of PDZ domain proteins does not hinder the access of target proteins 
to the carboxylate binding site, and thus does not influence binding of their partners 
(Fanning et al., 2007; Im et al., 2003a; Im et al., 2003b). Although little is understood 
about the role of PDZ-PDZ interactions, it has been speculated that dimerization might 
increase the scaffolding capacity of PDZ domain proteins, which would facilitate 
clustering of binding partners at specific sites, such as the postsynaptic membrane 
(Fanning et al., 2007; Kim and Sheng, 2004).  
As for Periaxin, I have provided biochemical evidence in section 3.1 that 
homodimerization fails to occur in the absence of the PDZ domain, confirming that PDZ 
domain self-association is essential for stabilization of the PDG complex and apposition 
formation in the Schwann cell. Nevertheless, since elimination of 116 amino acids from 
the N-terminus of Periaxin might induce drastic changes in the protein folding 
mechanism, the inability of the Periaxin PDZ domain to homodimerize may not be 
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solely attributed to the lack of the PDZ domain in mutant Periaxin, but could also be due 
to misfolding of the truncated protein. Completely ruling out the possibility of protein 
misfolding leading to abrogation of PDZ domain dimerization would be difficult within 
the time frame of this study. However, it would be possible to examine whether changes 
in the PDZ domain alone could result in disruption of dimerization when protein 
structure was largely preserved. In order to minimize drastic perturbations in the protein 
structure of Periaxin, I generated single amino acid mutations in the PDZ domain of 
Periaxin. 
3.3.1 Predicted three-dimensional structure of Periaxin PDZ domain 
To decide which amino acids in the PDZ domain to mutate, the predicted three-
dimensional structure of Periaxin PDZ domain was modelled using automated beta 
SWISS-MODEL based on the template of PDZ3 domain of PSD-95 (Arnold et al., 2006; 
Guex and Peitsch, 1997; Schwede et al., 2003). PSD-95 PDZ3 was selected as the 
modeling template because it displayed 32.6% sequence identity to the Periaxin PDZ 
sequence, the highest among all PDZ templates by template analysis using the SWISS-
MODEL repository (Kiefer et al., 2009; Kopp and Schwede, 2004). The PDZ domain of 
Periaxin was predicted to follow the canonical PDZ domain fold, adopting the 
 topology with six -strands and two -helices (one short and one long). 
Within the PDZ domain, strands 1 and 6 arrange in an anti-parallel orientation; strand 
2 is followed by a loop that turns ~180
o
, enabling the following sequence to form the 
anti-parallel strand 3. A short 1-helix is formed between strands 3 and 4, and a 
long 2-helix between 5 and 6 (Fig. 47A). The conventional structure of Periaxin 
PDZ domain may allow it to self-associate by employing one or a combination of the 






















Figure 47. Periaxin maintains the canonical PDZ-fold. 
A. The predicted 3D structure of the PDZ domain of Periaxin (residues 14-98) was 
modeled using SWISS-MODEL based on the template of the third PDZ domain 
of PSD-95. A ribbon diagram shows the monomeric structure of the Periaxin 
PDZ domain, which follows the canonical PDZ-fold. The -strands are labeled 
1-6, and the -helices are labeled 1 and 2.  
B. Amino acid sequence alignment of the PDZ domains of proteins that dimerize. 
The sequences were aligned using ClustalX in MacVector software. The 
sequence of Periaxin PDZ domain (PrxPDZ; residues 14-98) was compared with 
amino acid sequences of PSD-95 PDZ3 (residues 306-399), GRIP1 PDZ6 
(residues 665-753), Shank1 PDZ (residues 585-690), nNOS PDZ (residues 12-
112), ZO-1 PDZ2 (residues 182-273), ZO-2 PDZ2 (residues 305-392) and 
tamalin PDZ (residues 94-192). Residues conserved or identical in all sequences 
are shaded in gray. Secondary structure elements involved in this mutation study 
are labeled and shown in rectangles. The residues in Periaxin colored in red: the 
threonine residue (T23) in the 1 strand, glycine 31 in 2 strand or the highly 
conserved aspartate D63 in the 4 strand were mutated in this study (See section 
3.3.3).  
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3.3.2 Truncation of 1 strand in Periaxin PDZ domain abrogates PDZ-PDZ 
interactions 
In light of the speculation by Im et al. that the anti-parallel N-terminal 1 strand 
dimerization might be a common mechanism among PDZ dimers (Im et al., 2003a; Im et 
al., 2003b), as well as their finding that a single amino acid mutation Y671D in the 1 
strand of GRIP-1 PDZ6 has been demonstrated to completely abolish dimerization of the 
protein (Im et al., 2003b), I explored the possibility of abrogating PDZ domain self-
association of Periaxin by truncation of the N-terminus of Periaxin including the 1 
strand of the PDZ domain (Fig. 47B).  
Deletion mutants were generated for yeast two-hybrid interaction assays. The N-
terminal 1 strand truncated Periaxin PDZ, namely PDZ1 (aa 25-103) and the 6 
strand deletion mutant PDZ6 (aa 2-88) in GAL4 binding domain vector pGBKT7 
containing a myc-epitope tag were expressed in yeast as shown by Western blot (Fig. 
48A). In contrast to the non-mutated PDZ domain control, binding of PDZ1 to the N-
terminal PDZ domain of Periaxin (aa 2-164) was abolished as demonstrated by the lack 
of -galactosidase (-gal) activity, indicating that the 1 strand of the Periaxin PDZ 
domain was required for activating GAL4 transcription, and thus crucial for 
homodimerization. Interaction of the N-terminal region of Periaxin with PDZ6 
lacking the 6 strand, which is normally anti-parallel to the 1 strand, was considerably 
attenuated, suggesting that the 6 strand was also involved but likely not essential for 
dimerization. Similar results obtained using the deletion mutants subcloned into another 
GAL4 binding domain vector pAS2-1, further confirmed the importance of the 1 strand 





























Figure 48. The PDZ domain 1 strand in Periaxin is crucial for PDZ-PDZ 
interactions.  
A. The PDZ domain deletion constructs PDZ1 (aa 25-103) and PDZ6 (aa 2-
88), alongside unmutated PDZ domain (aa 2-103) control construct in GAL4 
binding domain vector pGBKT7, which contains a c-myc epitope tag, were 
transformed and expressed in yeast strain Y190. Protein expression was analyzed 
by Western blot using anti-Periaxin N-terminus (PeriN) antibody for PDZ 
control and PDZ6 mutant, and anti-myc antibody for PDZ1 because it lacks 
the extreme N-terminus of Periaxin recognized by the Periaxin antibody used 
here. The mobility of molecular weight marker (in kilodaltons) is shown on the 
left of the blots. The molecular weights of PDZ, PDZ1 and PDZ6 fusion 
proteins are 31 kDa, 29 kDa and 30 kDa.  
B. Interaction of the intact N-terminus of Periaxin (aa 2-164) with PDZ1 was 
disrupted, and with PDZ6 was diminished. The strength of the interaction 
between the Periaxin N-terminal GAL4 activation domain fusion protein and the 
PDZ domain deletion fusion proteins, PDZ1 and PDZ6 in pGBKT7 and 
pAS2-1 in a yeast two-hybrid -galactosidase assay was semi-quantitatively 
evaluated by the time taken for the development of blue colonies (+++, <30 min; 
++, 30-60 min; +, 60-180 min). A schematic representation of the full length 
Periaxin is shown for comparison. Amino acid residues are indicated in brackets. 
The first and last amino acids for the control and mutants, as well as the -
strands involved were specified on the diagram.   
 178 
3.3.3 Single amino acid changes in Periaxin PDZ domain are sufficient to disrupt 
homodimerization 
In trying to minimize disruption of the tertiary structure of the protein and to identify 
specific amino acid residues that are important for homodimerization, single amino acid 
changes were introduced in the PDZ domain of Periaxin. Interactions were tested by a 
yeast two-hybrid assay.  
 Since 1-1 strand anti-parallel interactions in PDZ dimers are primarily 
maintained by hydrogen bonding and weak electrostatic forces (Im et al., 2003a; Im et 
al., 2003b), sequence comparison of the 1 strand in Periaxin’s PDZ domain with that of 
GRIP-1 PDZ6 and Shank1 PDZ domains provided clues as to the possible polar residues 
that might participate in hydrogen bonding in the dimeric conformation, such as 
threonine 23 (Fig. 49B). Substitution of T23 by an alanine (T23A) was predicted to 
disrupt hydrogen bonding in the dimeric interface of the Periaxin PDZ domain.  
Sequence alignment of PDZ domains from proteins that are known to dimerize 
showed that the aspartate residue in the 4 strand was highly conserved. This aspartate is 
crucial for stabilization of the -finger in the nNOS PDZ (Fig. 49B). Although there is 
no evidence that the Periaxin PDZ domain forms a -hairpin finger as in the nNOS PDZ 
domain (Hillier et al., 1999; Tochio et al., 2000), the highly conserved aspartate (D63) in 
the 4 strand may be critical for maintaining the canonical structure of the PDZ dimer. 
The aspartate was therefore selected for mutation in this study. 
The third mutant, which was used as a control, was a single amino acid 
substitution of the glycine in the carboxylate binding site to alanine (G31A). Despite the 
fact that substituting both the adjacent glycine (G31) and phenylalanine (F32) residues 
by alanines in the carboxylate binding loop of the Periaxin PDZ domain diminishes 
homodimerization (Sherman et al., 2001), previous work in our laboratory had suggested 
that mutating only one of these two amino acids, namely the conserved glycine residue 
did not alter PDZ-PDZ binding (unpublished data). Hence, the G31A mutation was used 
as an internal control. 
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Single amino acid mutant constructs (T23A, D63A and G31A) alongside the intact 
PDZ domain control construct in pGBKT7 were transformed into yeast and fusion 
proteins were expressed (Fig. 49A). Interaction of the Periaxin N-terminal region fusion 
protein with the G31A mutant fusion protein was positive for -gal activity, and the 
strength of interaction was comparable to that of the non-mutated PDZ domain control. 
On the contrary, neither the T23A nor D63A mutated fusion protein interacted with the 
bait PDZ domain fusion protein as shown by the absence of GAL4 transcription 
activation, suggesting the importance of these amino acids in PDZ domain 




Figure 49. Single amino acid mutations in Periaxin PDZ domain disrupt PDZ-PDZ 
binding. 
A. An immunoblot shows the yeast protein expression of single amino acid mutants 
(G31A, D63A and T23A) in pGBKT7 detected by the PeriN antibody. The 
molecular weights of the control and mutant PDZ constructs are 31 kDa.  
B. Substitution of threonine 23 in the 1 strand or aspartate 63 in the 4 strand of 
Periaxin PDZ domain by an alanine abrogates self-association of the PDZ 
domain. Interactions of the N-terminal PDZ domain of Periaxin (residues 2-164) 
with the PDZ-G31A, T23A and D63A (residues 2-103) mutations in vector 
pGBKT7 were assessed for -galactosidase activity in a yeast two-hybrid assay. 
Interaction results were confirmed using mutant constructs in pAS2-1. The G31A 
mutation was used as a control showing a positive interaction with the intact 
Periaxin N-terminus. The strength of the interaction was unaltered compared to 
the unmutated PDZ control. The amino acid sequence of the Periaxin PDZ 
domain (residues 15-65) is displayed. The positions of the amino acids mutated 
to alanine are denoted in red.  
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  To determine whether these single amino acid mutations would interrupt 
homodimerization in a cellular environment, full-length Periaxin was co-expressed with 
the full-length PDZ mutants in HEK 293 cells and interactions were tested by co-
immunoprecipitation. Expression of the constructs was confirmed by 
immunofluorescence analysis of transfected cells with anti-FLAG and anti-myc 
antibodies (data not shown). Similar to the non-mutated PDZ domain control, the myc-
tagged Periaxin G31A mutant was co-immunoprecipitated with FLAG-tagged Periaxin, 
confirming that glycine 31 in the carboxylate binding loop was not essential for 
homodimerization. In agreement with the yeast two-hybrid results (section 3.3.2), the 
myc-tagged Periaxin D63A mutant failed to bind FLAG-tagged Periaxin, indicating that 
the highly conserved aspartate (D63A) in the 4 strand was essential for 
homodimerization (Fig. 50). Mutation of the threonine residue in the 1 strand (T23A) 
of Periaxin also substantially reduced binding with full-length Periaxin (Fig. 50). These 








Figure 50. Full-length single amino acid Periaxin mutants D63A and T23A show 
reduction in homodimerization with full-length Periaxin in transfected HEK 293 
cells by co-immunoprecipitation.  
HEK293 cells transiently expressing myc-tagged single amino acid mutants and FLAG-
tagged full-length Periaxin were lysed. FLAG-tagged-Periaxin was immunoprecipitated 
using anti-FLAG M2 beads. Immunoprecipitates were analyzed by Western blot with 
anti-FLAG or anti-myc antibodies. In contrast to the G31A mutation control, the D63A 
mutant could not bind full-length Periaxin. Binding of the T23A mutant to Periaxin was 
significantly decreased. The relative protein expression levels of the transfected 
constructs are shown in the input lanes. 
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3.3.4 Summary 
In this chapter, I have shown by deletion mutant study in a yeast two-hybrid system that 
the 1 strand of Periaxin PDZ domain is important for dimerization. I have also 
identified specific amino acids critical for stabilizing the dimeric form of Periaxin PDZ 
domain, both by yeast two-hybrid interaction assays and co-immunoprecipitation. 
Homodimerization was considerably reduced by mutations of two amino acid residues, 
aspartate 63 and threonine 23. The highly conserved aspartate 63 in the 4 strand may 
contribute to homodimerization of the PDZ domain by virtue of formation of a salt 
bridge to maintain the structure of the dimer. Disruption of PDZ domain dimerization by 
mutation of the polar residue threonine 23 may suggest that the dimeric structure of the 
Periaxin PDZ domain is partly supported by hydrogen bonds formed by polar residues in 
the 1 strand.  
Although it cannot be excluded that inappropriate folding of mutant Periaxin 
lacking 116 amino acids is responsible for disrupting PDZ domain dimerization in vivo, 
these biochemical data point to the fact that introducing minimal changes in the protein 
structure of Periaxin by single amino acid mutations in the PDZ domain, thus bypassing 
protein misfolding, is sufficient to abolish homodimerization, further confirming the 







Diverse biological activities are regulated through protein-protein interactions in 
signaling cascades. These proteins often contain modular protein interaction domains, 
such as WW domains, Src homology (SH2 and SH3) domains, pleckstrin-homology 
(PH) domains and PDZ domains. PDZ domains are found in many proteins that localize 
to the plasma membrane and interact with the cytoplasmic tails of membrane proteins 
(Lee and Zheng, 2010). It has been suggested that PDZ domains have two major 
functions. First, PDZ proteins may serve as a scaffold that allows organization and 
assembly of multiprotein signaling complexes at specific sites of cytoplasmic surfaces 
(Kim and Sheng, 2004). Secondly, they may link transmembrane proteins with 
cytoskeletal elements, such as the actin cytoskeleton as has been proposed for human 
disc-large (Dlg) (Lue et al., 1994).  
 Periaxin has an N-terminal PDZ domain that is known to homodimerize in the 
Periaxin-DRP2 dystroglycan complex in Schwann cell appositions  (Sherman et al., 
2001). In this work, the function of the Periaxin PDZ domain and the role of 
dimerization were studied in the PNS of a mouse mutant lacking the N-terminus of 
Periaxin. The offspring of mice carrying the Prx gene in which exon 5 was floxed, 
crossed with a glial specific Cnp-Cre line (Lappe-Siefke et al., 2003) had originally been 
generated in order to eliminate Periaxin protein expression in Schwann cells. However, 
these mice synthesized a truncated form of Periaxin lacking the N-terminal PDZ domain 
after Cre-mediated recombination. This fortuitous outcome allowed me to specifically 
study the function of the PDZ domain of Periaxin in peripheral nerves. In the absence of 
the PDZ domain, Periaxin does not homodimerize. Schwann cells lack appositions and 
have reduced internodal lengths. Prx
fl/fl
/Cnp-Cre mice (known as PDZ-Prx mice in this 
study) develop a progressive peripheral neuropathy with prominent myelin folding and 
redundant myelin loops. In this section, I will discuss the importance of the dimerization 
of the Periaxin PDZ domain in the clustering of DRP2 and apposition maintenance. I 
will also speculate how the loss of Periaxin’s PDZ domain may contribute to a reduction 
of internodal length and dysregulation of myelin production.  
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4.1 GENERATION OF A CONDITIONAL MUTANT MOUSE LACKING THE 
PDZ DOMAIN OF PERIAXIN IN PERIPHERAL NERVES  
4.1.1 An N-terminal truncation of Periaxin through translation reinitiation at a 
downstream methionine 
The inability of the Periaxin specific N-terminus antibody to recognize immunoreactive 
Periaxin that was, nevertheless, detected by both the repeat region and C-terminus 
antibodies prompted me to investigate the possibility that protein synthesis is initiated at 
an internal methionine to generate an N-terminally truncated Periaxin in PDZ-Prx 
Schwann cells. Here I have shown that PDZ-Prx mice generated a partially functional 
truncated Periaxin lacking 116 amino acids at the N-terminus as a result of translation 
reinitiation. Following Cre-mediated recombination of the loxP sites in exon 5 of the Prx 
gene, an in-frame termination codon is introduced in exon 6, which was predicted to 
lead to a large frameshift gene deletion. However, by the mechanism of translation 
reinitiation, when a premature termination codon (PTC) follows shortly after the first 
initiation AUG codon, ribosomes may continue to scan along to reinitiate at downstream 
AUG codons in an optimal context (Kozak, 1984; Kozak, 1986a; Kozak, 1987b). In the 
recombined ‘floxed’ Prx mRNA, reinitiation was most favorable at the fourth AUG in 
exon 6 downstream of the in-frame stop codon. Translation reinitiated at this AUG 
produced a form of Periaxin lacking the N-terminal PDZ domain. This was verified by 
N-terminal Edman degradation sequencing.  
Transcripts with PTCs are prone to degradation by nonsense-mediated mRNA 
decay, resulting in low transcript levels (Maquat, 1995). Intriguingly, the abundance of 
the Periaxin transcript from PDZ-Prx peripheral nerves was not altered, indicating that 
the transcript yielded after recombination, albeit in the presence of a PTC, is resistant to 
nonsense-mediated mRNA decay (NMD) (section 3.1.2). Previous studies of the human 
triosephosphate isomerase, BRCA1, and -globin mRNA have shown that reinitiation 
downstream of a PTC will, at least partly, protect the transcript from NMD (Inacio et al., 
2004; Perrin-Vidoz et al., 2002; Zhang and Maquat, 1997). Translation reinitiation is 
likely to explain the failure of the frameshift stop codon in exon 6 of the Prx gene to 
trigger NMD, and thus does not undermine the stability of the recombined transcript. 
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This results in the generation of an N-terminally truncated protein of Periaxin in PDZ-
Prx nerves.  
The mutant Periaxin was, however, expressed at slightly reduced levels. The 
similarity of Periaxin transcript levels between WT and PDZ-Prx peripheral nerves 
excludes the possibility of changes in mRNA expression leading to the reduction in 
protein expression observed. One explanation for the reduced yield of mutant Periaxin  
may be the decline in the efficiency of reinitiation as the intercistronic distance between 
the minicistron (short translated sequence) upstream of the premature stop codon and the 
downstream translated sequence is exceedingly far apart, as proposed by Marilyn Kozak 
(Kozak, 1987b). 
4.1.2 Translation reinitiation of protein and hereditary disorders 
Several studies have demonstrated translation reinitiation in patients with inherited 
disorders, such as in Menkes disease, peroxisome-biogenesis disorder, methylmalonic 
acidemia and androgen resistance (Chang and Gould, 1998; Ledley, 1990; Paulsen et al., 
2006; Zoppi et al., 1993). A report on mutations in ATP7A gene, which cause Menkes 
disease, an X-linked recessive disorder of copper metabolism, has provided evidence 
that the generation of a partly functional Menkes protein from the NMD-resistant 
ATP7A transcript by translation reinitiation may modulate the disease phenotype. The 
patient carrying the N-terminally truncated protein displayed milder clinical symptoms 
and survived through adulthood (Paulsen et al., 2006). In addition, reinitiation of protein 
translation has been shown in individual patients suffering from peroxisome-biogenesis 
disorder or androgen resistance (Chang and Gould, 1998; Zoppi et al., 1993), which may 
or may not modulate the clinical phenotype. In this study, PDZ-Prx mice showed a less 
severe demyelinating neuropathy both morphologically and electrophysiologically than 
Periaxin-null mice. The moderation of the phenotypic symptoms in these mice may be 
attributed to the production of the partially functional Periaxin form by downstream 
reinitiation. 
Of the 16 Periaxin mutations reported in human patients up until now, most of 
the mutations occur in exon 7, with the exception of R82fsX96, which occurred in exon 
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6 resulting in a frameshift termination codon replacing a leucine residue at position 96 
(Marchesi et al., 2010; Takashima et al., 2002). The patient with the R82fsX96 mutation 
showed severe neuropathy with features not distinct from those observed in other 
patients carrying exon 7 mutations, such as proximal and distal muscle weakness and 
sensory ataxia, but surprisingly displayed normal sensory conduction velocities. The 
authors predicted that this mutation would abrogate protein translation due to NMD, 
resulting in a complete loss of Periaxin expression (Takashima et al., 2002). Although 
translation reinitiation has not been demonstrated in patients carrying human PRX 
mutations, the R82fsX96 mutation could, in principle, lead to the generation of an N-
terminally truncated protein by virtue of reinitiation at a downstream start codon. If this 
were the case, protein translation would initiate at the first AUG (M140) in exon 7 of the 
human Prx gene, which is in a favorable context, producing a form of Periaxin lacking 
the PDZ domain and a portion of the basic domain. PDZ dimerization of Periaxin should 
not occur. The predicted effect on the clinical phenotype may be similar to the less 
severe demyelinating neuropathy observed in PDZ-Prx mice.    
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4.2 CHARACTERIZATION OF PDZ-PRX MICE CONTAINING PERIAXIN 
LACKING THE PDZ DOMAIN IN PERIPHERAL NERVES 
4.2.1 DRP2 is depleted in the absence of the PDZ domain of Periaxin 
Dystrophin-related protein 2 (DRP2) is the only molecule that has been shown thus far 
to interact with Periaxin in the dystroglycan complex (DGC) found in the appositions 
between the abaxonal Schwann cell membrane and the outer layer of the myelin sheath 
(Sherman et al., 2001). Clustering of DRP2 to appositions requires Periaxin since DRP2 
is depleted and appears non-phosphorylated in Periaxin-null Schwann cells deficient of 
Periaxin (D. Sherman, personal communication). DRP2+ patches fail to form and 
appositions are disrupted (Sherman et al., 2001). In PDZ-Prx mice, mislocalization and 
depletion of DRP2 suggests that homodimerization of the Periaxin PDZ domain is 
essential for proper localization of DRP2 and stabilization of the PDG complex. 
Although the mutant Periaxin without the PDZ domain contains an intact basic domain, 
which interacts with DRP2 albeit at reduced levels, abrogation of PDZ domain 
homodimerization destabilizes its association with DRP2.  
Similar to Periaxin-null nerves, DRP2 is reduced in expression and exists 
primarily in the non-phosphorylated form in PDZ-Prx mice. How phosphorylation of 
DRP2 is regulated remains obscure. One plausible mechanism is that DRP2 
phosphorylation is facilitated by PDZ-PDZ dimerization of Periaxin, which might 
provide a clustered scaffold for recruitment and targeting of protein kinases to the 
vicinity of DRP2 for phosphorylation. In this context, when Periaxin homodimerization 
does not occur in the absence of the PDZ domain, the multimolecular scaffold is not 
assembled, perhaps due to a reduced ability of the truncated Periaxin protein to localize 
to patches. Hence, DRP2 is not phosphorylated and stays in the non-phosphorylated 
state, which renders it unstable and likely destined for proteasome-mediated 
degradation. Indeed components of dystroglycan complexes are known to be degraded 
by the proteasome (Bonuccelli et al., 2003; Gazzerro et al., 2010). PDZ domain protein 
interactions have been demonstrated to recruit protein kinases for phosphorylation of 
complex components in other signaling complexes, such as the SAP97-AKAP79-cAMP-
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dependent protein kinase complex (Gardner et al., 2007). In this complex, the PDZ 
domain at the carboxyl terminus of 1-adrenergic receptor binds to disc large Dlg/ 
SAP97, another PDZ domain-containing membrane-associated guanylate kinase 
(MAGUK) protein, which associates with AKAP79 and cyclic AMP-dependent protein 
kinase (PKA). The interaction brings PKA in close proximity with 1-AR for 
phosphorylation of the 1-AR at Ser312 that is required for efficient recycling of the 1-
AR.  
It is also likely that DRP2 is phosphorylated prior to association with Periaxin. 
Interaction with dimeric Periaxin stabilizes and maintains the phosphorylated form of 
DRP2 for proper targeting of DRP2 to patches and protecting it from dephosphorylation 
or subsequent proteasome-dependent degradation. In a similar fashion, the PDZ domain 
protein -syntrophin in the dystrophin protein complex plays a crucial role in 
stabilization of acetylcholine receptor clusters and localization of utrophin and nNOS at 
the neuromuscular junction (NMJ) (Adams et al., 2010; Adams et al., 2001). Specifically 
the PDZ domain of syntrophin is required for targeting of nNOS to the sarcolemma and 
postsynaptic NMJ (Adams et al., 2010; Adams et al., 2001). In Drosophila, Fasciclin II 
and Shaker potassium channels are localized to the NMJ and stabilized via PDZ domain 
interactions with Dlg, which selectively protects them from degradation (Zito et al., 
1997).  
Whether dimerization of Periaxin actively enhances DRP2 phosphorylation is 
unclear, it is, however, evident that the Periaxin PDZ domain dimer is important for 
stabilizing phosphorylated DRP2, since DRP2 no longer existed in the phosphorylated 
form when the PDZ domain of Periaxin was eliminated after the formation of Schwann 
cell compartments in adult Schwann cells by tamoxifen inducible recombination. In 
addition, it is worth noting that the interaction between Periaxin and DRP2 does not 
depend on the phosphorylated state of DRP2 because I have shown that a GST-DRP2 
fusion protein devoid of the potential phosphorylation sites was able to pull down 
Periaxin from normal nerves.  
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4.2.2 Stabilization of the PDG complex by Periaxin dimerization maintains 
appositions in the Schwann cell 
Myelinating Schwann cells are polarized radially and longitudinally for action potential 
propagation (Salzer, 2003). The cytoplasm of the Schwann cell is compartmentalized 
into discrete domains, called Cajal bands, which are formed between appositions. 
Appositions and Cajal bands harbor different DGCs (Albrecht et al., 2008; Court et al., 
2009). The DGC consisting of Periaxin, DRP2 and dystroglycan (PDG complex) found 
in appositions is required for Schwann cell compartmentalization. In the absence of 
Periaxin, appositions and Cajal bands are disrupted (Court et al., 2004; Sherman et al., 
2001). Here I have demonstrated that the self-association of the Periaxin PDZ domain in 
the PDG complex is required for apposition maintenance. In mutant mice lacking the 
Periaxin PDZ domain, most Schwann cells had no appositions and Cajal bands were 
disrupted. Therefore the PDZ domain protein Periaxin may be essential for maintaining 
cell polarity, as has been suggested to be a central role played by PDZ domain proteins. 
In Drosophila, ablation of the function of PDZ protein Scribble, an interactor of Dlg, 
leads to loss of cell polarity and tissue architecture (Bilder et al., 2000).  
  A recent report has suggested that the DGC composed of dystroglycan, utrophin 
in Cajal bands, together with laminin-2, is important for the regulation of cytoplasmic 
compartmentalization in the Schwann cell. Specific single deletion of dystroglycan, 
dystroglyan glycosylation, laminin-2 and utrophin in the Schwann cell results in a 
reduction in the size of DRP2+ patches and appositions (Court et al., 2009). However, a 
significant limitation of that study was that no information was provided about the strain 
backgrounds of the various mutants used. In a different study, the same group has also 
postulated that the size of Schwann cell domains is partly regulated by the degree of 
dystroglycan cleavage mediated by metalloproteases MMP2-9 in Schwann cells lacking 
laminin-2 (Court et al., 2011).  
Appositions are likely formed independently of the PDG complex, since it has 
been suggested that Schwann cell cytoplasm is separated into specific domains by actin 
cytoskeleton patterning thus restricting actin to Cajal bands prior to the appearance of 
DRP2+ patches. (Court et al., 2009). Hence, the PDG complex is assembled to maintain 
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Schwann cell compartments. The stability of DRP2+ patches and their structural 
correlate, appositions, appears to be exclusively regulated by Periaxin and is 
independent of the presence of dystroglycan in the plasma membrane. In Schwann cells 
lacking dystroglycan, DRP2 is present though reduced in expression (Saito et al., 2003), 
and appositions are formed despite being smaller in size (Court et al., 2009). 
Furthermore, expression of dystroglycan and other dystrophins (utrophin and Dp116) is 
normal in Periaxin-null mice (Sherman et al., 2001).  
 The mechanism by which Periaxin maintains appositions remains to be 
determined. A possibility is that the Periaxin PDZ homodimer helps stabilize the 
phosphorylated form of DRP2, which in turn stabilizes the PDG for proper maintenance 
of appositions. Interestingly, even after the Schwann cell compartments become 
established during myelination, these defined domains can be disrupted once PDZ 
domain homodimerization is abrogated in adult Schwann cells, as shown by the 
disruption of DRP+ patches and Cajal bands in tamoxifen-treated Prx
fl/fl
/P0CreERT 
mice. This further confirms the crucial role of Periaxin self-association in maintaining 
the PDG complex, and hence appositions. 
The PDZ scaffold of Periaxin may serve as a platform to target important 
signaling molecules that mediate compartmentalization of the Schwann cell 
cytoskeleton. Identifying other interactors of Periaxin would facilitate understanding of 
the role of Periaxin’s PDZ dimerization in apposition maintenance. In addition, in order 
to confirm that Periaxin regulates apposition stability through its PDZ domain, it would 
be important to examine whether appositions are present in Periaxin mutants lacking 
other domains, such as the C-terminal acidic domain. 
4.2.3 Regulation of Schwann cell internodal lengths by Periaxin 
4.2.3.1 Schwann cell compartmentalization and internodal length 
Similar to Periaxin-deficient Schwann cells, mutant Schwann cells lacking the PDZ 
domain of Periaxin in PDZ-Prx nerves display defects in elongation, resulting in a 
reduction in internodal lengths by one-third at 3 weeks of age. The decrease in Schwann 
cell longitudinal length is independent of changes in axon caliber or myelin thickness 
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since both parameters were unaltered in the mutant nerves. The longitudinal growth rate 
of PDZ-Prx Schwann cells remains lower than that of WT Schwann cells as axons 
extend with age, resulting in shorter internodal lengths also in the adult. How Schwann 
cell growth capacity is regulated remains unclear. A recent study has postulated that the 
degree of Schwann cell compartmentalization influences Schwann cell elongation (Court 
et al., 2009; Court et al., 2011). In Schwann cells with disrupted DGC in Cajal bands 
(Schwann cell-specific dystroglycan-null, laminin-2-null and utrophin-null mice), 
appositions are smaller, which has been associated with a reduction in Schwann cell 
internodal lengths.  
 Whether proper cytoplasmic compartmentalization regulates Schwann cell 
elongation capacity is controversial. Work in our laboratory has demonstrated that 
Schwann cell elongation is normal in DRP2-null mice that lack appositions (D. 
Sherman, personal communication). It appears that Periaxin influences Schwann cell 
extension through other yet unknown mechanisms. Proteomics analysis of PNS myelin 
content indicates that Periaxin is the second most abundant protein in peripheral myelin, 
comprising 16% of all myelin protein components. DRP2 constitutes about 0.18% of all 
PNS myelin proteins (Patzig et al., 2011). The abundance of Periaxin protein in 
peripheral nerves implies that Periaxin expression is not solely restricted to the PDG 
complex in appositions. It is possible that Periaxin localized elsewhere than appositions 
may regulate Schwann cell longitudinal extension by interacting with potential 
membrane proteins such as receptors, ion channels, or kinase and associated proteins via 
the PDZ domain. Certainly, Periaxin is not restricted to appositions, as DRP2 appears to 
be. Receptor and ion channel interactions have been reported in many PDZ domain 
proteins, such as PSD-95, -syntrophin, GRIP and Dlg (Adams et al., 2010; Gardner et 
al., 2007; Kornau et al., 1997; Luo et al., 2005).  
Interestingly, the effect of Periaxin on internodal growth is developmentally 
regulated. By replacing wild-type Periaxin with mutant Periaxin lacking the PDZ 
domain in adult Schwann cells of tamoxifen-inducible Prx
fl/fl
/P0CreERT mice, 
recombined Schwann cells had normal internodal lengths. This indicates that the 
influence of Periaxin (PDZ) on Schwann cell internodal growth is critical at early stages 
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of myelination. Once myelination is complete and Schwann cell compartments are well 
established, elimination of the Periaxin PDZ domain has no apparent effect on internodal 
length. 
4.2.3.2 Increase in the number of Schwann cells is proportionate with shortening 
of internodal lengths in PDZ-Prx nerves 
With a one-third reduction in Schwann cell internodal lengths, there should have been an 
increase in the number of Schwann cells and PDZ-Prx peripheral nerves harbor a 
proportionate excess of Schwann cell nuclei associated with myelinated axons, 
compared with normal nerves. Shortening of Schwann cell length has been described in 
PMP22-null mice at 3 weeks old, alongside abnormal myelin morphology (Neuberg et 
al., 1999). The authors proposed that PMP22 is implicated in early control of Schwann 
cell proliferation during development. It is unknown whether Periaxin plays a role in 
regulating Schwann cell proliferation in PNS development. As Periaxin mutant nerve 
fibers studied at all ages were completely populated by Schwann cells, this would 
suggest that Schwann cell proliferation prior to myelination before birth is not 
compromised.  
Since Schwann cell internodal lengths are comparable between WT and 
Periaxin-null mice at the onset of myelination (postnatal day 2) (Court et al., 2004), 
abnormally short internodes formed by Periaxin mutant Schwann cells during 
myelination implies that additional myelin-forming Schwann cells may be acquired from 
an existing pool of Schwann cells to associate with the growing axon. It is possible that 
non-myelinating Schwann cells, which have the potential to myelinate (Griffin and 
Thompson, 2008), proliferate to supply the additional cells needed to populate and 
myelinate axons in the Periaxin mutants. It has been shown that in the presence of 
exogenously administered GDNF, non-myelinating Schwann cells proliferate and are 
able to sort and myelinate normally unmyelinated small axons (Hoke et al., 2003). 
Expression of neuronal signal Neuregulin-1 type III in normally unmyelinated 
sympathetic neurons in vitro is also sufficient to instruct non-myelin forming Schwann 
cells to produce myelin (Taveggia et al., 2005). Proliferation assays using BrdU 
incorporation or other proliferation markers, alongside cell type specific markers, may 
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provide insights into the identity of the cell population that contributes to the surplus of 
myelinating Schwann cells in the Periaxin mutant nerves. 
4.2.3.3 Regulation of internodal length and cytoskeletal dynamics 
Control of Schwann cell longitudinal growth likely involves regulation of cytoskeletal 
dynamics. The microtubule network is disrupted in Cajal band-lacking Prx KO Schwann 
cells affecting mRNA transport to the paranodal regions (Court et al., 2004). It would be 
of interest to investigate whether Periaxin regulates Schwann cell elongation through 
Rho/Rho kinase (ROCK) signaling, which regulates myosin light chain phosphorylation, 
leading to the stimulation of myosin II activity and actin polymerization for forming 
stress fibers (Tapon and Hall, 1997). By inhibiting ROCK in Schwann cells in vitro, 
myelin segments are shorter (Melendez-Vasquez et al., 2004). The authors proposed that 
Rho/ROCK is important for organizing the movement of Schwann cell membrane 
around the axon during myelination. Another central regulator of the actin cytoskeleton 
is the Rho GTPase Rac1, which is activated by 1-integrin signaling and is essential for 
Schwann cell shape, process extension and stabilization during axonal sorting and 
myelination (Benninger et al., 2007; Nodari et al., 2007). 
4.2.4 Myelin abnormalities  
4.2.4.1 Hypermyelination with aberrantly folded myelin is a major morphological 
feature of PDZ-Prx peripheral nerves 
The mature myelin sheath of PDZ-Prx peripheral nerves is characterized by extensive 
infoldings and outfoldings, as well as focal paranodal thickenings. Paranodal tomacula 
were observed in over 70% quadriceps nerve teased fibers at 6 weeks old. Myelin 
foldings increased gradually in number and complexity with time. Redundant myelin 
loops invading the axon leading to axonal constrictions were frequently noted. However, 
PDZ-Prx mice develop a milder form of demyelinating neuropathy than that seen in 
Periaxin-null mice since major onion bulb formations in PDZ-Prx nerves were not 
pronounced. No secondary axonal loss was found in PDZ-Prx nerves up to the age of 9 
months (oldest age examined). Since abnormal overproduction of myelin renders the 
myelin sheath unstable, the appearance of myelin foldings and tomacula often precedes 
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demyelination and remyelination (Adlkofer et al., 1997; Maycox et al., 1997). Hence, 
the increased severity of the progressive neuropathy developed in PDZ-Prx mice may 
likely allow manifestation of the full development of the demyelinating neuropathy at 
ages older than 9 months.  
The presence of other structural domains in the truncated Periaxin, such as the C-
terminal acidic domain may account for the modulation of the morphological phenotype. 
Indeed, the C-terminus of Periaxin is crucial for myelin maintenance since severe 
demyelination and axonal loss has been described in the peripheral nerves of CMT 4F 
patients with the R1070X mutation in the PRX gene expressing a form of Periaxin 
protein without the acidic domain at the C-terminus (Kijima et al., 2004; Otagiri et al., 
2006; Parman et al., 2004). Analysis of Periaxin mouse mutants lacking the C-terminus 
may provide insights into the regulation of peripheral myelin production and stability, as 
well as whether demyelination is regulated differently from apposition formation and 
internodal lengths. In this light, the Periaxin PDZ domain may act as a modulator of the 
C-terminus function in maintaining myelin integrity.  
4.2.4.2 Schwann cell compartments and myelin stabilization 
It is unclear whether intact Schwann cell compartments such as Cajal bands contribute to 
maintaining myelin integrity. A speculation is that destabilization of the PDG complex, 
and thus disruption of appositions leads to myelin abnormalities. Nevertheless, PDZ-
Prx and Prx KO mutants, both with disruption of appositions and Cajal bands, exhibit 
different degrees of demyelination. Other mutants with disrupted DGC, and thus 
abnormal Schwann cell compartments including Schwann cell dystroglycan-knockout 
mice, and human patients with laminin-2 mutations display a rather mild dysmyelinating 
neuropathy with focally folded myelin (Di Muzio et al., 2003; Nodari et al., 2008; Saito 
et al., 2003). It seems unlikely that the lack of appositions is the cause of myelin 
instability and eventually destruction. This may suggest that apposition maintenance and 
myelin stability are likely regulated via independent mechanisms.  
Interestingly in the inducible conditional system, disruption of the Periaxin PDZ 
domain postnatally in Schwann cells after myelination is complete and Schwann cell 
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appositions and Cajal bands are established also leads to excessive folding of the myelin 
sheath and mild demyelinating and remyelinating phenotype, suggesting that the 
regulation of myelin maintenance by Periaxin is a late event and further confirming the 
requirement of Periaxin for a stable myelin sheath. Importantly, the finding that 
Schwann cell internodal length is normal in recombined Schwann cells of tamoxifen-
treated mice suggests that the regulatory role of Periaxin on Schwann cell longitudinal 
growth is independent of its function in myelin stability control.   
4.2.4.3 Increase in supernumerary Schwann cells in mature PDZ-Prx nerves 
A notable feature of PDZ-Prx nerves is the enlargement of nerve area as a result of an 
increase in endoneurial and perineurial space, as has been commonly described in 
human patients with the demyelinating form of CMT neuropathies (Donaghy, 2003) and 
dystroglycan-deficient mouse nerves (Saito et al., 2003).  This phenomenon is associated 
with the activation and proliferation of supernumerary Schwann cells, leading to the 
generation of extracellular matrix in the endoneurium (Kagitani-Shimono et al., 2008). 
Indeed, an increase in Schwann cell number was noted in both PDZ-Prx and Prx KO 
mutants, which could not be solely accounted for by the addition of Schwann cells due a 
shortening of internodal lengths. There was a striking increase in supernumerary 
Schwann cells lying in the endoneurial space outside the basal lamina of neighboring 
nerve fibers. Non-myelinating supernumerary Schwann cells were frequently seen 
enveloping abnormally or thinly myelinated axons in Periaxin mutant nerves.  
Demyelination results in active proliferation of Schwann cells. One source of 
dividing Schwann cells that give rise to supernumerary Schwann cells is the Schwann 
cells that have lost the myelin sheath (Hall and Gregson, 1974). Consistent with severe 
demyelination and the increase in ERK activation, which is sufficient to drive 
dedifferentiation of Schwann cells (Harrisingh et al., 2004), the total number of 
Schwann cells indicated by Sox10+ nuclei was elevated by fivefold in Prx KO nerves, 
alongside a threefold increase in Krox20+ cells representing myelin-forming Schwann 
cells, or those that are committed to myelination (Zorick et al., 1996a). In addition, the 
recruitment of Schwann cells of unmyelinated Remak fibers to proliferate may 
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contribute to the remarkable increase in non-myelinating Schwann cells in mature Prx 
KO nerves (Griffin et al., 1987; Griffin et al., 1990).  
Nevertheless, in PDZ-Prx nerves, the limited degree of demyelination would 
not be sufficient to explain the significant increase in Schwann cell number since 
dedifferentiation of Schwann cells would not be a major source of proliferating Schwann 
cells. In the case where demyelination is rare, supernumerary Schwann cells in the 
endoneurial space may be derived from proliferation of Schwann cells of unmyelinated 
fibers, as shown previously in an induced model of axonal swellings and paranodal 
demyelination (Griffin et al., 1987).  
4.2.4.4 Periaxin and a potential mechanism for regulation of myelin stabilization 
The pathological hallmark of extensively folded myelin sheaths, but relatively mild 
demyelination observed in PDZ-Prx mice is similar to the myelin alterations described 
in mouse models of other subtypes of CMT4, including MTMR2-null (CMT 4B1) mice 
and MTMR13-null (CMT 4B2) (Bolino et al., 2004; Bolis et al., 2005; Bonneick et al., 
2005; Robinson et al., 2008; Tersar et al., 2007). These mutant mice develop a 
progressive neuropathy exhibiting excessive myelin depositions as focally folded 
myelin; however, primary demyelination and remyelination are not evident. In MTMR2-
deficient mice, the disruption of the interaction between MTMR2 and PDZ domain 
protein mammalian discs large 1 (Dlg1), also known as synapse associated protein 97 
(SAP 97) has been attributed to the dysregulation of myelin membrane homeostasis, 
leading to aberrant myelin outfoldings (Bolino et al., 2004; Bolis et al., 2009). Dlg1, a 
multidomain scaffolding protein in the abaxonal domain, negatively controls myelin 
production by interacting with the adaxonal apical domain-protein phosphatase and 
tensin homolog (PTEN), which acts by inhibition of AKT activation (Cotter et al., 
2010). However, how these two components that are localized in distinct Schwann cell 
compartments interact in vivo is currently not understood. Loss of PTEN in Schwann 
cells results in hypermyelination in the PNS (Goebbels et al., 2010).  
The high frequency of myelin tomacula at the paranodes after postnatal week 3 
in teased fibers of PDZ-Prx quadriceps nerves prompted me to analyze levels of Dlg1, 
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which is preferentially enriched at the nodal/ paranodal regions (Bolino et al., 2004; 
Bolis et al., 2005). Unexpectedly, I observed an increased level of Dlg1 by 
immunofluorescence and Western blot analysis, in contrast to that described in 
MTMR2-deficient mutants (Bolino et al., 2004). In a recent report, the same group 
proposed a mechanism for coordination of myelin membrane homeostatic control by 
Dlg1, Sec8 and MTMR2. Dlg1 interacts with Sec8 exocyst component to promote 
membrane formation in Schwann cells in vitro, and with MTMR2 to oppose membrane 
addition (Bolis et al., 2009). Periaxin that is membrane-associated in the abaxonal 
domain of the myelinating Schwann cell may signal through the Dlg1/Sec8 complex 
localized in the same region, to regulate myelin membrane homeostasis. It may be 
possible that in PDZ-Prx mice, formation of redundant myelin folds is mediated by an 
upregulation of Dlg1/Sec8 complex that results in excessive membrane transport to the 
paranodes.  
Evidence from previous studies might support this model. In Drosophila, Dlg has 
been shown to promote membrane formation by interaction with t-SNARE Gtaxin at the 
postsynaptic junction during larvae development (Gorczyca et al., 2007). In another 
study, Dlg forms a complex with the integral membrane protein Stbm to promote 
membrane formation in Drosophila epithelial cells. More importantly, overexpression of 
the Dlg/Stbm complex in cells stimulates excessive formation of the plasma membrane, 
likely by increasing vesicle transport to these sites (Lee et al., 2003). In addition, Sec8 
has been shown to regulate oligodendrocyte morphology and membrane formation 
through targeting transport vesicles to sites of rapid membrane growth (Anitei et al., 
2006). Indeed, the balance between exocytosis and endocytosis of myelin proteins has 
been implicated in oligodendroglial membrane remodeling (Trajkovic et al., 2006; 
Winterstein et al., 2008).  
The abundant expression of Periaxin in the Schwann cell may suggest other yet 
unknown functions of the protein, one of which may be regulation of Dlg1 function. 
Further study of Dlg1 or the Dlg1/Sec8 complex in the Periaxin mutant mice is required. 
Moreover, identification of additional interactors of the Periaxin PDZ domain will 
facilitate understanding of its regulatory role in myelin sheath homeostasis in the PNS.   
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4.2.5 Electrophysiological analysis in PDZ-Prx mice 
4.2.5.1 Nerve conduction velocity is not altered in the presence of myelin foldings 
in adult PDZ-Prx nerves 
Axon caliber, myelin thickness, internodal length and nodal architecture are important 
determinants of conduction velocity in myelinated nerve fibers (Waxman, 1980). In 
classes of fibers showing geometric similarity, myelin thickness and internodal length 
vary linearly to axon diameter, which is proportional to conduction velocity (Hursh, 
1939; Rushton, 1951). How conduction velocity varies in response to changes in these 
parameters has been tested mathematically and experimentally. The reduction in nerve 
conduction velocity in Periaxin-deficient nerve fibers with shorter internodes is the first 
experimental evidence of the direct influence of internodal lengths in nerve conduction 
velocity, when all other parameters known to affect nerve conduction remain normal 
(Court et al., 2004). In the absence of the Periaxin N-terminal PDZ domain, mutant 
Schwann cell internodal lengths are shorter, resulting in decreased nerve conduction 
velocities at 3 weeks old. This result confirms the role of internodal lengths in nerve 
conduction regulation. Poorer motor coordination in PDZ-Prx mice determined by 
RotaRod performance further validates the electrophysiological abnormalities in mutant 
nerves at 3 weeks old.  
Intriguingly, I found that in the mature PNS, PDZ-Prx nerves with an 
aberrantly folded myelin sheath were able to conduct normally, despite the impairment 
of Schwann cell elongation. Normal conduction velocities in adult PDZ-Prx mice 
resulted in normal motor coordination. In PDZ-Prx mice, the presence of a functional 
truncated Periaxin, albeit lacking an important PDZ domain in Schwann cells seems to 
slow down the progression of myelin sheath destruction. Unlike in mature Prx KO 
nerves where severe demyelination leads to a reduced safety factor for normal 
transmission of action potentials and hence conduction delay or failure (Sircar, 2008), 
limited demyelination and absence of secondary axonal loss in PDZ-Prx nerves 
resulted in no effect on nerve conduction. Similarly, mouse mutants that display focally 
folded myelin and a mild demyelinating phenotype, such as connexin 32-, 
MTMR13/Sbf2- or MTMR2-mutant mice also exhibit minor electrophysiological 
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abnormalities and normal conduction velocities in mature nerves even up to advanced 
ages (Anzini et al., 1997; Bonneick et al., 2005; Tersar et al., 2007), suggesting that low 
level of demyelination is not sufficient to affect nerve conduction.  
However, it was perhaps surprising that the presence of myelin foldings and 
tomacula did not alter nerve conduction in adult PDZ-Prx mice. Theoretical and 
mathematical analysis of the effects of fiber size on conduction velocity in myelinated 
fibers suggested that myelin thickness measured in terms of g-ratio (axon diameter/ fiber 
diameter) should have an optimal value of 0.6-0.7 for maximum conduction velocity 
(Rushton, 1951; Smith and Koles, 1970). Changes in the g-ratio between 0.47 (for 
hypermyelinated fibers) and 0.74 (for hypomyelinated fibers) would lead to a reduction 
in nerve conduction velocity of not more than 5% (Rushton, 1951). Moreover, 
mathematical models have shown that for a fixed axon diameter, conduction velocity 
increases with myelin thickness (Smith and Koles, 1970). Experimentally the proximal 
stump fibers of crushed nerves during the early stage of regeneration have smaller axon 
diameters but thicker myelin sheaths than normal nerves. These regenerating fibers 
conduct considerably faster than normal fibers (Sanders and Whitteridge, 1946). 
Therefore, in PDZ-Prx mice the heterogeneity of myelin thickness along an internode 
due to focally folded myelin may not negatively affect nerve conduction. Nevertheless, 
axon compression by major myelin infoldings, as shown in MTMR13/Sbf2-null mice, 
influences compound muscle action potential (CMAP) amplitudes (not determined in 
this work) but not the conduction velocity per se (Tersar et al., 2007).  
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4.2.5.2 Sensitivity of nerve conduction velocity to internodal length change 
Computer simulations of conduction through myelinated nerve fibers have shown that 
nerve conduction velocity is sensitive to internodal lengths in the shorter range, but 
becomes less sensitive at longer Schwann cell lengths (Brill et al., 1977; Moore et al., 
1978). The development of a mild demyelinating phenotype in PDZ-Prx mice has 
proved to be extremely useful because it has allowed me to study experimentally the 
sensitivity of nerve conduction velocity to internodal length changes with age in detail.  
The normal nerve conduction of adult PDZ-Prx nerves, albeit with shorter 
internodes, is a result of Schwann cells having elongated sufficiently to allow for 
optimal conduction, alongside an increase in axon diameter and myelin thickness as the 
axon extends. I showed this by determining the conduction velocity of PDZ-Prx 
quadriceps nerves at an age between 3 weeks and 4 months. Schwann cells of 6-week-
old PDZ-Prx nerves had internodal lengths intermediary of those in 3-week and 4-
month-old mutant mice, corresponding to the conduction velocity at a value between 
those at 3 weeks and 4 months. A tendency towards increasing nerve conduction 
velocity was demonstrated with Schwann cell internodal growth over time in PDZ-Prx 
nerves, indicating that mutant Schwann cells had reached a threshold length for normal 
conduction of action potentials in the adult. Therefore, the internodal lengths of adult 
PDZ-Prx Schwann cells probably lie in the range in which mathematical models have 
been shown not to affect nerve conduction velocity. It is interesting to compare this with 
the results from a study of nerve conduction velocity in regenerated fibers by Sanders 
and Whitteridge. After regeneration, axon diameters and myelin sheath thickness regain 
their normal sizes, but internodal lengths are reduced and nerve conduction velocity is 
normal (Sanders and Whitteridge, 1946). The internodal lengths of regenerated fibers are 
in the range where conduction velocity is no longer sensitive to internodal length. 
As the phenotype of PDZ-Prx mice increases in severity with age, with more 
myelin foldings that contribute to severe axonal constrictions, as well as progressive 
myelin degeneration, PDZ-Prx mice at older ages (10 months old) showed a slowing of 
nerve conduction. 
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4.2.6 Periaxin and other signaling pathways 
I have also examined the expression of activated mTOR and a downstream signal S6 
ribosomal protein in the PI3K/AKT/mTOR signaling cascade in PDZ-Prx and Prx KO 
nerves. mTOR, best known for regulating cell growth and protein synthesis via the 
phosphorylation of downstream substrates p70 S6 kinase 1 (p70S6K1) and 4E-BP1 
(Guertin and Sabatini, 2009), is required for oligodendrocyte differentiation (Narayanan 
et al., 2009; Tyler et al., 2009). Activation of rapamycin-sensitive mTOR (mTORC1) 
mediated by AKT signaling has been implicated in the regulation of CNS myelination 
(Narayanan et al., 2009). Maximal activation of AKT is brought about by 
phosphorylation at Thr308 by the constitutively active phosphate-dependent kinase 
(PDK1), and at Ser473 by mTOR (rapamycin-insensitive mTORC2) (Calleja et al., 
2009; Iwanami et al., 2009). At postnatal week 3, activated mTOR levels were not 
altered in these nerves. Consistently, AKT phosphorylation at Ser473 was normal in 
both PDZ-Prx and Prx KO nerves. It remains to be determined whether levels of AKT 
phosphorylated at Thr308 are altered. 
Unexpectedly, phosphorylated S6 ribosomal protein, a substrate of mTOR’s 
downstream target p70S6K1 was upregulated in PDZ-Prx and Prx KO nerves at 3 
weeks old, with a more substantial increase in nerves from Prx KO mice. Since mTOR, 
the key regulator of p70S6K1, was not affected in the Periaxin mutants, the upregulation 
of activated S6 ribosomal protein may be mediated directly by PDK-1, and 
independently of the PI3K/AKT signaling. PDK1 regulates several other enzymes such 
as p70S6K1, PKC kinases and SGK that are involved in cancer growth, proliferation and 
survival (Bayascas, 2008; Iwanami et al., 2009; Mora et al., 2004). The elevated levels 
of activated S6 ribosomal protein in PDZ-Prx and Prx KO nerves may reflect an 
increase in proliferation, perhaps of unmyelinating and myelinating Schwann cells. It 
would be necessary to perform immunofluorescence analysis of these signaling 
molecules in Schwann cells to confirm the observations from Western blotting. Further 
investigation of these important signaling pathways is needed to define the mechanisms 
for regulation of internodal growth, cell proliferation and myelination in the Periaxin 
mutants. 
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4.2.7 A possible dimerization mechanism for the Periaxin PDZ domain 
Deletion of 116 amino acids (less than 10% of the protein) at the N-terminal PDZ 
domain of Periaxin may cause changes in the structure of the protein as well as 
removing the PDZ domain. Without the PDZ domain, Periaxin does not dimerize in 
vitro. In PDZ-Prx nerves, it would be difficult to rule out the possibility of protein 
misfolding leading to the loss of Schwann cell compartments. I have demonstrated by 
biochemical methods that introducing minimal changes in the structure of Periaxin 
protein using single amino acid substitutions in the PDZ domain is sufficient to abrogate 
Periaxin dimerization. Two amino acids in the Periaxin PDZ domain were identified to 
play essential roles in maintaining the dimeric structure of Periaxin. This supported the 
view that even subtle changes to the PDZ domain could undermine its function. 
Formation of a dimeric conformation requires the 1 strand of Periaxin’s PDZ 
domain. Specific disruption of the 1 strand affects Periaxin dimerization. Self-
association of the Periaxin PDZ domain is partly dependent on hydrogen bonding 
contributed by polar residues in the 1 strand, since substitution of polar threonine 23 by 
an alanine in the same strand results in attenuation of PDZ-PDZ binding. It remains to 
be determined whether the PDZ domain dimerizes via anti-parallel 1-1 strand 
interactions as described in GRIP PDZ6 and Shank1 PDZ (Im et al., 2003a; Im et al., 
2003b), or through 1 strand interaction with other secondary elements of the PDZ 
domain. In order to identify the structural basis for PDZ-domain mediated dimerization 
in Periaxin, it would be necessary to determine the crystal structure of the PDZ dimer. 
The highly conserved aspartate 63 in 4 strand is also required for establishment 
of the dimeric structure of Periaxin. The mechanism by which this residue contributes to 
PDZ-PDZ dimerization in Periaxin is not known. One possibility is that aspartate 63 
forms a salt bridge with another residue in the main body of the PDZ domain for 
stabilization of the Periaxin PDZ dimeric configuration, similar to that formed in nNOS 
PDZ of the nNOS/syntrophin and nNOS/PSD-95 heterodimers (Hillier et al., 1999; 
Tochio et al., 2000). To confirm the function of the PDZ domain in vivo, it would be 
necessary to generate a Periaxin mutant mouse that carries a single amino acid change, 




The function of homodimerization of PDZ domain proteins has not been well defined. 
Homodimerization of GRIP PDZ 6 has been suggested to facilitate the PDZ domains to 
simultaneously interact with multiple ligands to form a network (Im et al., 2003b). In 
this thesis, I have studied the role of the Periaxin N-terminal PDZ domain and its 
dimerization in myelinating Schwann cells of the PNS.  
By characterizing a conditional mouse mutant expressing a version of Periaxin 
lacking the N-terminal PDZ domain in peripheral nerves, I have shown that 
homodimerization of the Periaxin PDZ domain is required for maintaining cytoplasmic 
compartments, namely Cajal bands and appositions. The PDZ domain of Periaxin is also 
required for Schwann cell elongation and establishment of extensive myelinated 
segments around the axon, which in turn regulates the speed of action potential 
propagation. In mature peripheral nerves, myelin production is dysregulated in the 
absence of the Periaxin PDZ domain in Schwann cells, indicating its importance in 
myelin sheath maintenance. Disrupting Periaxin homodimerization in Schwann cells 
after myelination is accomplished and Schwann cell compartments established also 
destabilizes the complex Periaxin associates with, and causes myelin abnormalities. This 
work suggests that the regulation of Schwann cell elongation and myelin stability may 
be through independent mechanisms. 
Finally, I have shown by biochemical means that introducing subtle changes in 
the Periaxin PDZ domain structure could attenuate its dimerization capacity. I have also 
suggested a possible mechanism for the homodimerization of the Periaxin PDZ domain.   
Collectively, these findings highlight the crucial role of the protein interacting 
PDZ domain of Periaxin in regulating Schwann cell function. Future studies in 
identifying other interacting partners of the Periaxin PDZ domain, perhaps elsewhere 
than at appositions, will facilitate understanding of the underlying mechanisms by which 




4.4 FUTURE WORK 
 
Specific deletion of the N-terminal PDZ domain of Periaxin in Schwann cells 
phenocopies the defects in Schwann cell compartmentalization as well as longitudinal 
growth described in complete Periaxin-null mutants (Court et al., 2004). In the absence 
of the Periaxin PDZ domain, the myelin sheath becomes unstable and mutant mice 
develop a peripheral neuropathy characterized by abnormal myelin folding and 
redundant myelin loops. Nevertheless, the myelin abnormalities in PDZ-Prx mice are 
less severe than the demyelinating phenotype in Prx KO mice. How does Periaxin 
regulate Schwann cell elongation and myelin stability? Indeed, this work has revealed 
the requirement of Periaxin’s PDZ domain dimerization for these functions. As 
mentioned, it would be essential to identify other protein binding partners of the Periaxin 
PDZ domain. Perhaps one possible way is to search for binding partners of the dimeric 
PDZ domain of Periaxin in a yeast two-hybrid screen. 
 Determining the downstream signaling cascades of Periaxin would also facilitate 
the understanding of the mechanisms of internodal length regulation and control of 
myelin production. For this, I examined various signaling pathways that have been 
implicated in regulating cell growth and myelin production. Further investigation into 
the role of Dlg1 in myelin membrane homeostasis in the Periaxin mutants will be 
required. In addition, detailed examination of the AKT/mTOR pathway, as well as 
downstream targets such as S6 kinase, in cell growth control in the Periaxin mutants 
would be necessary. Furthermore, it would be important to understand how the normal 
Periaxin-DRP2 complex may interact with extracellular ligands in the basal lamina in 
maintaining Schwann cell-axon integrity.  
 Besides the PDZ domain, other domains of Periaxin such as the basic domain 
that binds DRP2, and the C-terminal acidic domain may play distinct roles in the 
regulatory function of Periaxin, such as control of myelin stability and targeting of 
DRP2. Studying Periaxin mutants lacking these individual domains would help to 
understand Periaxin’s function in myelinating Schwann cells. 
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 Finally, since minimal disruption of the PDZ domain structure has been proven 
to effectively abrogate PDZ-PDZ dimerization of Periaxin, it would be interesting to 
generate and analyze a mouse mutant containing a full-length Periaxin with a mutated 
PDZ domain in order to confirm the current findings in the role of Periaxin’s PDZ 
domain. One possible single amino acid mutation would be substituting aspartate 63 
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